<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia - Jones, C - 2018 | Cochrane Library</title> <meta content="Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia - Jones, C - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007964.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia - Jones, C - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007964.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007964.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia" name="citation_title"/> <meta content="Christopher Jones" name="citation_author"/> <meta content="University of Birmingham" name="citation_author_institution"/> <meta content="c.a.jones@bham.ac.uk" name="citation_author_email"/> <meta content="David Hacker" name="citation_author"/> <meta content="Birmingham and Solihull Mental Health Foundation NHS Trust" name="citation_author_institution"/> <meta content="Jun Xia" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Alan Meaden" name="citation_author"/> <meta content="Birmingham and Solihull Mental Health Foundation NHS Trust" name="citation_author_institution"/> <meta content="Claire B Irving" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Sai Zhao" name="citation_author"/> <meta content="The Ingenuity Centre, The University of Nottingham" name="citation_author_institution"/> <meta content="Jue Chen" name="citation_author"/> <meta content="Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine" name="citation_author_institution"/> <meta content="Chunhu Shi" name="citation_author"/> <meta content="University of Manchester, Manchester Academic Health Science Centre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD007964.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/12/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007964.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007964.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007964.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Ambulatory Care; Cognitive Behavioral Therapy [*methods]; Combined Modality Therapy [methods]; Patient Readmission [statistics &amp; numerical data]; Patient Satisfaction; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Schizophrenia [mortality, *therapy]; Schizophrenic Psychology; Social Behavior" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007964.pub2&amp;doi=10.1002/14651858.CD007964.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="UDgTyLGV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007964\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007964\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ms","ja","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007964.pub2",title:"Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia",firstPublishedDate:"Dec 20, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007964.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007964.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007964.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007964.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007964.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007964.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007964.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007964.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007964.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007964.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10713 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007964.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0430"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0111"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-sec-0416"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/appendices#CD007964-sec-0440"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/table_n/CD007964StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/table_n/CD007964StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Christopher Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0003">David Hacker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0004">Jun Xia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0005">Alan Meaden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0006">Claire B Irving</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0007">Sai Zhao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0008">Jue Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information#CD007964-cr-0009">Chunhu Shi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information/en#CD007964-sec-0443">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 December 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007964.pub2">https://doi.org/10.1002/14651858.CD007964.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007964-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007964-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007964-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007964-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007964-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007964-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007964-abs-0001" lang="en"> <section id="CD007964-sec-0001"> <h3 class="title" id="CD007964-sec-0001">Background</h3> <p>Cognitive behavioural therapy (CBT) is a psychosocial treatment that aims to re‐mediate distressing emotional experiences or dysfunctional behaviour by changing the way in which a person interprets and evaluates the experience or cognates on its consequence and meaning. This approach helps to link the person's feelings and patterns of thinking which underpin distress. CBT is now recommended by the National Institute for Health and Care Excellence (NICE) as an add‐on treatment for people with a diagnosis of schizophrenia. This review is also part of a family of Cochrane CBT reviews for people with schizophrenia. </p> </section> <section id="CD007964-sec-0002"> <h3 class="title" id="CD007964-sec-0002">Objectives</h3> <p>To assess the effects of cognitive behavioural therapy added to standard care compared with standard care alone for people with schizophrenia. </p> </section> <section id="CD007964-sec-0003"> <h3 class="title" id="CD007964-sec-0003">Search methods</h3> <p>We searched the Cochrane Schizophrenia Group's Trials Register (up to March 6, 2017). This register is compiled by systematic searches of major resources (including AMED, BIOSIS CINAHL, Embase, MEDLINE, PsycINFO, PubMed, and registries of clinical trials) and their monthly updates, handsearches, grey literature, and conference proceedings, with no language, date, document type, or publication status limitations for inclusion of records into the register. </p> </section> <section id="CD007964-sec-0004"> <h3 class="title" id="CD007964-sec-0004">Selection criteria</h3> <p>We selected all randomised controlled clinical trials (RCTs) involving people diagnosed with schizophrenia or related disorders, which compared adding CBT to standard care with standard care given alone. Outcomes of interest included relapse, rehospitalisation, mental state, adverse events, social functioning, quality of life, and satisfaction with treatment.We included studies fulfilling the predefined inclusion criteria and reporting useable data. </p> </section> <section id="CD007964-sec-0005"> <h3 class="title" id="CD007964-sec-0005">Data collection and analysis</h3> <p>We complied with the Cochrane recommended standard of conduct for data screening and collection. Where possible, we calculated relative risk (RR) and its 95% confidence interval (CI) for binary data and mean difference (MD) and its 95% confidence interval for continuous data. We assessed risk of bias for included studies and created a 'Summary of findings' table using GRADE. </p> </section> <section id="CD007964-sec-0006"> <h3 class="title" id="CD007964-sec-0006">Main results</h3> <p>This review now includes 60 trials with 5,992 participants, all comparing CBT added to standard care with standard care alone. Results for the main outcomes of interest (all long term) showed no clear difference between CBT and standard care for relapse (RR 0.78, 95% CI 0.61 to 1.00; participants = 1538; studies = 13, low‐quality evidence). Two trials reported global state improvement. More participants in the CBT groups showed clinically important improvement in global state (RR 0.57, 95% CI 0.39 to 0.84; participants = 82; studies = 2 , very low‐quality evidence). Five trials reported mental state improvement. No differences in mental state improvement were observed (RR 0.81, 95% CI 0.65 to 1.02; participants = 501; studies = 5, very low‐quality evidence). In terms of safety, adding CBT to standard care may reduce the risk of having an adverse event (RR 0.44, 95% CI 0.27 to 0.72; participants = 146; studies = 2, very low‐quality evidence) but appears to have no effect on long‐term social functioning (MD 0.56, 95% CI ‐2.64 to 3.76; participants = 295; studies = 2, very low‐quality evidence, nor on long‐term quality of life (MD ‐3.60, 95% CI ‐11.32 to 4.12; participants = 71; study = 1, very low‐quality evidence). It also has no effect on long‐term satisfaction with treatment (measured as 'leaving the study early') (RR 0.93, 95% CI 0.77 to 1.12; participants = 1945; studies = 19, moderate‐quality evidence). </p> </section> <section id="CD007964-sec-0007"> <h3 class="title" id="CD007964-sec-0007">Authors' conclusions</h3> <p>Relative to standard care alone, adding CBT to standard care appears to have no effect on long‐term risk of relapse. A very small proportion of the available evidence indicated CBT plus standard care may improve long term global state and may reduce the risk of adverse events. Whether adding CBT to standard care leads to clinically important improvement in patients' long‐term mental state, quality of life, and social function remains unclear. Satisfaction with care (measured as number of people leaving the study early) was no higher for participants receiving CBT compared to participants receiving standard care. It should be noted that although much research has been carried out in this area, the quality of evidence available is poor ‐ mostly low or very low quality and we still cannot make firm conclusions until more high quality data are available. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007964-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007964-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007964-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007964-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007964-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007964-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007964-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007964-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007964-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007964-abs-0005" lang="en"> <h3>Is Cognitive behavioural therapy as effective as standard care for people with schizophrenia</h3> <p><b>Background</b> </p> <p>People with serious mental illnesses such as schizophrenia can experience severe disturbances in their thought processes, which may lead to delusions (beliefs that are not based on reality) and hallucinations (seeing and hearing things that are not really there). The mainstay (provides most support for the condition) treatment for schizophrenia is antipsychotic medication, but these medications are not always successful on their own and additional treatments such as psychosocial therapies (including cognitive behavioural therapy (CBT)) are recommended for people with schizophrenia. CBT aims to help people re‐evaluate their views of their symptoms. This process is thought to help reduce distress and change behaviours. It is often used to help people with illnesses such as anxiety and depression. However, CBT is expensive and the evidence for its effectiveness is not clear, particularly for people with schizophrenia. </p> <p><b>Searches</b> </p> <p>The Information Specialist of Cochrane Schizophrenia searched the specialised register for trials that allocated people with schizophrenia to receive either CBT or standard care (the care the participant would normally receive for their condition, in the area the trial was conducted), up to March 2017. These searches found 1730 records. The review authors inspected and screened these records. </p> <p><b>Main results</b> </p> <p>After screening search results we were able to include 60 trials with 5992 participants. These studies randomly allocated people with schizophrenia to receive either CBT as an add‐on treatment to their standard care or standard care alone. The quality of evidence for our main outcomes of interest was mainly very low, or at best, low. Results showed that adding CBT to standard care did not appear to affect the long‐term risk of relapse. Only two trials (82 participants) provided useful data for long‐term global state; these data showed CBT could be better for long‐term improvement in global state than standard care alone. Adding CBT to standard care may reduce the risk of adverse events but appears to have no advantage over standard care for improving long‐term mental state. Whether adding CBT to standard care improves patient quality of life or social function also remains unclear. </p> <p><b>Conclusions</b> </p> <p>Currently, the evidence available is unclear and not robust enough to make firm conclusions about the effectiveness of adding CBT to standard care for people with schizophrenia compared to standard care alone. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007964-sec-0430" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007964-sec-0430"></div> <h3 class="title" id="CD007964-sec-0431">Implications for practice</h3> <section id="CD007964-sec-0431"> <section id="CD007964-sec-0432"> <h5 class="title">1. For people with schizophrenia</h5> <p>Becoming involved in an additional CBT programme is a big commitment for people with schizophrenia but, the moderate‐quality evidence for people leaving the study early in this review suggests that this is acceptable. Having CBT might help people with schizophrenia to avoid (the often damaging) relapses, and could help mental state.There is no convincing evidence that there will be any effect on social functioning or quality of life. </p> <p>In any event, people with schizophrenia, if offered this therapy, should know that any effects are likely to be modest in degree. If offered inclusion in a trial, people with schizophrenia could insist in ensuring study outcomes truly reflect their needs and that their data are accessible to all once the trial is completed. </p> </section> <section id="CD007964-sec-0433"> <h5 class="title">2. For clinicians</h5> <p>If a skilled CBT therapist is available, adding this approach to standard care might reduce negative outcomes such as relapse, even in the long term, without putting off the person attending care. However, the investment for any modest benefit is considerable. We think it unlikely that the findings of this review would encourage many to instigate programmes of CBT for people with schizophrenia. </p> </section> <section id="CD007964-sec-0434"> <h5 class="title">3. For policy makers</h5> <p>All important evidence in this review is of low‐ or very low‐quality ‐ or non‐existent. These data are not strong enough to support encouragement of wide use of additional CBT of the sort reviewed in this work ‐ even if resources are infinite. </p> </section> </section> <h3 class="title" id="CD007964-sec-0435">Implications for research</h3> <section id="CD007964-sec-0435"> <section id="CD007964-sec-0436"> <h5 class="title">1. General</h5> <p>There could have been more information to report should there have been some sort of concordance on outcomes and generosity in sharing data. This review alone provides strong argument for the work of the <a href="http://www.comet-initiative.org/" target="_blank">COMET</a> and <a href="http://www.alltrials.net/" target="_blank">ALLTRIALS</a> initiatives. </p> </section> <section id="CD007964-sec-0437"> <h5 class="title">2. Specific to cognitive behavioural therapy trials</h5> <p>We are genuinely unsure if more trials are really needed. Although data are not good, it would seem unlikely that large better studies would fully overturn the findings of this review. However, should that argument be being made, we have given thought to the design for future trials (<a href="#CD007964-tbl-0009">Table 8</a>). </p> <div class="table" id="CD007964-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Suggested design of study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: randomised, fully explicit description of methods of randomisation and allocation concealment.<br/> Blinding: single, tested.<br/> Setting: community rather than hospital.<br/> Duration: 12 weeks treatment, and then follow‐up to at least 52 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: schizophrenia (ICD).<br/> N = 300.*<br/> Age: adults.<br/> Sex: both. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Cognitive behaviour therapy plus standard care. N = 150.</p> <p>Content:</p> <p> <ul id="CD007964-list-0071"> <li> <p>a discrete psychological intervention, which is in addition to, and separate from, other therapeutic interventions (for example, behavioural family therapy) and </p> </li> <li> <p>recipients establish links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour, and </p> </li> <li> <p>the re‐evaluation of their perceptions, beliefs or reasoning relating to the target symptoms; this may include the re‐evaluation of specific 'inferential' beliefs or more global 'evaluative' beliefs. </p> </li> </ul> </p> <p>Delivered by: experienced therapists.</p> <p>2. Other psychosocial therapy plus standard care . N = 150.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General: time to all‐cause treatment failure marked by its discontinuation, relapse/rehospitalisation, general impression of clinician (CGI), carer/other, compliance with treatment.<br/> Mental state: BPRS and PANSS.<br/> Global state: CGI (Clinical Global Impression).<br/> Quality of life. QOL (Quality of Life Questionnaire).<br/> Social functioning: return to everyday living for 80% of time.*<br/> Economic outcomes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* Powered to be able to identify a difference of ˜ 20% between groups for primary outcome with adequate degree of certainty. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BPRS = Brief Psychiatric Rating Scale<br/> CGI = <br/> ICD = International Classification of Diseases<br/> PANSS = Positive and Negative Syndrome Scale<br/> QOL = </p> </div> </div> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007964-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007964-sec-0029"></div> <div class="table" id="CD007964-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">COMPARISON 1: CBT+ STANDARD CARE compared to STANDARD CARE ALONE for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COMPARISON 1: CBT+ STANDARD CARE compared to STANDARD CARE ALONE for people with schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/> <b>Setting:</b> inpatient and outpatient<br/> <b>Intervention:</b> CBT+ standard care<br/> <b>Comparison:</b> Standard care alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with STANDARD CARE ALONE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with COMPARISON 1: CBT+ STANDARD CARE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: 1a. Relapse ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.78<br/> (0.61 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1538<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>260 per 1,000<br/> (203 to 333) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: 2. Clinically important change (no improvement) ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.57<br/> (0.39 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>82<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>750 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>428 per 1,000<br/> (293 to 630) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mental state: General ‐ clinically important change (no improvement) ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.81<br/> (0.65 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>501<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>423 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>343 per 1,000<br/> (275 to 431) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: General: any adverse event</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.44<br/> (0.27 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>146<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>432 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1,000<br/> (117 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: Social (average endpoint score SOFAS, high = good) ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.56 higher<br/> (2.64 lower to 3.76 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>295<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The predefined outcome: 'Functioning: clinically important change in social functioning' was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: General (average endpoint score QLS, high = good) ‐ long term *</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.6 lower<br/> (11.32 lower to 4.12 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* The predefined outcome of importance: 'Quality of life: clinically important change was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Satisfaction with treatment: 1. Leaving the study early ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.77 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1945<br/> (19 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>184 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1,000<br/> (141 to 206) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to heterogeneity. </p> <p><sup>2</sup> Downgraded one level due to imprecision: confidence interval of the effect estimation includes both appreciable benefit and harm. </p> <p><sup>3</sup> Downgraded one level due to study limitations: several bias domains were of high or unclear risk, including blinding of trialists and participants (high risk) and random sequence generation and allocation concealment (unclear risk). </p> <p><sup>4</sup> Downgraded two levels due to imprecision: very small sample size and very low number of events </p> <p><sup>5</sup> Downgraded one level due to imprecision: low number of events. </p> <p><sup>6</sup> Downgraded one level due to indirectness: average scale scores used to measure outcome, not clinically important change. </p> <p><sup>7</sup> Downgraded one level due to indirectness: leaving the study early used to predict satisfaction with treatment. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007964-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007964-sec-0030"></div> <section id="CD007964-sec-0031"> <h3 class="title" id="CD007964-sec-0031">Description of the condition</h3> <p>Schizophrenia is a serious mental illness affecting one per cent of the population, irrespective of culture, class, or race. It varies in its severity and in range of symptoms. Every year, one person per 10,000 falls ill with schizophrenia, making it about twice as common as epilepsy (<a href="./references#CD007964-bbs2-0193" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Association, 1995. ">APA 1995</a>). The first episode of schizophrenia often occurs when a person is in their early twenties (<a href="./references#CD007964-bbs2-0281" title="World Health Organization. Report of the International Pilot Study of Schizophrenia. WHO. ">WHO 1973</a>) and the course of the illness is variable. Many people experience considerable disability and there is a substantial increase in mortality (<a href="./references#CD007964-bbs2-0214" title="DrakeRE , CottonPG . Depression, hopelessness and suicide in chronic schizophrenia. British Journal of Psychiatry1986;148:554. ">Drake 1986</a>). Some people have difficulties with their thoughts, making illogical associations and developing false and sometimes bizarre explanations for their feelings (delusions). Hallucinations may occur, for example, hearing voices or seeing visions. Difficulties with concentration, attention, and motivation may also lead to poor social and occupational functioning. The range of emotional expression, capacity to think and behave appropriately may be reduced, together with a reduced ability to experience pleasure. It is customary to view the symptoms of schizophrenia as falling into two broad categories: (i) 'positive' symptoms, which are unusual by their presence (for example, hearing voices); and (ii) 'negative' symptoms, which are unusual by their absence (for example, restricted range and intensity of emotional expression). </p> </section> <section id="CD007964-sec-0032"> <h3 class="title" id="CD007964-sec-0032">Description of the intervention</h3> <p>Medication is the mainstay of treatment for schizophrenia, but 5% to 25% of people continue to experience symptoms in spite of medication (<a href="./references#CD007964-bbs2-0204" title="ChristisonGW , KirchDG , WyattRJ . When symptoms persist: choosing among alternative somatic symptoms for schizophrenia. Schizophrenia Bulletin1991;17:217‐45. ">Christison 1991</a>; <a href="./references#CD007964-bbs2-0207" title="DavisJM , CasperR . Antipsychotic drugs: clinical pharmacology and therapeutic use. Drugs1977;14:260‐82. ">Davis 1977</a>; <a href="./references#CD007964-bbs2-0254" title="MeltzerHY . Treatment of the neuroleptic‐nonresponsive schizophrenic patient. Schizophrenia Bulletin1992;18:515‐42. ">Meltzer 1992</a>) and may experience side effects that are unwanted and unpleasant. </p> <p> <ol id="CD007964-list-0001"> <li> <p>Talking therapies are often used in addition to medication. In cognitive behaviour therapy (CBT), links are made between the person's feelings and patterns of thinking which underpin their distress. The participant is encouraged to take an active part by using the following techniques.People are encouraged to establish links between their thoughts, feelings or actions and their current or past symptoms, and/or functioning. It should promote re‐evaluation of people's perceptions, beliefs or reasoning related to the target symptoms and include at least one of the following: people monitoring their own thoughts, feelings or behaviours with respect to their symptoms or recurrence of symptoms promoting alternative ways of coping with the target symptom reducing distress improving functioning.Examining and disputing the evidence for and against the problematic and/or distressing beliefs and reasons for maintaining problematic behaviours. </p> </li> <li> <p>Examining and disputing the evidence for and against the problematic and/or distressing beliefs and reasons for maintaining problematic behaviours. </p> </li> <li> <p>Using reasoning abilities and personal experience to develop rational, useful and personally acceptable alternative explanations and interpretations (<a href="./references#CD007964-bbs2-0188" title="AlfordBA , BeckAT . Cognitive therapy of delusional beliefs. Behaviour Research and Therapy1994;32:369‐80. ">Alford 1994</a>); and to test these alternative explanations and abandon associated safety behaviours in real‐world situations. <a href="./references#CD007964-bbs2-0272" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry1993;162:524‐32. ">Tarrier 1993</a> has also stressed the beneficial effects of enhancing coping strategies and general problem‐solving skills. </p> </li> </ol> </p> <p>We note that the above description of CBT is consistent with that within the National Institute for Health and Care Excellence (NICE) guidance for CBT‐P (<a href="./references#CD007964-bbs2-0259" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018). ">NICE 2014</a>). NICE guidance proposes that CBT should be delivered on a one‐to‐one basis over at least 16 planned sessions (where typically each session lasts between 30 minutes to 60 minutes and occurs weekly or fortnightly) and follow a treatment manual. </p> <p>During the evolution of CBT for schizophrenia, a variety of interventions have been labelled as CBT. We note that not all of these interventions specifically target beliefs (e.g. psychoeducation, relapse prevention, symptom‐focused coping strategies, etc.), and it is difficult to provide a single, unambiguous definition of the interventions which can be included under the rubric of CBT. Many of the trials of CBT for psychosis have incorporated additional active therapeutic elements (e.g. psychoeducation and relapse prevention, etc.) that would be considered adjunctive to techniques which are specifically targeted at eliciting beliefs and behavioural changes (e.g. guided discovery or behavioural experiments). In recognition, the review authors have constructed criteria that are felt to be workable and to capture the elements of good practice in CBT. These criteria are described below. </p> </section> <section id="CD007964-sec-0033"> <h3 class="title" id="CD007964-sec-0033">How the intervention might work</h3> <p>CBT aims to re‐mediate distressing emotional experiences or dysfunctional behaviour by changing the way in which the individual interprets and evaluates the experience or cognates on its consequence and meaning. CBT encourages the person to identify and challenge biased interpretations of experiences that may be maintaining symptoms. </p> </section> <section id="CD007964-sec-0034"> <h3 class="title" id="CD007964-sec-0034">Why it is important to do this review</h3> <p>Despite national treatment guidelines recommending CBT as an adjunct therapy for serious mental illness (<a href="./references#CD007964-bbs2-0259" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018). ">NICE 2014</a>), CBT is still not as widely available for people with schizophrenia as it is for people with other disorders (for example, depression and panic disorder). </p> <p>The first case report of CBT for delusional beliefs in 1952, reported by <a href="./references#CD007964-bbs2-0198" title="BeckAT . The current state of cognitive therapy. Archives of General Psychiatry2005;62:953‐9. ">Beck 2005</a>, did not lead to widespread development of CBT for schizophrenia or its symptoms. Psychological interventions have become more widely accepted over the past two decades and are now seen as part of a comprehensive set of routine interventions in the treatment and management of schizophrenia (<a href="./references#CD007964-bbs2-0259" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018). ">NICE 2014</a>). However, the availability of CBT and other evidence‐based therapies in the NHS is extremely limited. The 2012 National Audit reveals that 34% had not been offered psychological therapy, with 20% waiting over a year (<a href="./references#CD007964-bbs2-0265" title="Royal College of Psychiatrists. Report of the National Audit of Schizophrenia (NAS) 2012. London: Healthcare Quality Improvement Partnership. ">Royal College of Psychiatrists 2012</a>). The delivery of CBT to people with schizophrenia also depends upon having a commitment from health service managers to support and facilitate training and supervision (<a href="./references#CD007964-bbs2-0274" title="TurkingtonD , DudleyR , WarmanDM , BeckAT . Cognitive‐behavioral therapy for schizophrenia: a review. Journal of Psychiatric Practice2004;10(1):5‐16. ">Turkington 2004</a>). </p> <p>Since the publication of the original Cochrane Review entitled Cognitive behavioural therapy for schizophrenia (<a href="./references#CD007964-bbs2-0242" title="JonesC , CormacI , MotaJ , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524.pub2] ">Jones 2004</a>), there has been a substantial increase in the number of published and relevant randomised controlled trials (RCTs), and a refinement in the definition and working models of CBT. In addition, there has also been a diversification of research, with trials not only assessing overall effectiveness of CBT but investigating more specific aspects of CBT. It was necessary to update and split the original review on CBT to create a family of CBT reviews (<a href="./references#CD007964-bbs2-0243" title="JonesC , CormacI , CampbellC , MeadenA , HackerD , IrvingCB . Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007965] ">Jones 2009a</a> and <a href="./references#CD007964-bbs2-0244" title="JonesC , HackerD , MeadenA , CormacI , IrvingCB , XiaJ , et al. Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Cochrane Database of Systematic Reviews2018, Issue 11. [DOI: 10.1002/14651858.CD008712.pub3] ">Jones 2018</a>) to incorporate and address these new more diverse data. This particular review provides information about CBT's relative effectiveness compared with standard care. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007964-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007964-sec-0035"></div> <p>To assess the effects of adding cognitive behavioural therapy to standard care compared with standard care alone for people with schizophrenia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007964-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007964-sec-0036"></div> <section id="CD007964-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007964-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included all relevant randomised controlled trials. We excluded quasi‐randomised trials, such as those where allocation was undertaken on surname. If a trial had been described as double‐blind, but it was implied it had been randomised, we would have included these trials in a <a href="#CD007964-sec-0102">Sensitivity analysis</a>. We would have included randomised cross‐over trials but only used data up to the point of first cross‐over because of the instability of the problem behaviours and the likely carry‐over effects of all treatments (<a href="./references#CD007964-bbs2-0218" title="ElbourneD , AltmanDG , HigginsJP , CurtinaF , WorthingtondHV , VaileA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). </p> <p>As CBT requires the person to actively engage and participate in the therapy, it may not be possible to blind the participant to treatment condition (that is, it may not be possible to provide a placebo control condition to reduce the effects of anticipated outcome on behalf of the participant). However, it is both possible and desirable to blind the researcher to condition (that is, the person collecting outcome data is unaware of the allocation of the individual participant). Accordingly, single‐blind trials were considered of appropriate methodological quality for the assessment of this type of intervention. </p> <p>We compared the outcomes of trials that described a single‐blind procedure with trials that did not describe any blinding procedure in a <a href="#CD007964-sec-0102">Sensitivity analysis</a>. If there was no substantive difference within primary outcomes (see <a href="#CD007964-sec-0043">Types of outcome measures</a>) when these non‐blinded studies were added, then we included them in the final analysis. If there was a substantive difference, we used only single‐blinded randomised trials. The results of the sensitivity analysis are also described in the text. </p> </section> <section id="CD007964-sec-0039"> <h4 class="title">Types of participants</h4> <p>Participants were people with a current diagnosis of schizophrenia or closely related illness such as schizoaffective disorder, diagnosed by any criteria, irrespective of gender or race. </p> <p>We did not include trials where participants had a very late onset of illness (onset after the age of 60 years) or those where the majority of participants had disorders such as bipolar affective disorder, substance‐induced psychosis. If studies randomised people with a range of diagnoses, we only included trials where more than 50% of the participants had a diagnosis of schizophrenia or similar illness. </p> <p>This review did not include trials that reported outcomes from participants deemed to be 'at‐risk' of developing schizophrenia in the future. </p> <p>We are interested in making sure that information is as relevant as possible to the current care of people with schizophrenia, so aimed to highlight the current clinical state clearly (acute, early post‐acute, partial remission, remission), as well as the stage (prodromal, first episode, early illness, persistent), and whether the studies primarily focused on people with particular problems (for example, negative symptoms, treatment‐resistant illnesses). </p> </section> <section id="CD007964-sec-0040"> <h4 class="title">Types of interventions</h4> <section id="CD007964-sec-0041"> <h5 class="title">1. Cognitive behavioural therapy (CBT)</h5> <p>The label cognitive behavioural therapy has been applied to a variety of interventions and it is difficult to provide a single, unambiguous definition. Recognising this, the review authors constructed criteria that were felt to be both workable and to capture the elements of good practice in CBT. </p> <p>In order to be classified as 'well‐defined', the intervention must clearly demonstrate the following components: </p> <p> <ul id="CD007964-list-0002"> <li> <p>a discrete psychological intervention, which is in addition to, and separate from, other therapeutic interventions (for example, behavioural family therapy); and </p> </li> <li> <p>recipients establish links between their symptoms, thoughts, and beliefs, and consequent distress or problem behaviour; and </p> </li> <li> <p>the re‐evaluation of their perceptions, beliefs, or reasoning relating to the target symptoms; this may include the re‐evaluation of situation specific 'inferential' beliefs or more global 'evaluative' beliefs. </p> </li> </ul> </p> <p>All therapies that did not meet these criteria (or that provided insufficient information) but were labelled as 'CBT' or 'Cognitive Therapy' were included as 'less‐well‐defined CBT'. We conducted a sensitivity analysis on the primary outcomes of this review (see <a href="#CD007964-sec-0043">Types of outcome measures</a>) in order to investigate whether a 'well‐defined' implementation of this therapy presented with differential outcomes. </p> <p>In addition, for primary outcomes, we undertook sensitivity analyses between studies that employed experienced CBT therapists compared with relatively inexperienced CBT therapists. Experienced CBT therapists were defined as: </p> <p> <ul id="CD007964-list-0003"> <li> <p>persons possessing appropriate professional qualifications for the provision of CBT (e.g. British Association of Behavioural and Cognitive Psychotherapy (BABCP) accreditation, Diploma in CBT, or other professionally accredited qualifications involving CBT as major part of training (e.g. Clinical or Counselling Psychologist)); or </p> </li> <li> <p>persons where their qualifications were unclear but they appeared to have received training in CBT or specific training for the trial and there was clear evidence of the use a thorough adherence protocol. </p> </li> </ul> </p> </section> <section id="CD007964-sec-0042"> <h5 class="title">2. Standard care</h5> <p>We defined this as the care a person with schizophrenia would normally receive had they not been involved in the trial. This could, in some areas, just involve treatment with antipsychotics, but normally included a biological, psychological, and social approach to care, including antipsychotic medication, and utilisation of services including hospital stay, day hospital attendance, and community psychiatric nursing involvement. </p> </section> </section> <section id="CD007964-sec-0043"> <h4 class="title">Types of outcome measures</h4> <p>Outcomes could be categorised as being short‐, medium‐ or long‐term. A short‐term outcome was defined as occurring within the period typically associated with active treatment. The National Institute for Health and Care Excellence (NICE) asserts that "for it to make a difference, [the patient] should have CBT treatment for more than 16 planned sessions" (<a href="./references#CD007964-bbs2-0259" title="National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. nice.org.uk/guidance/cg178/chapter/1‐Recommendations (accessed on 01 January 2018). ">NICE 2014</a>). Accordingly, in this review, we have grouped outcomes into those measured in the short term (within 24 weeks of the onset of therapy), medium term (within 24 to 52 weeks of the onset of therapy) and long term (over 52 weeks since the onset of therapy). </p> <p>We aimed to report binary outcomes recording clear and clinically meaningful degrees of change (e.g. global impression of much improved, or more than 50% improvement on a rating scale ‐ as defined within the trials) before any others. Thereafter, we listed other binary outcomes and then those that were continuous. </p> <p>* see <a href="#CD007964-sec-0447">Differences between protocol and review</a>. </p> <section id="CD007964-sec-0044"> <h5 class="title">Primary outcomes</h5> <section id="CD007964-sec-0045"> <h6 class="title">1. Global state</h6> <p>1.1 Relapse<br/> 1.2 Clinically important change ‐ as defined by the individual studies (for example, global impression much improved, or less than 50% reduction on a specified rating scale) ‐ short‐, medium‐ and long‐term. </p> </section> <section id="CD007964-sec-0046"> <h6 class="title">2. Mental state</h6> <p>2.1 Clinically important change ‐ as defined by the individual studies (for example, mental state much improved, or less than 50% reduction on a specified rating scale) ‐ short‐, medium‐ and long‐term. </p> </section> </section> <section id="CD007964-sec-0047"> <h5 class="title">Secondary outcomes</h5> <section id="CD007964-sec-0048"> <h6 class="title">1. Global state</h6> <p>1.1 Hospitalisation<br/> 1.2 Healthy days<br/> 1.3 Average endpoint/change score global state scale </p> </section> <section id="CD007964-sec-0049"> <h6 class="title">2. Mental state</h6> <p>2.2 Any change in general mental state<br/> 2.3 Average endpoint general mental state score<br/> 2.4 Average change in general mental state scores<br/> 2.5 Clinically important change in specific symptoms<br/> 2.6 Any change in specific symptoms<br/> 2.7 Average endpoint specific symptom score<br/> 2.8 Average change in specific symptom scores </p> </section> <section id="CD007964-sec-0050"> <h6 class="title">3. Adverse effects</h6> <p>3.1 Any adverse effect/event(s)<br/> 3.2 Average endpoint general adverse effect score<br/> 3.3 Average change in general adverse effect scores<br/> 3.4 Clinically important specific adverse effect ‐ as defined by individual studies<br/> 3.5 Any specific adverse effects<br/> 3.6 Average endpoint specific adverse effects<br/> 3.7 Average change in specific adverse effects </p> </section> <section id="CD007964-sec-0051"> <h6 class="title">4. Functioning</h6> <p>4.1 Average endpoint general functioning score<br/> 4.2 Average change in general functioning scores<br/> 4.3 Clinically important change in specific aspects of functioning, such as social or life skills<br/> 4.4 Any change in specific aspects of functioning, such as social or life skills<br/> 4.5 Average endpoint specific aspects of functioning, such as social or life skills<br/> 4.6 Average change in specific aspects of functioning, such as social or life skills </p> </section> <section id="CD007964-sec-0052"> <h6 class="title">5. Quality of life</h6> <p>5.1 Clinically important change in quality of life ‐ as defined by individual studies<br/> 5.2 Any change in quality of life<br/> 5.3 Average endpoint quality of life score<br/> 5.4 Average change in quality of life scores<br/> 5.5 Clinically important change in specific aspects of quality of life ‐ as defined by individual studies<br/> 5.6 Any change in specific aspects of quality of life<br/> 5.7 Average endpoint specific aspects of quality of life<br/> 5.8 Average change in specific aspects of quality of life </p> </section> <section id="CD007964-sec-0053"> <h6 class="title">6. Satisfaction with treatment</h6> <p>6.1 Leaving the study early: specific reason<br/> 6.2 Recipient of care satisfied with treatment<br/> 6.3 Recipient of care average satisfaction score<br/> 6.4 Recipient of care average change in satisfaction scores<br/> 6.6 Carer satisfied with treatment<br/> 6.7 Carer average satisfaction score<br/> 6.8 Carer average change in satisfaction scores </p> </section> <section id="CD007964-sec-0054"> <h6 class="title">7. Engagement with services</h6> <p>7.1 Clinically important engagement ‐ as defined by individual studies<br/> 7.2 Any engagement<br/> 7.3 Average endpoint engagement score<br/> 7.4 Average change in engagement scores<br/> 7.5 Compliance with medication/treatment </p> </section> <section id="CD007964-sec-0055"> <h6 class="title">8. Economic</h6> <p>8.1 Direct costs<br/> 8.2 Indirect costs </p> </section> <section id="CD007964-sec-0056"> <h6 class="title">'Summary of findings' tables</h6> <p>We used the GRADE approach to interpret findings (<a href="./references#CD007964-bbs2-0267" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>); and used <a href="http://community.cochrane.org/tools/review-production-tools/gradepro-gdt" target="_blank">GRADEpro GDT</a> to export data from our review to create a 'Summary of findings' table. These tables provide outcome‐specific information concerning the overall certainty of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rated as important to patient care and decision making. We selected the following main outcomes for inclusion in the 'Summary of findings' table. </p> <p> <ol id="CD007964-list-0004"> <li> <p>Global state: relapse</p> </li> <li> <p>Global state: clinically important change</p> </li> <li> <p>Mental state: general ‐ clinically important change ‐ as defined by individual studies</p> </li> <li> <p>Adverse effect: clinically important adverse event ‐ as defined by individual studies</p> </li> <li> <p>Functioning: clinically important change in social functioning</p> </li> <li> <p>Quality of life: clinically important change</p> </li> <li> <p>Satisfaction with treatment ‐ leaving the study early for any reason</p> </li> </ol> </p> <p>If data were not available for these prespecified outcomes but were available for ones that were similar, we presented the closest outcome to the prespecified one in the table but took this into account when grading the finding. </p> </section> </section> </section> </section> <section id="CD007964-sec-0057"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007964-sec-0058"> <h4 class="title">Electronic searches</h4> <section id="CD007964-sec-0059"> <h5 class="title">Cochrane Schizophrenia Group's Study‐Based Register of Trials</h5> <p>On 6 March 2017, the information specialist searched the register using the following search strategy: </p> <p>*Cognit* in Intervention Field of STUDY</p> <p>In such a study‐based register, searching the major concept retrieves all the synonyms and relevant studies because all the studies have already been organised based on their interventions and linked to the relevant topics (<a href="./references#CD007964-bbs2-0268" title="ShokranehF , AdamsCE . Study‐based registers of randomized controlled trials: starting a systematic review with data extraction or meta‐analysis. BioImpacts2017;7(4):209‐17. [DOI: 10.15171/bi.2017.25] ">Shokraneh 2017</a>; <a href="./references#CD007964-bbs2-0269" title="ShokranehF , AdamsCE . Gallstone, snake venom and witchcraft for schizophrenia: the challenges of classifying [schizophrenia] trials. Evidence‐Based Medicine2018;23(Suppl. 1):A18. [DOI: 10.1136/bmjebm‐2018‐111024.36] ">Shokraneh 2018</a>). </p> <p>This register is compiled by systematic searches of major resources (AMED, BIOSIS, CENTRAL, CINAHL, ClinicalTrials.Gov, Embase, MEDLINE, PsycINFO, PubMed, WHO ICTRP) and their monthly updates, ProQuest Dissertations and Theses A&amp;I and its quarterly update, Chinese databases (CBM, CNKI, and Wanfang) and their annual updates, handsearches, grey literature, and conference proceedings (see <a href="http://schizophrenia.cochrane.org/register-trials" target="_blank">Group's website</a>). There is no language, date, document type, or publication status limitations for inclusion of records into the register. </p> <p>For previous search strategy see <a href="./appendices#CD007964-sec-0441">Appendix 1</a>. </p> </section> </section> <section id="CD007964-sec-0060"> <h4 class="title">Searching other resources</h4> <section id="CD007964-sec-0061"> <h5 class="title">1. Reference searching</h5> <p>We inspected references of all included studies for further relevant studies.</p> </section> <section id="CD007964-sec-0062"> <h5 class="title">2. Personal contact</h5> <p>We did not contact the first author of each included study for information regarding unpublished trials. </p> </section> </section> </section> <section id="CD007964-sec-0063"> <h3 class="title" id="CD007964-sec-0063">Data collection and analysis</h3> <p>The methods employed below have been updated to reflect changes to Cochrane methods since publication of the protocol in 2009. </p> <section id="CD007964-sec-0064"> <h4 class="title">Selection of studies</h4> <p>Review authors (SZ and CS) independently inspected citations from the searches and identified relevant abstracts. A random 20% sample was independently re‐inspected by JX and CJ to ensure reliability. Where disputes arose, we acquired the full report for more detailed scrutiny. SZ and CS inspected the full reports of the abstracts meeting the review criteria. JX and CJ inspected a random 20% of full reports in order to ensure reliable selection. We resolved disagreement by discussion and did not need to contact the authors of original studies for clarification on selection. </p> </section> <section id="CD007964-sec-0065"> <h4 class="title">Data extraction and management</h4> <section id="CD007964-sec-0066"> <h5 class="title">1. Extraction</h5> <p>Review authors (SZ and CS) extracted data from all included studies. In addition, to ensure reliability, JX independently extracted data from a random sample of these studies, comprising 10% of the total. We resolved any disagreement by discussion, and documented decisions. We intended, where necessary, to contact authors of original studies for more data. We we would have presented data presented only in graphs and figures only if SZ and CS independently extracted the same result. Where multicentre studies reported outcomes separately for each component centre, we would have extracted data relevant to each component centre and would have reported these separately. Review author JC helped with data extraction for Chinese trials. </p> </section> <section id="CD007964-sec-0067"> <h5 class="title">2. Management</h5> <section id="CD007964-sec-0068"> <h6 class="title">2.1 Forms</h6> <p>We extracted data onto standard, simple forms.</p> </section> <section id="CD007964-sec-0069"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:</p> <p> <ol id="CD007964-list-0005"> <li> <p>the psychometric properties of the measuring instrument had been described in a peer‐reviewed journal (<a href="./references#CD007964-bbs2-0251" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249‐52. ">Marshall 2000</a>); </p> </li> <li> <p>the measuring instrument had not been written or modified by one of the trialists for that particular trial; and </p> </li> <li> <p>the instrument was a global assessment of an area of functioning and not subscores which are not, in themselves, validated or shown to be reliable. </p> </li> </ol> </p> <p>It should be noted that some subscale scores were included in this review (for instance, we did include subscores from mental state scales measuring specific mental state symptoms of schizophrenia), however, in all cases the subscale scores were well‐validated and were in common use within the empirical literature. </p> <p>Ideally, the measuring instrument would either be i. a self‐report, or ii. completed by an independent rater or relative (not the therapist). We realised that this is not often reported clearly; in <a href="#CD007964-sec-0112">Description of studies</a>, where possible, we noted if this was the case or not. </p> </section> <section id="CD007964-sec-0070"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data: change data can remove a component of between‐person variability from the analysis; however, calculation of change needs two assessments (baseline and endpoint) that can be difficult to obtain in unstable and difficult‐to‐measure conditions such as schizophrenia. We preferred to use endpoint data throughout. </p> </section> <section id="CD007964-sec-0071"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non‐parametric data, we applied the following standards to relevant continuous endpoint data before inclusion. </p> <p>For endpoint data from studies including fewer than 200 participants:</p> <p>a) when a scale started from the finite number zero, we subtracted the lowest possible value from the mean, and divided this by the standard deviation (SD). If this value was lower than one, it strongly suggests that the data are skewed and we excluded these data. If this ratio was higher than one but less than two, there is a suggestion that the data are skewed: we entered these data and tested whether their inclusion or exclusion would change the results substantially. If the data changed results, we presented them as 'other' data. Finally, if the ratio was larger than two, we included these data, because it is less likely they are skewed (<a href="./references#CD007964-bbs2-0189" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313(7066):1200. ">Altman 1996</a>; <a href="./references#CD007964-bbs2-0237" title="HigginsJP , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). </p> <p>b) if a scale started from a positive value (such as the Positive and Negative Syndrome Scale (PANSS), which can have values from 30 to 210 (<a href="./references#CD007964-bbs2-0245" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda (NY): Multi‐Health Systems, 1986. ">Kay 1986</a>)), we modified the calculation described above to take the scale starting point into account. In these cases, it was considered that skewed data were present if 2 SD &gt; (S − S min), where S was the mean score and 'S min' was the minimum score. </p> <p>Please note: we entered all relevant data from studies of more than 200 participants in the analysis irrespective of the above rules, because skewed data posed less of a problem in large studies. </p> </section> <section id="CD007964-sec-0072"> <h6 class="title">2.5 Common measure</h6> <p>To facilitate comparison between trials, where possible, we converted variables that were reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD007964-sec-0073"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Where possible, we converted continuous outcome measures to dichotomous data. This could be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there had been a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD007964-bbs2-0260" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>) or the PANSS (<a href="./references#CD007964-bbs2-0246" title="KaySR , FiszbeinA , OplerLA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13:261‐76. ">Kay 1987</a>), this can be considered as a clinically significant response (<a href="./references#CD007964-bbs2-0249" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry2005;187:366‐71. [PUBMED: 16199797] ">Leucht 2005</a>; <a href="./references#CD007964-bbs2-0250" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . What does the PANSS mean?. Schizophrenia Research2005;79:231‐8. ">Leucht 2005a</a>). If data based on these thresholds were not available, we used the primary cut‐off presented by the original authors. </p> </section> <section id="CD007964-sec-0074"> <h6 class="title">2.7 Direction of graphs</h6> <p>We aimed to enter data in such a way that the area to the left of the line of no effect indicated a favourable outcome for CBT. </p> </section> </section> </section> <section id="CD007964-sec-0075"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Again, review authors (SZ and CS) assessed risk of bias using the tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions (</i><a href="./references#CD007964-bbs2-0238" title="HigginsJP , AltmanDG , SterneJA . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). This tool encourages consideration of how the randomisation sequence was generated, how allocation was concealed, the integrity of blinding at outcome measurement, the completeness of outcome data, selective reporting, and other biases. We excluded studies where sequence generation was at a high risk of bias or where allocation was clearly not concealed. If disputes arose as to the correct category for a trial, this was resolved through discussion and, if necessary, adjudication by the other review authors (AM and CI). If this was not possible because further information was necessary, we intended not to enter the data but to allocate the trial to the list of those awaiting assessment. Review authors were not blinded to the names of the authors, institutions, journal of publication, or results of the trials. </p> </section> <section id="CD007964-sec-0076"> <h4 class="title">Measures of treatment effect</h4> <p>We adopted P = 0.05 as the conventional level of a clear difference (statistically significant) but we were especially cautious where results were only slightly below this, and, in these situations, we reported 95% confidence intervals (CI) in preference to P values. </p> <section id="CD007964-sec-0077"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI) as it has been shown that RR is more intuitive than odds ratios (<a href="./references#CD007964-bbs2-0202" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Aperçu sur la problématique des indices d'efficacité thérapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie1999;54(4):405‐11. [PUBMED: 10667106] ">Boissel 1999</a>) and that odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD007964-bbs2-0208" title="DeeksJ . Issues in the selection for meta‐analyses of binary data. 8th International Cochrane Colloquium; 2000 Oct 25‐28; Cape Town. Cape Town: The Cochrane Collaboration, 2000. ">Deeks 2000</a>). Although the number needed to treat for an additional beneficial outcome (NNTB) and the number needed to treat for an additional harmful outcome (NNTH), with their CIs, are intuitively attractive to clinicians, they are problematic to calculate and interpret in meta‐analyses (<a href="./references#CD007964-bbs2-0240" title="HuttonJL . Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology2009;146(1):27‐30. [PUBMED: 19438480] ">Hutton 2009</a>). For binary data presented in the 'Summary of findings' table(s), where possible, we calculated illustrative comparative risks. </p> </section> <section id="CD007964-sec-0078"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, we estimated mean differences (MD) and the 95% confidence interval between groups. We preferred not to calculate standardised effect size measures (SMD). However if scales that were very similar had been used, we would have presumed there was a small difference in measurement, and we would have calculated the effect size and transformed the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD007964-sec-0079"> <h4 class="title">Unit of analysis issues</h4> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD007964-bbs2-0211" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7(6):623‐9. ">Divine 1992</a>) whereby P values are spuriously low, CIs unduly narrow, and statistical significance overestimated. This causes type I errors (<a href="./references#CD007964-bbs2-0201" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315(7108):600. ">Bland 1997</a>; <a href="./references#CD007964-bbs2-0229" title="GullifordMC . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876‐83. ">Gulliford 1999</a>). </p> <p>Where clustering was not accounted for in primary studies, we had planned to present data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, if such data are reported, we will seek to contact first authors of studies to obtain intra‐class correlation coefficients for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD007964-bbs2-0229" title="GullifordMC . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876‐83. ">Gulliford 1999</a>). Where clustering has been incorporated into the analysis of primary studies, we will present these data as if from a non‐cluster randomised study, but adjust for the clustering effect. </p> <p>We have sought statistical advice and been advised that the binary data presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the intra‐class correlation coefficient (ICC) [Design effect = 1 + (m ‐ 1) * ICC] (<a href="./references#CD007964-bbs2-0213" title="DonnerA , KlarN . Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine2002;21(19):2971‐80. ">Donner 2002</a>). If the ICC was not reported, it was assumed to be 0.1 (<a href="./references#CD007964-bbs2-0275" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPGJ . Methods for evaluating area‐wide and organisation‐based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):iii‐92. ">Ukoumunne 1999</a>). </p> <p>If cluster studies had been appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies would have been possible using the generic inverse variance technique. </p> <section id="CD007964-sec-0080"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. It occurs if an effect (e.g. pharmacological, physiological, or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase, the participants can differ systematically from their initial state despite a wash‐out phase. For the same reason, cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD007964-bbs2-0218" title="ElbourneD , AltmanDG , HigginsJP , CurtinaF , WorthingtondHV , VaileA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). As both effects are very likely in severe mental illness, we planned to use data from only the first phase of the study. </p> </section> <section id="CD007964-sec-0081"> <h5 class="title">3. Trials with multiple treatment groups</h5> <p>Where a study involved more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. If data were binary we simply added and combined within the two‐by‐two table. If data were continuous, we combined data following the formula in the <i>Cochrane Handbook for Systemic reviews of Interventions</i><a href="./references#CD007964-bbs2-0237" title="HigginsJP , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>. Where the additional treatment arms were not relevant, we did not use these data. </p> </section> </section> <section id="CD007964-sec-0082"> <h4 class="title">Dealing with missing data</h4> <section id="CD007964-sec-0083"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss to follow‐up, the findings of a trial must lose credibility (<a href="./references#CD007964-bbs2-0285" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El‐SayehH , et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254‐7. ">Xia 2009</a>). We were forced to make a judgment where the level of loss to follow‐up was too great for short‐term trials to be included in this review. If more than 40% of data were unaccounted for at eight weeks, we did not use these data within the analyses. </p> </section> <section id="CD007964-sec-0084"> <h5 class="title">2. Binary</h5> <p>If attrition for a binary outcome was between 0% and 40% and if the outcomes of these participants were described, we included these data as reported. Where these data were not clearly described for the primary outcome, we assumed the worst for each person who was lost to follow‐up, and for adverse effects, we assumed rates similar to those among participants who did continue to have their data recorded. </p> </section> <section id="CD007964-sec-0085"> <h5 class="title">3. Continuous</h5> <section id="CD007964-sec-0086"> <h6 class="title">3.1 Attrition</h6> <p>We have reported data where attrition for a continuous outcome was between 0% and 40% and completer‐only data were reported in the study. </p> </section> <section id="CD007964-sec-0087"> <h6 class="title">3.2 Missing standard deviations</h6> <p>We first tried to obtain the missing values from the authors. If not available, where there were missing measures of variance for continuous data but an exact standard error (SE) and CI were available for group means, and either 'P' value or 't' value were available for differences in the mean, we noted these, and calculated them according to the rules described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007964-bbs2-0237" title="HigginsJP , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). When only the SE is reported, standard deviations (SDs) can be calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007964-bbs2-0237" title="HigginsJP , GreenS . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>) present detailed formula for estimating SDs from P values, t or F values, CIs, ranges, or other statistics. If these formula do not apply, in the future we will calculate SDs according to a validated imputation method which is based on the SDs of the other included studies (<a href="./references#CD007964-bbs2-0221" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7‐10. ">Furukawa 2006</a>). Some of these imputation strategies can introduce error. The alternative would be to exclude a given study’s outcome and thus to lose information. We will examine the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD007964-sec-0088"> <h6 class="title">3.3 Assumptions about participants who left the trials early or were lost to follow‐up</h6> <p>Various methods are available to account for participants who left the trials early or were lost to follow‐up. Some trials just present the results of study completers; others use the method of last‐observation‐carried‐forward (LOCF); while more recently, methods such as multiple imputation or mixed‐effects models for repeated measurements (MMRM) have become more of a standard. While the latter methods seem to be somewhat better than LOCF (<a href="./references#CD007964-bbs2-0248" title="LeonAC , MallinckrodtCH , Chuang‐SteinC , ArchibaldDG , ArcherGE , ChartierK . Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry2006;59(11):1001‐5. [PUBMED: 16905632] ">Leon 2006</a>), we feel that the high percentage of participants leaving the studies early and differences between groups in their reasons for doing so is often the core problem in randomised schizophrenia trials. Therefore, we did not exclude studies based on the statistical approach used. However, by preference we used the more sophisticated approaches, i.e. we preferred to use MMRM or multiple‐imputation to LOCF, and we only presented completer analyses if some kind of ITT data were not available at all. Moreover, we addressed this issue in the item 'Incomplete outcome data' of the 'Risk of bias' tool. </p> </section> </section> </section> <section id="CD007964-sec-0089"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD007964-sec-0090"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations which we had not predicted would arise. When such situations or participant groups arose, we fully discussed these. </p> </section> <section id="CD007964-sec-0091"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise. When such methodological outliers arose, we fully discussed these. </p> </section> <section id="CD007964-sec-0092"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD007964-sec-0093"> <h6 class="title">3.1 Visual inspection</h6> <p>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD007964-sec-0094"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>Heterogeneity between studies was investigated by considering the I<sup>2</sup> method alongside the Chi<sup>2</sup> 'P' value. The I<sup>2</sup> provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD007964-bbs2-0235" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on i. magnitude and direction of effects, and ii. strength of evidence for heterogeneity (e.g. 'P' value from Chi<sup>2</sup> test, or a CI for I<sup>2</sup>). We interpreted an I<sup>2</sup> estimate greater than or equal to 75% accompanied by a statistically significant Chi<sup>2</sup> statistic as evidence of substantial levels of heterogeneity (<a href="./references#CD007964-bbs2-0209" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for heterogeneity (<a href="#CD007964-sec-0099">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD007964-sec-0095"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD007964-bbs2-0216" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). These are described in section 10.1 of the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD007964-bbs2-0271" title="SterneJA , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> <section id="CD007964-sec-0096"> <h5 class="title">1. Protocol versus full study</h5> <p>We attempted to locate protocols of included randomised trials. If the protocol was available, we compared outcomes in the protocol and in the published report. If the protocol was not available, we compared outcomes listed in the methods section of the trial report with actual reported results. </p> </section> <section id="CD007964-sec-0097"> <h5 class="title">2. Funnel plot</h5> <p>We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small‐study effects. We did not use funnel plots for outcomes where there were ten or fewer studies, or where all studies were of similar size. In other cases, where funnel plots were possible, we sought statistical advice in their interpretation. </p> </section> </section> <section id="CD007964-sec-0098"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random‐effects model takes into account differences between studies even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random‐effects model. It puts added weight onto small studies which often are the most biased ones. Depending on the direction of effect these studies can either inflate or deflate the effect size. We used a fixed‐effect model for analyses, except if there was a statistically significant heterogeneity where the source of heterogeneity could not be identified. </p> </section> <section id="CD007964-sec-0099"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD007964-sec-0100"> <h5 class="title">1. Subgroup analyses</h5> <p>We anticipated subgroup analyses to test the hypothesis that CBT may be highlighted to have different effects when compared with: </p> <section id="CD007964-sec-0101"> <h6 class="title">1.1 Standard care including antipsychotics as opposed to standard care not including antipsychotics </h6> <p>We aimed to undertake the analysis for only the primary outcomes of this review or the nearest we could find to them (see <a href="#CD007964-sec-0043">Types of outcome measures</a>), and, if data were available, we would have discussed the findings. </p> </section> </section> </section> <section id="CD007964-sec-0102"> <h4 class="title">Sensitivity analysis</h4> <p>If there were substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed below, we would not have added data from the lower‐quality studies to the results of the higher‐quality trials, but would have presented these data within a subcategory. If their inclusion did not result in a substantive difference, they remained in the analyses. </p> <section id="CD007964-sec-0103"> <h5 class="title">1. Implication of randomisation</h5> <p>We planned to include trials in a sensitivity analysis if they were described in some way as to imply randomisation. For the primary outcomes, if there was no substantive difference when the implied randomised studies were added to those studies with better description of randomisation, we would have included these studies. </p> </section> <section id="CD007964-sec-0104"> <h5 class="title">2. Blinding</h5> <p>We compared the outcomes of trials that described a single‐blind procedure with trials that did not describe any blinding procedure. If there was no substantive difference within primary outcomes (see <a href="#CD007964-sec-0043">Types of outcome measures</a>) when these non‐blinded studies were added, then we included them in the final analysis. If there was a substantive difference, we only used only single‐blinded randomised trials. </p> </section> <section id="CD007964-sec-0105"> <h5 class="title">3. Well‐defined CBT versus less‐well‐defined CBT</h5> <p>For the primary outcomes, we compared findings for trials meeting our criteria for 'well‐defined' CBT as opposed to those studies that labelled the therapy as CBT but either did not contain the 'inferential' and 'evaluative' component or who did not provide enough information for this discrimination to be made (see <a href="#CD007964-sec-0040">Types of interventions</a>). </p> </section> <section id="CD007964-sec-0106"> <h5 class="title">4. Therapist experience</h5> <p>For the primary outcomes, we compared findings for trials meeting the criteria for experienced CBT therapists compared with trials using relatively inexperienced CBT therapists or who did not provide enough information for this discrimination to be made (see <a href="#CD007964-sec-0040">Types of interventions</a>). </p> </section> <section id="CD007964-sec-0107"> <h5 class="title">5. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD007964-sec-0082">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumption and where we made the comparison with completer data only. If there was a substantial difference, we reported these results and discussed them, but continued to employ our assumption. </p> </section> <section id="CD007964-sec-0108"> <h5 class="title">6. Risk of bias</h5> <p>For the primary outcomes, we analysed the effects of excluding trials that had a high risk of bias across one or more of the domains (see <a href="#CD007964-sec-0075">Assessment of risk of bias in included studies</a>). </p> </section> <section id="CD007964-sec-0109"> <h5 class="title">7. Imputed values</h5> <p>We undertook a sensitivity analysis to assess the effects of including data from trials where we used imputed values for ICC in calculating the design effect in cluster‐randomised trials. </p> </section> <section id="CD007964-sec-0110"> <h5 class="title">8. Fixed‐ and random‐effects</h5> <p>For the primary outcomes, we synthesised data using a random‐effects model to evaluate whether this altered the significance of the results. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007964-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007964-sec-0111"></div> <section id="CD007964-sec-0112"> <h3 class="title">Description of studies</h3> <section id="CD007964-sec-0113"> <h4 class="title">Results of the search</h4> <p>The electronic search yielded 1730 citations and, additionally, we identified 72 references through cross‐reference check of relevant papers. After duplicates were removed, 1802 unique records remained for screening. We excluded 1571 references through inspection of titles and abstracts, and obtained full texts for the remaining 231 articles to further assess eligibility. We excluded 103 trials with 116 references; the reasons for exclusion are described in <a href="#CD007964-sec-0144">Excluded studies</a>. Eight studies with nine references are in the <a href="./references#CD007964-bbs1-0003" title="">Studies awaiting classification</a> list as we had no access to the full‐text article (<a href="./references#CD007964-bbs2-0164" title="ChenG . Efficacy of cognitive‐behavioral therapy on schizophrenia patients during recovery stage [认知行为疗法治疗精神分裂症患者康复期的疗效观察]. 14th academic annual meeting of the Committee on Mental Illness of China Association of Traditional Chinese and Western Medicine [中国中西医结合学会精神疾病专业委员会第十四届学术年会暨首届国际中西医结合精神病学研究进展培训班]. 2015:4. ">Chen 2015c</a>; <a href="./references#CD007964-bbs2-0165" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . Capopus. Randomized clinical trial: specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4(Suppl. 1):160. HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4(Suppl. 1):160. ">Fohlmann 2010</a>; <a href="./references#CD007964-bbs2-0166" title="HardyA , SteelC , SmithB , WykesT , RoseS , EnrightS , et al. Cognitive behavioural therapy for the treatment of posttraumatic stress disorder in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience2015;1:S31‐2. ">Hardy 2015</a>; <a href="./references#CD007964-bbs2-0167" title="HassanS , GanguliR , FlettG , SuleimanA , HewittP . Perfectionism and working alliance in a cognitive‐behavioral intervention for weight loss in psychotic illness. Schizophrenia Research2014;153:S166. ">Hassan 2014</a>; <a href="./references#CD007964-bbs2-0168" title="MounV , TripathiA , DalalPK , SinhaPK . Home based cognitive training in patients of schizophrenia. Indian Journal of Psychiatry2015;57:S78. ">Moun 2015</a>; <a href="./references#CD007964-bbs2-0169" title="RizkDN , SalamaH , MolokhiyaT , KassemL . Effectiveness of brief individual cognitive behavioral therapy for auditory hallucinations in a sample of Egyptian patients with schizophrenia. European Psychiatry2016;33(Suppl.):S259‐60. ">Nagui 2016</a>; <a href="./references#CD007964-bbs2-0170" title="TangW , ZhangJ , WenN , PanJ , YangF , JiangS . Effects on prognosis recurrence and efficacy in schizophrenia patients treated with palpiperone palmitate long‐acting injection and cognitive‐behavioral intervention [棕榈酸帕利哌酮长效针剂联合认知行为干预对精神分裂症患者疗效及预后复发的影响]. 30th anniversary of the establishment of China Mental Health Association and the eighth National Academic Conference on Mental Health [中国心理卫生协会成立30周年纪念活动暨第八次全国心理卫生学术大会]. 2015:192. ">Tang 2015</a>; <a href="./references#CD007964-bbs2-0171" title="TecicT , GuttgemannsJ , LehmkuhlG , MuellerK , StoesserD , WiedemannG , et al. Modified cognitive behavioral therapy in adolescents with persistent psychotic symptoms ‐ results of a randomized controlled trial. Schizophrenia Research2012;136:S302. ">Tecic 2012</a>). Fifteen trials with 15 references meeting our inclusion criteria are ongoing trials (<a href="./references#CD007964-bbs2-0172" title="EdwardsJ , HarrisM , HarriganS , MerrittA , AmmingerG , DeLurdes SantosM , et al. A clinical audit of the first six months of care of first‐episode psychosis patients in seven European sites. Early Intervention in Psychiatry2008;2:A25. ">Edwards 2008</a>; <a href="./references#CD007964-bbs2-0173" title="ISRCTN06022197 . A pilot study of a randomised controlled trial of antipsychotic medication in comparison to cognitive behaviour therapy and a combined treatment in adults with psychosis. www.isrctn.com/ISRCTN06022197. Uk, [Date Accessed: 20 March 2014]. ">ISRCTN06022197</a>; <a href="./references#CD007964-bbs2-0174" title="ISRCTN12668007 . The nightmare intervention study. www.isrctn.com/ISRCTN12668007 [Date Accessed: 20 November 2015]. ">ISRCTN12668007</a>; <a href="./references#CD007964-bbs2-0175" title="ISRCTN33695128 . Better Sleep Trial: a pilot randomised controlled trial for patients with delusions and/or hallucinations. www.isrctn.com/ISRCTN33695128 [Date Accessed: 26 September 2012]. ">ISRCTN33695128</a>; <a href="./references#CD007964-bbs2-0176" title="ISRCTN61621571 . Sustaining positive engagement and recovery (supereden) ‐ the next step after early intervention for psychosis. Study 3: Improving social recovery in young people with emerging severe social disability: a proof of principle randomised controlled trial. www.isrctn.com/ISRCTN61621571 [Date Accessed: 26 June 2012]. ">ISRCTN61621571</a>; <a href="./references#CD007964-bbs2-0177" title="NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. clinicaltrials.gov/ct2/show/NCT00484302 [Date Accessed: 8 June 2007]. ">NCT00484302</a>; <a href="./references#CD007964-bbs2-0178" title="NCT00495911 . A randomized controlled trial of individual therapy for first episode psychosis. clinicaltrials.gov/ct2/show/NCT00495911 [Date Accessed: 25 July 2008]. ">NCT00495911</a>; <a href="./references#CD007964-bbs2-0179" title="NCT02134418 . Evaluation of an intervention program designed to improve understanding of Irony on the hemispheric processing of ambiguous figurative language in adults with schizophrenia. clinicaltrials.gov/ct2/show/NCT02134418 [Date Accessed: 9 May 2014]. ">NCT02134418</a>; <a href="./references#CD007964-bbs2-0180" title="NCT02380885 . RCT social cognition training and therapeutic alliance focused therapy for persons with severe mental illness. clinicaltrials.gov/ct2/show/NCT02380885 [Date Accessed: 5 March 2015]. ">NCT02380885</a>; <a href="./references#CD007964-bbs2-0181" title="NCT02408198 . The Street Smart Group: a feasibility trial of a group intervention targeting anxiety processes in paranoia. clinicaltrials.gov/ct2/show/NCT02408198 [Date Accessed: 3 April 2015]. ">NCT02408198</a>; <a href="./references#CD007964-bbs2-0182" title="NCT02427542 . Feasibility trial of CBT for depersonalisation in psychosis. clinicaltrials.gov/ct2/show/NCT02427542 [Date Accessed: 28 April 2015]. ">NCT02427542</a>; <a href="./references#CD007964-bbs2-0183" title="NCT02653729 . CBT for psychosis and affect on psychosis symptoms. clinicaltrials.gov/ct2/show/NCT02653729 [Date Accessed: 12 January 2016]. ">NCT02653729</a>; <a href="./references#CD007964-bbs2-0184" title="NCT02787122 . Pilot‐trial of emotion‐focused cognitive behavior therapy for patients with schizophrenia. clinicaltrials.gov/ct2/show/NCT02787122 [Date Accessed: 1 June 2016]. ">NCT02787122</a>; <a href="./references#CD007964-bbs2-0185" title="NCT02787135 . Efficacy and mechanisms of change of an emotion‐oriented version of cognitive‐behavioral therapy for psychosis. clinicaltrials.gov/ct2/show/NCT02787135 [Date Accessed: 1 June 2016]. ">NCT02787135</a>; <a href="./references#CD007964-bbs2-0186" title="WallerH , CraigT , LandauS , Fornells‐AmbrojoM , HassanaliN , IredaleC , et al. The effects of a brief CBT intervention, delivered by frontline mental health staff, to promote recovery in people with psychosis and comorbid anxiety or depression (the GOALS study): study protocol for a randomized controlled trial. Trials2014;15:255. ">Waller 2014</a>). In all, 60 trials with 91 references were included in this review. <a href="#CD007964-fig-0001">Figure 1</a> presents the study screening flow diagram. </p> <div class="figure" id="CD007964-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram for 2017 search" data-id="CD007964-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for 2017 search</p> </div> </div> </div> </section> <section id="CD007964-sec-0114"> <h4 class="title">Included studies</h4> <p>We included a total of 60 trials with 5992 participants.</p> <section id="CD007964-sec-0115"> <h5 class="title">1. Size</h5> <p>The sample size of included trials ranged from 30 participants to 422 participants, and the treatment duration ranged from 28 days (<a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>) to two years (<a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>). </p> </section> <section id="CD007964-sec-0116"> <h5 class="title">2. Duration</h5> <p> <ul id="CD007964-list-0006"> <li> <p>In 27 trials, the treatment duration was no longer than 12 weeks (<a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>; <a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a>; <a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>; <a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>; <a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a>; <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>). </p> </li> <li> <p>In 19 trials, the treatment duration ranged from 13 weeks to 26 weeks (<a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>; <a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>; <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>; <a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a>; <a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a>; <a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a>; <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>; <a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>). </p> </li> <li> <p>In 13 trials, the treatment duration was longer than 26 weeks (<a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a>). </p> </li> </ul> <ul id="CD007964-list-0007"> <li> <p>The remaining trial did not report the treatment duration (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>). </p> </li> </ul> </p> </section> <section id="CD007964-sec-0117"> <h5 class="title">3. Setting</h5> <p>Participants were recruited from inpatient, outpatient, or community settings.</p> <p> <ul id="CD007964-list-0008"> <li> <p>Thirty‐one trials with 2812 participants were conducted in China (<a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>; <a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>; <a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a>; <a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>; <a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a>; <a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a>; <a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a>; <a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a>; <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>; <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a>; <a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>; <a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>; <a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a>; <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>). </p> </li> <li> <p>Eighteen trials with 2440 participants were conducted in the United Kingdom (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>;). </p> </li> <li> <p>Of the remaining 11 trials, three were conducted in Australia (n = 223) (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>), two in America (n = 161) (<a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>; <a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a>); three in Canada (n = 148) (<a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>), one in Norway (n = 50; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>) and two in Parkistan (n = 158) (<a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>). </p> </li> </ul> </p> </section> <section id="CD007964-sec-0118"> <h5 class="title">4. Participants</h5> <section id="CD007964-sec-0119"> <h6 class="title">4.1 Diagnosis</h6> <p> <ul id="CD007964-list-0009"> <li> <p>Forty‐five trials with 4119 participants were diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or paranoid schizophrenia (DSM‐IV, CCMD‐3 or ICD‐10) (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>; <a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>; <a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a>; <a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>; <a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a>; <a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a>; <a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a>; <a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a>; <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>; <a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a>; <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>; <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>; <a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>; <a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a>; <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>). Participants were reported to have comorbid symptoms, such as depression (<a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>) or hallucination (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>). </p> </li> <li> <p>The other fifteen trials with 1873 participants were diagnosed with schizophrenia and other psychosis such as delusional disorders, mood disorders, bipolar disorder, major depressive disorder, substance‐induced psychotic disorder, and others; however, only a small proportion of people within in each study was diagnosed with other psychotic disorders (less than 50%). </p> </li> </ul> <ul id="CD007964-list-0010"> <li> <p>Most trials excluded participants with comorbid substance abuse or dependency; however, four trials did include such participants (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>). </p> </li> </ul> <ul id="CD007964-list-0011"> <li> <p>No included studies clearly described the severity of illness.</p> </li> </ul> <ul id="CD007964-list-0012"> <li> <p>Only nine studies (n = 801) reported participants with first episode schizophrenia (<a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>; <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>; <a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a>). Forty out of 60 included studies reported the average length of illness, which ranged from more than one month (<a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>) to 30.1 years (<a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>); the other studies did not report this information. Most of the trials excluded people with comorbid substance misuse, evidence of organic brain disorder, learning disability, or marked thought disorder and/or conceptual disorganisation. </p> </li> </ul> </p> </section> <section id="CD007964-sec-0120"> <h6 class="title">4.1 Age and gender</h6> <p>The age of all included participants ranged from 16 years to 78 years old. The included participants involved 3228 males and 2023 females. It should be noted that these numbers are a good representation of the proportional sex distribution, but they are not exact, as six trials did not report the accurate number or distribution by sex (<a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>). </p> </section> </section> <section id="CD007964-sec-0121"> <h5 class="title">5. Interventions</h5> <p>Details of the cognitive behavioural therapy arms of each included trial can be seen in <a href="./references#CD007964-sec-0453" title="">Characteristics of included studies</a>. In addition, <a href="#CD007964-tbl-0002">Table 1</a> gives further details. </p> <div class="table" id="CD007964-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">More detailed description of interventions in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Cognitive Behavioural Therapy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Study ID</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>No other active therapies</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Experienced therapists</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Well‐defined CBT</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Details about CBT</b> </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content:</p> <p>The interventions began with the motivational interviewing phase and five initial weekly sessions designed to assess and then enhance the patient’s motivation to change. If the patient’s commitment was obtained, changes in substance use were negotiated on an individual basis. With the introduction of the individual cognitive behaviour therapy at week 6 (or earlier, if appropriate), the motivational interviewing style was integrated into subsequent cognitive behaviour therapy sessions. The individual cognitive behaviour therapy took place over approximately 18 weekly sessions, followed by six biweekly sessions (a total of 29 individual sessions, including the motivational interviewing). </p> <p>Six clinicians (five clinical psychologists and one nurse therapist) conducted the cognitive behaviour therapies (individual and family). All had experience in cognitive behaviour therapy work with psychotic patients and were eligible for accreditation as cognitive behaviour therapists with the </p> <p>British Association for Behavioural and Cognitive Psychotherapy. Therapy was detailed in a comprehensive treatment manual (available from CB), and the therapists received weekly supervision based on audiotape sessions to ensure treatment fidelity. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychological therapy consisted of 26 individual sessions delivered over 12 months. Treatment was built around two phases. The first phase used motivational interviewing to reinforce motivation to change. In phase two of the intervention, CBT from both the psychosis and substance misuse evidence base was used to formulate a change plan to help the patients to implement and maintain changes (e.g. strategies for dealing with distressing voices and depressed mood, responding to relapses, and coping with cravings and urges). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: motivation building which is to elicit and understand patients' perspective in relation to life goals, explore and resolve ambivalence so as to facilitate motivation for change; CBT techniques from both the psychosis and substance use evidence base were used to help the patient implement and maintain changes; </p> <p>Delivered by: The trial therapists all had experience in conducting CBT with people with first‐episode psychosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognitive behaviour therapy techniques are used to assess and modify conviction in four beliefs linked to the construct of voice power. Protocol for cognitive therapy for command hallucinations was developed by MB and details are provided in our casebook manuals. </p> <p>Delivered by: cognitive therapists who were supervised in each centre by a lead clinician with expertise in cognitive behaviour therapy for psychosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The intervention included health education to help patients recognize and correct their wrong beliefs or cognition; behavioural therapy included relaxation training. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation: help for participants to figure out their inappropriate beliefs and attitude; help participants recognize their cognition problems, and rebuild their personality and behaviour. Psychoeducation was given to families. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: the content of CBT was not stated.</p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: An initial emphasis on engagement, education and building a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; development of a normalising rationale for the patient's psychotic experiences; exploration and enhancement of current coping strategies; acquisition of additional coping strategies for hallucinations and delusions; and focus on accompanying affective symptomatology using relaxation training, personal effectiveness training and problem‐solving, as appropriate. </p> <p>Delivered by: five clinical nurse specialists with extensive professional experience of severe mental disorder. The therapists received training mainly focused on CBT. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: A manualised CBT program, the systematic treatment of persistent psychosis (STOPP; Hermann‐Doig 2003). </p> <p>Delivered by: not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT was applied by delivery of 12, 90‐min sessions of individualised counselling to voice hearers over a period of 4 months. CBT consisted of reasoning and decision support, counselling strategies tied to the techniques of Socratic learning, the verbal challenge, or empirical reality trial, homework assignments, and summarisation of the counselling sessions. The counselling sessions were audio‐taped to allow for audit of the nurse's counselling strategies. </p> <p>Delivered by: an experienced psychiatric clinical nurse specialist.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The CBT intervention is based on efficacy trials conducted in the UK (Kuipers 1998). It is similar in scope and content to the therapy outlined by Fowler 1995. </p> <p>Therapists work with patients for 12‐24 sessions on agreed recovery goals using one or more of the following recovery therapy components: </p> <p> <ul id="CD007964-list-0013"> <li> <p>everyday coping,</p> </li> <li> <p>working with symptoms,</p> </li> <li> <p>understanding the experience of psychosis,</p> </li> <li> <p>strengthening adaptive view of self,</p> </li> <li> <p>personal/emotional issues or comorbid disorders,</p> </li> <li> <p>relapse prevention, and</p> </li> <li> <p>family or social reintegration.</p> </li> </ul> </p> <p>Delivered by: 12 clinical psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: An initial emphasis on engagement, education, and building a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; development of a normalising rationale for the patient's psychotic experiences; exploration and enhancement of current coping strategies; acquisition of additional coping strategies for hallucinations and delusions; and focus on accompanying affective symptomatology using relaxation training, personal effectiveness training, and problem‐solving, as appropriate. </p> <p>Delivered by: five clinical nurse specialists with extensive professional experience of severe mental disorder. The therapists received training mainly focused on CBT. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: 1. negative thoughts about the self, 2. positive activities, and 3. positive thoughts about the self. </p> <p>Delivered by: clinical psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The main techniques were psychoeducation about worry, identification and reviewing of positive and negative beliefs about worry, increasing awareness of the initiation of worry and individual triggers, use of worry periods, planning activity at times of worry (whichcould include relaxation), and learning to let go of worry. </p> <p>Delivered by: not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT targeted at relapse prevention, done by exploring people's understanding of triggers and risks of relapse and by developing a new model of disorder emphasising alternatives to delusional thinking; targets often included persistent negative beliefs about self and others, characteristic reasoning styles such as jumping to conclusions and distressing emotional reactions to events and anomalous experiences; administered by skilled practitioners (doctorial level clinical psychologists) and treatment fidelity assessed using the Cognitive Therapy for Psychosis Adherence Scale. </p> <p>Delivered by: five clinical nurse specialists with extensive professional experience of severe mental disorder. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT focused upon relapse prevention although nonadherence to treatment, substance abuse, coping with stress, and comorbid anxiety and depression were also targeted. There were parallel individual CBT sessions and family therapy sessions (based upon cognitive behavioural family therapy for schizophrenia (Falloon, 1988; Mueser &amp; Glynn, 1999). The family therapy focused upon communication skills, psychoeducation regarding relapse risk, and a review of early warning signs and documentation of a relapse prevention plan. </p> <p>Delivered by: individual research therapist, who additionally adopted the role of outpatient cases. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The treatment manual included a patient workbook that contained homework forms. The CBT was developed specifically for patients with schizophrenia; the age‐relevant content modifications were added. To simplify learning and to help patients remember to use cognitive techniques in everyday life, mnemonic aids were provided; there were also behavioural role‐playing exercises and problem‐solving skills. </p> <p>Delivered by: psychologists or senior graduate students who had 2 years of clinical experience. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: integrated treatment provided by multidisciplinary team, including pharmacotherapy and case management. Structured family psychoeducation, cognitive behavioural family education, problem‐solving skills training, individual cognitive behavioural strategies for residue symptoms. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT was divided into two phases. Targeted CBT included identifying and targeting beliefs and behaviours, which increased risk to self or others, identifying and targeting beliefs and behaviours accelerating relapse and developing alternative beliefs and reinforcing those through behaviour change. During the study period, the CBT group received a median(range) of 6 (0–14) outpatient medical consultations and 28.5 (0 – 86) community mental health team contacts. </p> <p>Delivered by: a clinical psychologist.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT procedure was edited according to previous study and guideline (<a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a> and Wright 2010). </p> <p>Delivered by: rehabilitation therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Therapy was provided according to a manualised treatment protocol (Kingdon and Turkington, 1994), and was culturally adapted. </p> <p>Delivered by: psychologist who had received training in CBTp.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content:The intervention was based on a cognitive behavioural therapy handbook developed by the investigators. The therapeutic milieu and content was applied according to the handbook. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT and risperidone.</p> <p>Delivered by: six experienced psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The cognitive behavioural therapy included wrong behaviour correction, relaxation, etc. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The cognitive therapy based recovery intervention (CRI) was designed to be delivered on a weekly basis over a 6‐month period (i.e. it was limited to a maximum of 26 sessions) and followed a protocol‐based modular approach. There were three key components: (a) engagement and formulation; (b) trauma processing; and (c) appraisals of psychotic illness (shame, loss, and entrapment). The intervention, therefore, is not just designed for those who could be described as 'traumatised' by their experiences of psychosis. It is intended to be helpful for all first‐episode patients adjusting to and recovering from a first episode of psychosis. </p> <p>Delivered by: four clinical psychologists and a cognitive behavioural psychotherapist. All clinicians had over 4 years experience in the practice of cognitive therapy for early psychosis and received regular case supervision. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Rational thinking training, helping the participant realise his or her inappropriate cognition, behavioural training, diary and health education. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: to help participants understand their symptoms and strategies to prevent the symptoms, cognitive rebuild, communication with therapists. </p> <p>The dosage of risperidone was 3.8 ± 0.7 mg/day.</p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Initial sessions were focused on facilitating engagement in treatment. Considerable effort was spent on building and maintaining a good basic therapeutic relationship, and this relationship was characterised by considerable flexibility on the part of the therapist. When necessary, treatment was arranged in locations convenient to the client, including home visits and proactive outreach. Behavioural therapy techniques, including activity scheduling, relaxation and skills training. </p> <p>Delivered by: experienced clinical psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The CBT was manual‐based with four stages.</p> <p><i>Stage 1</i>: a cognitive behavioural analysis of how symptoms might relate to cognitions, behaviour and coping strategies. Education about the nature and treatment of psychosis, using a stress vulnerability model to link biological and psychological mechanisms, was used to help engagement. </p> <p><i>Stage 2</i>: a problem list was generated collaboratively with the patient. This was then prioritised according to the degree of distress attached, feasibility and, where relevant, clinical risk involved. Prioritised problems were assessed in detail and a formulation was agreed which included such issues as trigger situations and cognitions. </p> <p><i>Stage 3</i>: Interventions particularly addressed positive psychotic symptoms of delusions and hallucinations, generating alternative hypotheses for abnormal beliefs and hallucinations, identifying precipitating and alleviating factors and reducing associated distress. </p> <p><i>Stage 4</i>: monitoring positive psychotic symptoms of delusions and hallucinations. </p> <p>Delivered by:one of five therapists trained in CBT in psychosis, supervised by experienced cognitive therapists. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Cognitive therapy was conducted to help participant correct their wrong beliefs or thinking process; establish and intensify the right cognition. </p> <p>Delivered by: not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation about voice; discuss the content of hallucinations; introduction of the ABC model; discuss the link between voice and behaviour; coping strategies. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: building of a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; scheduling of activity; simulated scene training and case explanation; exploration and enhancement of current coping strategies; homework assignments. </p> <p>Delivered by: therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: functional analysis of symptoms and negative behaviour, providing treatment therapy, help patients to develop positive attitude, improve cognitive abilities, reduce conflicts with social interactions, improve clinical compliance, reduce negative mood, improve the way of thinking. </p> <p>Delivered by: specially trained therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: rehabilitation training, cognitive and behaviour modification, life skill training, rebuild the link between cognition, behaviour, and psychology. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognitive coping strategies, behavioural therapy, etc.</p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT therapy included a therapeutic alliance building with patients, help to develop personal behaviour control ability, help to correct cognitions in thought, beliefs and attitudes, help patients to aware of the importance of medications. </p> <p>Delivered by: therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: A spiritual dimension was included in formulation, understanding and in therapy plan; Urdu equivalents of CBT jargons were used in the therapy; culturally appropriate homework assignments were selected and participants were encouraged to attend even if they were unable to complete their homework; folk stories and examples relevant to the religious beliefs of the local population were used to clarify issues. </p> <p>Delivered by: psychology graduates with more than 5 years experience of working in mental health. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBTp consisted of a total of 17 handouts and eight worksheets, that could be flexibly given by a health professional over 12‐16 sessions. The handouts focused on psychoeducation, dealing with hallucinations, paranoia, changing negative thinking, behavioural activation, problem‐solving, improving relationships and communication skills. Health professionals were trained in formulating and devising a plan to suit the individuals' needs. The intervention was then delivered according to this plan. </p> <p>Frequency: a 15‐30 minutes CBT was conducted in each session.</p> <p>Delivered by: frontline mental health professionals.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: not stated.</p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT combined with antipsychotics. CBT involves: 1) establish the consultant connection between participants and investigator; 2) help the participants recognise their wrong beliefs and thinking process; 3) help the participants realize their wrong recognition based on their problematic beliefs and guiding them to the correct recognition style; 4) help the participants realise and correct the inappropriate points in their thinking process. 5) encourage the participant to express his/her own viewpoints and promote his/her introspectiveness. 6) help the participants inspect their external misconceptions and correct the deep cause of misconceptions by demonstration, imitation, or didactic suggestion; 7) help participants consolidate their reestablished conceptions and beliefs. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognition correction and group psychoeducation, training exercise.</p> <p>Delivered by: psychologists or nurse.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: coping strategies and relapse prevention.</p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The CBT approach in this study was guided by the principles and strategies developed by Beck et al. (1979, 1985). The first phase of therapy focused on engagement and assessment. The second phase of therapy aimed to socialise the patient to the cognitive model and to impart cognitive and behavioural coping skills, including self‐monitoring with a thought record and the completion of homework tasks. Overlapping with the first two phases of treatment, a third aspect of treatment focused on providing psychoeducation with a normalising rationale. </p> <p>Delivered by: two doctoral level psychologists and one psychiatrist, all with formal training and practice in cognitive behavioural interventions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: This is a highly individualised, needs‐based form of CBT for psychotic disorders and is based on collaborative empiricism and (evolving) cognitive‐behavioural formulations. </p> <p>Delivered by: clinical psychologists who were employed as specialists in serious mental illness and conducted CBT for schizophrenia on a routine basis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT included the building of a therapeutic alliance with patients, functional analysis of symptoms, help to deal with hallucinations and delusions, relaxation training, personal effectiveness training and problem‐solving, as appropriate. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: coping strategy enhancement, training in problem‐solving, strategies to reduce relapse plus standard care. </p> <p>Delivered by: three experienced clinical psychologists and followed a protocol manual.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBSPp was based on a treatment manual and was derived from an explanatory model of suicide behaviour; the intervention consisted of three phases: 1) Information processing biases; 2) appraisals of defeat, entrapment, social isolation, emotional dysregulation, and interpersonal problem‐solving. 3) suicide schema. </p> <p>Delivered by: clinical psychologists (JK, JM) who had extensive experience in delivering CBT for psychosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: four core dysfunctional beliefs (and their functional relation to behaviour and emotion) that define the client ‐ voice (social rank) power relationship. Using the methods of collaborative empiricism and Socratic dialogue, the therapist seeks to engage the client to question, challenge and undermine the power beliefs, then to use behavioural tests to help the client gain disconfirming evidence against the beliefs. These strategies are also used to build clients' alternative beliefs in their own power and status, and finally, where appropriate, to explore the origins of the schema so clients have an explanation for why they developed those beliefs about the voice in the first place. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: based on same manual used in Turkington 2000, including assessment and engaging, developing explanations, case formulation, symptom management, adherence, working with core beliefs and relapse prevention. </p> <p>Delivered by: nurses receiving 10 days of intensive training.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The focus of the sessions was on patient‐identified problems, particularly those that interfered with daily functioning or were distressing, normalising symptoms, and using CBT techniques to develop alternative explanations. </p> <p>Delivered by: master's and doctoral level professionals with &gt; 2 years' experience in assessment and treatment of serious mental illness. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: help patients to understand their symptoms and the impact of symptoms to emotion, realise the relationship between behaviour and disease; strengthened behaviour therapy; cognitive behavioural therapy. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation about symptoms and relapse, coping strategies to hallucination and delusions; cognitive modification. </p> <p>Delivered by: 6 psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The intervention was based on two published cognitive behavioural therapy handbooks. </p> <p>Delivered by: psychologist who had been trained to conduct CBT.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: establishing therapeutic relationship and collating comprehensive illness history of individual patients. Treatment is divided into psychological and behaviour aspects. Participants were give psychoeducation about schizophrenia symptoms in order to improve treatment compliance, and meanwhile, behavioural intervention was given to reinforce symptom self‐monitoring, relapse prevention, and ways of managing thoughts and actions. Standard care is Risperidol, 0.5 mg/day, increased to 4 mg/day by the second week of intervention and maximum dosage is 6 mg/day. </p> <p>Delivered by: psychologist who had been trained to conduct CBT.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT included: 1) active promotion of social activity; 2) help to deal with hallucinations, paranoia, changing negative thinking; 3) help to self‐regulate psychotic symptoms and improve social recovery from psychosis; 4) psychoeducation; 5) relax training with a duration of 30 minutes; 6) promoting of patients' and guardians' confidence; 7) activity scheduling. </p> <p>Delivered by: qualified doctors and senior nurse.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation and cognition modification.</p> <p>Delivered by: three psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT included cognitive therapy and rational‐emotive therapy. Cognitive therapy helped patients to change negative thinking by providing psychoeducation. In rational‐emotive therapy, doctors planned therapy for each patient individually depending on patients' background and symptoms, to help patients to build up confidence and solve emotional problems. The therapies included psycho‐diagnosis, helping patients to understand, analysis of patients' background, implementation and strengthening of therapies. </p> <p>Delivered by: qualified doctors.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation about symptoms and coping strategies to symptoms; cognition modification, and encouragement of social intercourse. </p> <p>Delivered by: five psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: practicing daily life activity, recreation therapy, and cognition modification.</p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognition modification, psychoeducation about disease, and physical exercise.</p> <p>Delivered by: nurses who had five years experience of CBT.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>√ = criteria fulfilled; ✗ = criteria not fulfilled; ? = unclear.</p> </div> </div> <section id="CD007964-sec-0122"> <h6 class="title">5.1 Cognitive behavioural therapy</h6> <p>In 47 trials, the CBT intervention was not mixed with other contemporaneous active psychological therapies which would not normally be a standard component of CBT. However, three trials (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>) did not describe enough detail in the report, therefore, it is not clear whether the CBT included other active therapies. Ten trials included other active therapies in the CBT arm. <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> used family intervention in the CBT arm, and the family therapy focused upon communication skills, psychoeducation regarding relapse risk, and a review of early warning signs and documentation of a relapse prevention plan. The differential effects of the CBT and the family intervention were not evaluated. Likewise, four trials (<a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>) incorporated life skill training or social skill training with CBT the intervention. <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a> described a CBT intervention which included skills training, however, did not provide more detail about the skills. Two trials (<a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a>; <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>) combined physical exercise with CBT therapy. <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> used case formulation which is not a standard component of CBT. <a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a> engaged the participants in the CBT group to receive recreation therapy such as watching television, listening to music, dancing, or other physical activity. </p> <p>The CBT interventions varied with regards to both the target of the therapy and the degree of specificity of the focus of the intervention. For example, <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a> and <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> used a CBT intervention focused on engagement in treatment, medication compliance, and enhancement of coping strategies, whereas <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> used a CBT only focused on relapse prevention. <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> had a wider focus, incorporating schizophrenia relevant symptoms, relapse prevention, personal/emotional issues or comorbid disorders, and family or social reintegration. </p> <p>Some trials focused on using CBT for specific symptoms. For example, <a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> and <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a> assessed CBT's effect on the command hallucination. <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> assessed the effect of CBT for worry. The CBT described by <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> focused on coping with stress, anxiety, and depression. </p> <section id="CD007964-sec-0123"> <p><b>5.1.1 Well‐defined CBT</b></p> <p>Only 27 trials met our criteria for 'well‐defined CBT' (see <a href="#CD007964-sec-0040">Types of interventions</a>), in that they clearly reported a therapeutic focus on belief change or re‐evaluating the subjective meaning of symptoms. We assessed 22 trials as not 'well‐defined' CBT as the CBT intervention did not explicitly establish links between participant's thoughts and symptoms and there was a lack of re‐evaluation regarding perceptions, beliefs, or reasoning related to the target symptoms. It is difficult to judge whether the CBT is well defined in 11 trials as the description about CBT was unclear. <a href="#CD007964-tbl-0002">Table 1</a> gives more details. </p> </section> <section id="CD007964-sec-0124"> <p><b>5.1.2 CBT provided by qualified therapists</b></p> <p>Twenty‐nine trials met the criteria for qualified CBT therapists (see <a href="#CD007964-sec-0040">Types of interventions</a>). The therapists in nine trials did not meet our criteria. The remaining 22 trials did not provide sufficient information to assess the experience of the CBT therapists. <a href="#CD007964-tbl-0002">Table 1</a> gives more details. </p> </section> </section> <section id="CD007964-sec-0125"> <h6 class="title">5.2 Standard care</h6> <p>Standard care in the included trials typically involved antipsychotics treatment, nursing care, community‐based healthcare such as community follow‐up, community‐based rehabilitative activities, early intervention, medication monitoring by their psychiatrists, case management, psychoeducation, as well as family support. For 12 trials, standard care involved only antipsychotic treatment (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>; <a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>; <a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a>; <a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>). </p> </section> </section> <section id="CD007964-sec-0126"> <h5 class="title">6. Outcomes</h5> <p>We grouped the symptoms into categories such as global state, mental state and others (<a href="#CD007964-tbl-0003">Table 2</a> presents further details of this categorisation). </p> <div class="table" id="CD007964-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcome categories</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These relate to meaningful changes in symptomatology and general clinical condition, recovery and well‐being. These outcomes include relapse, rehospitalisation, healthy days, or other clinical important change in global state. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mental state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These refer to presence or absence of symptoms of psychosis as well as continuous measures relating to characteristics of such symptoms (e.g. preoccupation; conviction; frequency; duration; intensity, loudness; perceived interference with daily living) and insight. Measures of general affect (e.g. anxiety, depression, shame, hopelessness, anger; self‐esteem) and symptom‐related affect measures (e.g. voice‐related distress; delusional distress) are also considered. The presence or frequency of problematic behaviours (suicide attempts; deliberate self‐harm; violence to others, etc.) and functional and adaptive behaviours (e.g. increased coping strategies) are included. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All health interventions have the capacity for unintended and unwanted side effects. To date, there has been a paucity of studies that have attempted to identify adverse effects of psychological therapies. Such outcomes might include dependency, increased distress, increased family dysfunction, and disengagement from mental health services. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include changes in employment, occupational and educational status, level of received benefits or social welfare, perceived quality of life, and level of social functioning. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include changes in the general quality of life or specific aspects relevant to quality of life. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfaction with treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include both recipients of care satisfied with treatment and carers' satisfaction with treatment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Engagement with service</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of service utilisation and functional outcomes may convey important information regarding health economic benefits, as well as provide indirect markers of personal independence. Such outcomes might include number of acute hospital/inpatient respite days, number of acute hospital admissions or equivalent (e.g. home treatment/crisis team intervention; respite admissions), changes in legal status (MHA 1983), changes in level of care (including accommodation type and intensity of service (Assertive Outreach Team versus Community Mental Health Team)). These outcomes would also include alterations in the degree of compliance with the prescribed medication regimen, as well as alterations to the prescribed medication including changes in type of medication and prescribed dosage. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Economic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Direct costs of care and Indirect costs of care.</p> </td> </tr> </tbody> </table> </div> <section id="CD007964-sec-0127"> <h6 class="title">6.1 Relapse</h6> <p>Relapse data were reported in 17 trials (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>; <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>). However, different trials used varied criteria for relapse. For instance, <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> defined relapse as "an exacerbation of psychotic symptoms that lasted for longer than 2 weeks and resulted in a change in participant management (increased observation by the clinical team, increase in antipsychotic medication, or both)". <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> defined relapse as "the re‐emergence of, or significant deterioration in, positive psychotic symptoms of at least moderate degree persisting for at least 2 weeks" whereas <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> adopted the following criteria for relapse: "3 (mild) or below to ratings of 6 or 7 (severe and very severe) on any one of the three items: (a) unusual thought content, (b) hallucinations, and (c) conceptual disorganization, with a duration criterion of 1 week added for the purpose of differentiating relapses from brief flurries of symptoms." Gumley and colleagues used two sets of criteria for relapse: "For participants with residual symptoms, a 50% increase in the positive scale score, sustained for at least 1 week, was defined as relapse; for those without residual symptoms, an increase in positive symptoms (rated ≥ 3), sustained for at least I week, was defined as relapse" (<a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>). Lewis and colleagues defined relapse as "an exacerbation of psychotic symptoms lasting longer than one week and leading to a change in patient management as recorded by hospital charts such as increases in medication, admission and so on" (<a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>). </p> </section> <section id="CD007964-sec-0128"> <h6 class="title">6.2 Rehospitalisation</h6> <p>Seven studies reported this outcome (<a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>). </p> </section> <section id="CD007964-sec-0129"> <h6 class="title">6.3 Global state</h6> <section id="CD007964-sec-0130"> <p><b>6.3.1 Clinically important change</b></p> <p>Three trials reported clinically important change in global state (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>). <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> used scores on the BPRS positive with a Clinical Global Impression (CGI) severity rating. In both these scales, low scores indicate less severity of symptoms. Participants with a score higher than 3 on the BPRS or a rating of moderate or higher on the CGI were considered to have 'no improvement'. <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> used scores on the CGI‐GI of less than 2 to indicate 'no improvement'. <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a> did not describe how they defined 'no improvement'. </p> </section> <section id="CD007964-sec-0131"> <p><b>6.3.2 Global state scales reporting useful data</b></p> <p> <ul id="CD007964-list-0014"> <li> <p>Clinical Global Impression scale ‐ CGI (<a href="./references#CD007964-bbs2-0230" title="GuyW , Rockville , MD , editor(s) . Clinical global impression. ECDEU Assessment Manual for Psychopharmacology. Washington DC (USA): US Department of Health, Education and Welfare, 1976. ">Guy 1976</a>) </p> </li> </ul> </p> <p>Three trials (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>) also reported continuous measurements of global state by using the Clinical Global Impression (CGI) scale. CGI is a three‐item scale used to measure the global severity of illness. Higher scores indicate greater severity of clinical condition. </p> </section> </section> <section id="CD007964-sec-0132"> <h6 class="title">6.3 Mental state</h6> <p><i>6.3.1 Clinically important change</i> </p> <p>Eleven trials reported clinically important change in mental health (<a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>). The definitions of important or reliable change varied between the trials; some used measures for 'improvement', others used measures for 'no improvement. For example, <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a> used the criteria of 50% decrease in symptom severity on the PANSS as clinically important change of mental state. <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> defined important or reliable change as partial or full remission of symptoms without further episode. Four trials (<a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>) defined no clinical improvement as a decrease rate of PANSS score &lt; 25%. <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a> and <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a> defined no clinical improvement as a decrease rate of BPRS score &lt; 30%, and <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a> defined that as a decreased rate of BPRS score &lt; 25% . <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a> used a change of less than five points on the BPRS as indicating no reliable clinical change. <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a> defined this outcome as less than 50% improvement in psychotic symptoms in both severity and number of symptoms. </p> <p><a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> also reported data for clinically important change in hallucination, which was defined as "a less than 3‐point improvement in hallucination severity scores measured as a voice hearer's score on item 12 of the BPRS". <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> reported data for clinically important change in depression. </p> <p>Trialists also reported a continuous measure of mental health outcomes.</p> <section id="CD007964-sec-0133"> <p><b>6.3.2 Mental state scales reporting useful data</b></p> <p> <ul id="CD007964-list-0015"> <li> <p>Auditory Hallucinations Rating Scale ‐ AHRS (<a href="./references#CD007964-bbs2-0239" title="HoffmanRE , HawkinsKA , GueorguievaR , BoutrosNN , RachidF , CarrollK , KrystalJH . Transcranial magnetic stimulation of left temporoparietal cortex and medication‐resistant auditory hallucinations. Archives General Psychiatry2003;60:49‐56. ">Hoffman 2003</a>) </p> </li> </ul> </p> <p>AHRS is a 7‐item questionnaire measuring the severity of hallucination including "hallucination frequency, number of distinct speaking voices, perceived loudness, vividness, attentional salience, length of hallucinations, and degree of distress". Higher score indicates severe hallucination. Two trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>). </p> <p> <ul id="CD007964-list-0016"> <li> <p>Beck Anxiety Inventory ‐ BAI/BAS (<a href="./references#CD007964-bbs2-0222" title="FydrichT , DowdallD , ChamblessDL . Reliability and validity of the Beck Anxiety Inventory. Journal of Anxiety Disorders1992;6:55‐61. ">Fydrich 1992</a>) </p> </li> </ul> </p> <p>BAI is a self‐reported 4‐point inventory for measuring the severity of anxiety. The scale includes 21 items describing common symptoms of anxiety. The total score ranges from 0 to 63, and a higher score indicates severe anxiety. Five trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>). </p> <p> <ul id="CD007964-list-0017"> <li> <p>Beliefs About Voices Questionnaire ‐ BAVQ (<a href="./references#CD007964-bbs2-0203" title="ChadwickP , LeesS , BirchwoodM . The revised Beliefs About Voices Questionnaire (BAVQ‐R). British Journal of Psychiatry2000;177:229‐32. ">Chadwick 2000</a>) </p> </li> </ul> </p> <p>BAVQ is a self‐reported scale measuring key beliefs about auditory hallucinations. Higher scores represent more severe symptoms. One study used this scale (<a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>). </p> <p> <ul id="CD007964-list-0018"> <li> <p>Beck Cognitive Insight Scale ‐ BCIS (<a href="./references#CD007964-bbs2-0197" title="BeckAT , BaruchE , BalterJM , et al. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophrenia Research2004;68:319‐29. ">Beck 2004</a>) </p> </li> </ul> </p> <p>BCIS (29) is a 15‐item self‐report inventory for measuring insight. The scale includes two subscales, self‐reflectiveness and self‐certainty, with higher scores indicating better cognitive insight. One trial reported outcomes on this scale (<a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>). </p> <p> <ul id="CD007964-list-0019"> <li> <p>Beck Depression Inventory ‐ BDI/BDS (<a href="./references#CD007964-bbs2-0195" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives General Psychiatry1961;4:561‐71. ">Beck 1961</a>) </p> </li> </ul> </p> <p>BDI is a self‐report questionnaire measuring the intensity of depressive symptoms. The 4‐point scale (0‐3) includes 21 items with total score ranging from 0 to 61. Higher scores indicate severe depression. Five trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>). </p> <p> <ul id="CD007964-list-0020"> <li> <p>Beck Hopelessness Scale ‐ BHS (<a href="./references#CD007964-bbs2-0196" title="BeckAT , WeissmanA , LesterD , et al. The measurement of pessimism: the Hopelessness Scale. Journal of Consulting and Clinical Psychology1974;42:861‐5. ">Beck 1974</a>) </p> </li> </ul> </p> <p>BHS is a 20‐item scale for assessment of hopelessness for the future. The possible score ranges from 0 to 20 with higher scores indicating poor hope for the future. Three trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>). </p> <p> <ul id="CD007964-list-0021"> <li> <p>Brief Psychiatric Rating Scale ‐ BPRS (<a href="./references#CD007964-bbs2-0260" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>) </p> </li> </ul> </p> <p>The BPRS is an 18‐item scale measuring positive symptoms, general psychopathology, and affective symptoms. Each item is rated on a 7‐point scale varying from 'not present' to 'extremely severe'. The possible score ranges from 0 to 126 with high scores indicating more severe symptoms. Nine trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>). </p> <p> <ul id="CD007964-list-0022"> <li> <p>Brief Core Schema Scales (BCSS) (<a href="./references#CD007964-bbs2-0220" title="FowlerD , FreemanD , SmithB , KuipersE , BebbingtonP , BashforthH . The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non‐clinical and psychosis samples. Psychological Medicine2006;36:749–59. ">Fowler 2006</a>) </p> </li> </ul> </p> <p>The self‐report BCSS is a five‐point scale assessing negative and positive beliefs about the self and others with 24 items. Higher scores reflect greater endorsement of items. One study used this scale (<a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>). </p> <p> <ul id="CD007964-list-0023"> <li> <p>Comphrehensive Schizophrenia Change Scale ‐ CPRS (<a href="./references#CD007964-bbs2-0194" title="AsbergM , MontgomerySA , PerrisC , SchallingD , SedvallG . A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica1978;271:5‐27. ">Asberg 1978</a>) </p> </li> </ul> </p> <p>CPRS is a scale for rating the severity of psychiatric symptoms and observed behaviour. It consists of 65 items covering symptoms commonly reported by participants with higher scores indicating more severe symptoms. One trial reported outcomes on this scale (<a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>). </p> <p> <ul id="CD007964-list-0024"> <li> <p>Choice of Outcome In Cbt for psychosEs ‐ CHOICE (<a href="./references#CD007964-bbs2-0228" title="GreenwoodKE , SweeneyA , WilliamsS , GaretyP , KuipersE , ScottJ , et al. CHoice of Outcome In Cbt for psychosEs (CHOICE): the development of a new service user‐led outcome measure of CBT for psychosis. Schizophrenia Bulletin2010;36(1):126‐35. [PUBMED: 19880823] ">Greenwood 2010</a>) </p> </li> </ul> </p> <p>CHOICE is a self‐reported 24‐item scale used to measure the severity of diease and satisfaction of participants. A higher score indicates better patient outcomes. One study used this scale (<a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>). </p> <p> <ul id="CD007964-list-0025"> <li> <p>Calgary Depression Scale ‐ CDS (<a href="./references#CD007964-bbs2-0187" title="AddingtonD , AddingtonJ , MatickatyndaleE . Assessing depression in schizophrenia: the Calgary Depression Scale. British Journal of Psychiatry1993;163(Suppl):39‐44. ">Addington 1993</a>) </p> </li> </ul> </p> <p>CDS is a 9‐item scale designed to measure depression in schizophrenia patients without negative symptoms. The possible score ranges from 0 to 27 with higher scores indicating poor depression state. Four trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>). </p> <p> <ul id="CD007964-list-0026"> <li> <p>Green Paranoid Thoughts Scale ‐ GPTS (<a href="./references#CD007964-bbs2-0227" title="GreenCE , FreemanD , KuipersE , et al. Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS). Psychological Medicine2008;38:101‐11. ">Green 2008</a>) </p> </li> </ul> </p> <p>GPTS is a 32‐item self‐reported scale measuring paranoid thinking. Each item is rated on a 5‐point scale. A high score means greater level of paranoid thinking. Two trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>). </p> <p> <ul id="CD007964-list-0027"> <li> <p>General Self‐Efficacy Scale ‐ GSES (<a href="./references#CD007964-bbs2-0278" title="WangX . Manual of Mental Health Rating Scales. Beijing: Journal of China Mental Health, 1998. ">Wang 1998</a>) </p> </li> </ul> </p> <p>GSES is a 10‐item psychometric scale that is designed to assess optimistic self‐beliefs to cope with a variety of difficult demands in life. A higher score indicates better self‐efficacy. Two trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a>; <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a>). </p> <p> <ul id="CD007964-list-0028"> <li> <p>Hospital Anxiety and Depression Scale ‐ HADS (<a href="./references#CD007964-bbs2-0286" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavia1983;67:361‐70. ">Zigmond 1983</a>) </p> </li> </ul> </p> <p>The Hospital Anxiety and Depression Scale consists of 14 items assessing the severity of anxiety and depression during hospitalisation. Each item is rated on 4‐point scale (0‐3). The possible score ranges from 0 to 52 with higher scores indicating poor depression/anxiety states. One trial reported data on this scale (<a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>). </p> <p> <ul id="CD007964-list-0029"> <li> <p>Hamilton Rating Scale for Depression/Hamilton Depression Rating Scale ‐ HAMD (<a href="./references#CD007964-bbs2-0231" title="HamiltonM . Development of a rating scale for primary depressive illness. British Journal Social Clinical Psychology1967;6:278‐96. ">Hamilton 1967</a>) </p> </li> </ul> </p> <p>HAMD is 17‐item scale used to assess the severity of depression. Each item is rated on 3‐ or 5‐ point scale. A higher score indicates severe depression. Three trials reported data on this scale (<a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>). </p> <p> <ul id="CD007964-list-0030"> <li> <p>Hamilton Anxiety Rating Scale ‐ HAMA (<a href="./references#CD007964-bbs2-0232" title="HamiltonM . HAMA Hamilton Anxiety Scale. ECDEU Assessment Manual for Psychopharmacology193‐8. ">Hamilton 1976</a>) </p> </li> </ul> </p> <p>HAMA is a 14‐item psychological questionnaire to assess the severity of anxiety. Each item is rated on 5‐point scale, with a possible total score varying from 0 to 56. A higher score indicates severe anxiety. One trial reported data on this scale (<a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>). </p> <p> <ul id="CD007964-list-0031"> <li> <p>Insight Treatment Attitude Questionnaire ‐ ITAQ (<a href="./references#CD007964-bbs2-0252" title="McEvoyJP , et al. Insight in schizophrenia. Its relationship to acute psychopathology. Journal of Nervous Mental Disorders1989;177:43‐7. ">McEvoy 1989</a>) </p> </li> </ul> </p> <p>ITAQ is a 11‐item questionnaire for measuring awareness of illness and attitude to medication and services, as well as follow‐up evaluation. The possible total score ranges from 0 to 22, with high scores indicating better insight. Two trials reported data on this scale (<a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>). </p> <p> <ul id="CD007964-list-0032"> <li> <p>Montgomery–Åsberg Depression Rating Scale ‐ MADRS (<a href="./references#CD007964-bbs2-0257" title="MontgomerySA , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134:382‐9. ">Montgomery 1979</a>) </p> </li> </ul> </p> <p>MADRS is a 10‐item scale for measuring severity of depressive episodes in people with mood disorders. The total possible score ranges from 0 to 54 points, with higher scores indicating worse outcome. Two trials reported data on this scale (<a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>). </p> <p> <ul id="CD007964-list-0033"> <li> <p>Negative Symptom Rating scale ‐ NSRS (<a href="./references#CD007964-bbs2-0241" title="IagerAC , KirchDG , WyattRJ . A negative symptom rating scale. Psychiatry Research1985;16:27‐36. ">Iager 1985</a>) </p> </li> </ul> </p> <p>NSRS is a valid instrument assessing negative symptoms in schizophrenia, with higher scores indicating worse outcomes. One trial reported data on this scale (<a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>). </p> <p> <ul id="CD007964-list-0034"> <li> <p>Positive and Negative Syndrome Scale ‐ PANSS (<a href="./references#CD007964-bbs2-0246" title="KaySR , FiszbeinA , OplerLA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13:261‐76. ">Kay 1987</a>) </p> </li> </ul> </p> <p>PANSS is a 30‐item scale including three subscales for measuring the severity of general psychopathology, positive symptoms, and negative symptoms. Each item is rated on a 7‐point scale, with higher scores indicating worse outcome. Thirty trials reported data on this outcome (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>; <a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>; <a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a>). </p> <p> <ul id="CD007964-list-0035"> <li> <p>Penn State Worry Questionnaire ‐ PSWQ (<a href="./references#CD007964-bbs2-0255" title="MeyerTJ , MillerML , MetzgerRL , BorkovecTD . Development and validation of the Penn state worry questionnaire. Behaviour Research and Therapy1990;28:487‐95. ">Meyer 1990</a>) </p> </li> </ul> </p> <p>PSWQ is a 16‐item questionnaire that aims to measure the trait of worry, using Likert rating from 1 (not at all typical of me) to 5 (very typical of me). Higher PSWQ scores reflect greater levels of pathological worry. One trial reported outcomes on this scale (<a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>). </p> <p> <ul id="CD007964-list-0036"> <li> <p>Psychotic Symptom Rating Scales ‐ PsyRATs (<a href="./references#CD007964-bbs2-0233" title="HaddockG , MccarronJ , TarrierN , FaragherE . Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine1999;29:879‐89. ">Hassock 1999</a>) </p> </li> </ul> </p> <p>PsyRATs aims to assess dimensions of hallucination and delusions reliably and validly. Higher scores indicate severer symptoms. Ten trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>; <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>). </p> <p> <ul id="CD007964-list-0037"> <li> <p>Perseverative Thinking Questionnaire ‐ PTQ (<a href="./references#CD007964-bbs2-0217" title="EhringT , ZetscheU , WeidackerK , WahlK , SchönfeldS , EhlersA . The Perseverative Thinking Questionnaire (PTQ): validation of a content‐independent measure of repetitive negative thinking. Journal of Behavior Therapy and Experimental Psychiatry2011;42:225‐32. ">Ehring 2011</a>) </p> </li> </ul> </p> <p>PTQ is a self‐administered, 15‐item, Likert‐type scale designed to measure the broad idea of repetitive negative thought. One trial reported outcomes on this scale (<a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>). </p> <p> <ul id="CD007964-list-0038"> <li> <p>Robson Self Concept Questionnaire ‐ RSCQ (<a href="./references#CD007964-bbs2-0263" title="RobsonP . Development of a new self report questionnaire to measure self‐esteem. Psychological Medicine1989;19:513‐8. ">Robson 1989</a>) </p> </li> </ul> </p> <p>RSCQ is a psychological scale used to measure self‐esteem. A score of 1 standard deviation below the mean (total score of &lt;= 120) indicates low self‐esteem. The scale comprises 30 items, with responses rated on an 8‐point scale (0 to 8) that range from "completely disagree" to "completely agree". Three trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a>; <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a>). </p> <p> <ul id="CD007964-list-0039"> <li> <p>Rosenberg Self‐Esteem Scale ‐ RSES/SES (<a href="./references#CD007964-bbs2-0264" title="Rosenberg . Society and the Adolescent Self‐image. Princeton, NJ: Princeton University Press, 1965. ">Rosenberg 1965</a>) </p> </li> </ul> </p> <p>RESR is a 10‐item self‐reported scale for measuring self‐esteem. Each item is rated on a 4‐point scale (from 1 to 4). Higher scores indicate higher self‐esteem. Two trials reported data on this scale (<a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>;). </p> <p> <ul id="CD007964-list-0040"> <li> <p>Schedule of Assessment of Insight ‐ SAI (<a href="./references#CD007964-bbs2-0206" title="DavidAS . Insight and psychosis. British Journal of Psychiatry1990;156:789‐808. ">David 1990</a>) </p> </li> </ul> </p> <p>SAI measures the dimensions of relabelling of unusual mental events as abnormal, awareness of illness, and recognition of the need for treatment. Four trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>). </p> <p> <ul id="CD007964-list-0041"> <li> <p>Scale for the Assessment of Negative Symptoms ‐ SANS (<a href="./references#CD007964-bbs2-0191" title="AndreasenNC . Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa, 1984. ">Andreasen 1984</a>) </p> </li> </ul> </p> <p>The SANS is a valid instrument to assess the negative symptoms of schizophrenia. Each item is based on 6‐point scale. Higher scores indicate more symptoms. Four trials reported data on this outcome (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>; <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a>). </p> <p> <ul id="CD007964-list-0042"> <li> <p>Scale for the Assessment of Positive Symptoms ‐ SAPS (<a href="./references#CD007964-bbs2-0190" title="AnderasenNC . Scale for the Assessment of Positive Symptoms (SAPS). 2004. ">Anderasen 2004</a>) </p> </li> </ul> </p> <p>SAPS is a rating scale to measure positive symptoms in schizophrenia. The scale is split into 4 domains, and within each domain separate symptoms are rated from 0 (absent) to 5 (severe). One trial reported outcomes on this scale (<a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>). </p> <p> <ul id="CD007964-list-0043"> <li> <p>Symptom Assessment Scale ‐ SAS (<a href="./references#CD007964-bbs2-0192" title="AounSM , MonterossoL , KristjansonLJ , et al. Measuring symptom distress in palliative care: psychometric properties of the Symptom Assessment Scale (SAS). Journal of Palliative Medicine2011;14:315‐21. ">Aoun 2011</a>) </p> </li> </ul> </p> <p>SAS describes the participant's level of distress relating to individual physical symptoms on a scale of 0 to 10. Two trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a>; <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a>). </p> <p> <ul id="CD007964-list-0044"> <li> <p>Symptom Checklist 90 ‐ SCL‐90 (<a href="./references#CD007964-bbs2-0210" title="DerogatisL R . SCL‐90‐R: Symptom Checklist‐90‐R: Administration, scoring, and procedures manual. NCS Pearson, 1975. ">Derogatis 1975</a>) </p> </li> </ul> </p> <p>SCL‐90 is a relatively brief self‐report psychometric instrument (questionnaire). It consists of 90 items, yielding nine scores along primary symptom dimensions and three scores among global distress indices. The primary symptom dimensions that are assessed are somatisation, obsessive‐compulsive disorder, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of 'additional items' which helps clinicians assess other aspect of the clients symptoms. Two trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a>; <a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a>). </p> <p> <ul id="CD007964-list-0045"> <li> <p>Severity of Dependence Scale ‐ SDS (<a href="./references#CD007964-bbs2-0224" title="GossopM , DarkeS , GriffithsP , et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction1995;90:607‐14. ">Gossop 1995</a>) </p> </li> </ul> </p> <p>SDS is a 5‐item questionnaire that provides a score indicating the severity of dependence on opioids. Each of the five items is scored on a 4‐point scale (0‐3). The total score is obtained through the addition of the 5‐item ratings. Two trials reported outcomes on this scale (<a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a>; <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a>). </p> <p> <ul id="CD007964-list-0046"> <li> <p>Self‐Esteem Rating Scale‐Short form ‐ SERS‐SF (<a href="./references#CD007964-bbs2-0247" title="LecomteT , CorbièreM , LaisnéF . Investigating self‐esteem in individuals with schizophrenia: relevance of the Self‐Esteem Rating Scale‐Short Form. Psychiatry Research2006;143:99‐108. ">Lecomte 2006</a>) </p> </li> </ul> </p> <p>SERS‐SF is a 20‐item scale measuring self‐esteem. It consists of two subscales: 10 items for positive symptoms and 10 items for negative symptoms. Each item is rated on a 7‐point scale with higher scores indicating better self‐esteem. The possible scores for positive symptoms ranges from 10 to 70 and for negative symptoms ranges from ‐10 to ‐70. One trial reported this outcome (<a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>). </p> <p> <ul id="CD007964-list-0047"> <li> <p>Self‐Reflection and Insight Scale ‐ SRIS (<a href="./references#CD007964-bbs2-0225" title="GrantAM , FranklinJ , LangfordP . The self‐reflection and insight scale: a new measure of private self‐consciousness. Social Behavior and Personality2002;30:821‐35. ">Grant 2002</a>) </p> </li> </ul> </p> <p>SRIS is a 20‐item scale, which delineates two different factors: self‐reflection and insight. One trial reported outcomes on this scale (<a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>). </p> <p><a href="./references#CD007964-bbs2-0107" title="LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous Mental Disorders2008;196:866‐75. ">Lecomte 2008</a>a also reported specific affective symptoms (insight) by the insight scale. </p> <p> <ul id="CD007964-list-0048"> <li> <p>The Voice Power Differential scale ‐ VPD (<a href="./references#CD007964-bbs2-0200" title="BirchwoodM , MeadenA , TrowerP , BirchwoodM , MeadenA , TrowerP , et al. The power and omnipotence of voices: subordination and entrapment by voices and significant others. Psychological Medicine2000;30:337‐44. ">Birchwood 2000</a>) </p> </li> </ul> </p> <p>The VPD is a five‐point rating scale to measure the perceived relative power differential between voice and voice hearer. Higher scores indicate severe power of the dominant voice. One study reported this outcome (<a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>) </p> <p> <ul id="CD007964-list-0049"> <li> <p>The Voice Compliance Scale ‐ VCS (<a href="./references#CD007964-bbs2-0266" title="Beck‐SanderA , BirchwoodM , ChadwickP . Acting on command hallucinations: a cognitive approach. British Journal of Clinical Psychology1997;36:139‐48. ">Sander 1997</a>) </p> </li> </ul> </p> <p>The VCS is an observer‐rated scale to measure the frequency of command hallucinations and the level of compliance/hallucinations. Higher scores indicated severe hallucinations. One study reported this outcome (<a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>). </p> </section> </section> <section id="CD007964-sec-0134"> <h6 class="title">6.4 Adverse effect(s)/event(s)</h6> <p>Two trials reported rates for any adverse effects (<a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>). Three trials (<a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a>) reported rates for specific adverse events such as suicide attempts, violent incidence, and others. Two trials (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>) reported data on the Treatment Emergent Symptom Scale (TESS). Mortality was only reported in nine trials (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>), with <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> specifically reporting suicides. </p> </section> <section id="CD007964-sec-0135"> <h6 class="title">6.4 Functioning</h6> <p><i>6.4.1 Scales reporting useful data</i> </p> <p> <ul id="CD007964-list-0050"> <li> <p>Children's Memory Scale ‐ CMS (<a href="./references#CD007964-bbs2-0205" title="CohenM . Children's Memory Scale Manual. San Antonio (TX): The Psychological Corporation, 1997. ">Cohen 1997</a>) </p> </li> </ul> </p> <p>CMS measures learning in a variety of memory dimensions including attention and working memory, verbal and visual memory, short‐ and long‐delay memory, recall and recognition, and learning characteristics. One trial (<a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0051"> <li> <p>Global Assessment of Functioning ‐ GAF (<a href="./references#CD007964-bbs2-0215" title="DSM(IV) . Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington DC: American Psychiatric Association, 1994. ">DSM (IV) 1994</a>) </p> </li> </ul> </p> <p>GAF is a 90‐point rating scale that assesses psychological, social, and occupational functioning. A high score indicates a better outcome. Six trials reported data on this scale (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>). </p> <p> <ul id="CD007964-list-0052"> <li> <p>Independent Living Skills Survey ‐ ILSS (<a href="./references#CD007964-bbs2-0277" title="WallaceCJ , LibermanRP , TauberR , WallaceJ . The Independent Living Skill Survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophrenia Bulletin2000;26:631‐58. ">Wallace 2000</a>) </p> </li> </ul> </p> <p>ILSS is a detailed assessment of a client’s social and independent living skills and has 103 items which assess 12 areas of skills. One trial (<a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0053"> <li> <p>Life Skills Progression ‐ LSP (<a href="./references#CD007964-bbs2-0261" title="ParkerG , RosenA , EmdurN , Hadzi‐PavlovicD . The life skills profile: psychometric properties of a measure assessing function and disability in schizophrenia. Acta Psychiatrica Scandinavica1991;83:145‐52. ">Parker 1991</a>) </p> </li> </ul> </p> <p>LSP describes individual parent and infant/toddler progress using 43 items of life skills, which are grouped into 5 scales (relationships, education, mental health/substance abuse and other risks, basic essentials, infant/toddler development). One trial (<a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0054"> <li> <p>Personal and Social Performance Scale ‐ PSP (<a href="./references#CD007964-bbs2-0270" title="SiTM , ShuL , TianCH , SuYA , YanJ , ChengJ , et al. Reliability and validity of the Chinese version of the Personaland Social Performancescale (PSP) among patients with schizophrenia. Chinese Mental Health Journal2009;23:790‐4. ">Si 2009</a>) </p> </li> </ul> </p> <p>PSP scale is a validated clinician‐related scale that measures personal and social functioning in the domains of: socially useful activities (e.g. work and study), personal and social relationships, self‐care, and disturbing and aggressive behaviours. Two trials (<a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0055"> <li> <p>Social Functioning Scale ‐ SFS (<a href="./references#CD007964-bbs2-0199" title="BirchwoodM , SmithJ , CochraneR , et al. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programme with schizophrenic patients. British Journal of Psychiatry1990;157:853‐9. ">Birchwood 1990</a>) </p> </li> </ul> </p> <p>SFS measures social role and behavioural functioning across seven basic areas of community functioning: social engagement, interpersonal behaviour, prosocial activities, recreation, independence, employment. Two trials reported data on this scale (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>). </p> <p> <ul id="CD007964-list-0056"> <li> <p>Social and Occupational Functioning Assessment Scale ‐ SOFAS (<a href="./references#CD007964-bbs2-0223" title="GoldmanHH , SkodolAE , LaveTR . Revising axisV for DSM‐IV: a review of measures of social functioning. American Journal of Psychiatry1992;149:1148‐56. ">Goldman 1992</a>) </p> </li> </ul> </p> <p>SOFAS is a measure of social and occupational functioning on a continuum from excellent to grossly impaired functioning. Four trials reported data on this scale (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>). </p> <p> <ul id="CD007964-list-0057"> <li> <p>University of California, San Diego, Performance‐Based Skills Assessment ‐ UPSA (<a href="./references#CD007964-bbs2-0262" title="PattersonTL , GoldmanS , McKibbinCL , HughsT , JesteD . UCSD performance‐based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin2001;27:235‐45. ">Patterson 2001</a>) </p> </li> </ul> </p> <p>UPSA assesses the skills necessary for functioning in the community by asking participants to perform relevant tasks and rating their performance. Skills are assessed in the following five areas: household chores, communication, finance, transportation, and planning recreational activities. One trial (<a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0058"> <li> <p>Wechsler Adult Intelligence Scale ‐ WAIS (<a href="./references#CD007964-bbs2-0256" title="MittenbergW ,  Theroux‐FicheraS ,  ZielinskiRE ,  HeilbronnerRL . Identification of malingered head injury on the Wechsler Adult Intelligence Scale‐Revised. Professional Psychology: Research and Practice1995;26:491‐8. ">Mittenberg 1995</a>) </p> </li> </ul> </p> <p>WAIS is an intelligence test that is used quite commonly, and it measures the verbal and nonverbal abilities of adults. Two trials (<a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a>; <a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0059"> <li> <p>Wisconsin Card Sorting Test ‐ WCST (<a href="./references#CD007964-bbs2-0219" title="ElingP ,  DerckxK ,  MaesR . On the historical and conceptual background of the Wisconsin Card Sorting Test. Brain and Cognition2008;67:247‐53. ">Eling 2008</a>) </p> </li> </ul> </p> <p>WCST is a neuropsychological test of 'set‐shifting', i.e. the ability to display flexibility in the face of changing schedules of reinforcement. One trial (<a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0060"> <li> <p>World Health Organization Disability Assessment Schedule ‐ WHODAS (<a href="./references#CD007964-bbs2-0276" title="ÜstünT , Bedirhan , Chatterji , Somnath , Kostanjsek , Nenad , et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization2010;88:815‐23. ">Ustun 2010</a>) </p> </li> </ul> </p> <p>WHODAS is a participant self‐report assessment tool that evaluates the participant's ability to perform activities in six domains of functioning over the previous 30 days, and uses these to calculate a score representing global disability. It comes in 36‐ and 12‐item questionnaires. One trial (<a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0061"> <li> <p>Wechsler Memory Scale ‐ WMS (<a href="./references#CD007964-bbs2-0280" title="WechslerD . Wechsler Memory Scale ‐ Fourth Edition (WMS‐IV). San Antonio (TX): Pearson Assessment, 2009. ">Wechsler 2009</a>) </p> </li> </ul> </p> <p>WMS is a neuropsychological test designed to measure different memory functions in a person. One trial (<a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a>) reported data on this scale. </p> <p> <ul id="CD007964-list-0062"> <li> <p>MATRICS Consensus Cognitive Battery ‐ MCCB (<a href="./references#CD007964-bbs2-0226" title="GreenMF . Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH‐MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry2004;56:301‐7. ">Green 2004</a>) </p> </li> </ul> </p> <p>MCCB is a scale to assess cognitive change in patients with schizophrenia. It consists of 10 items. Higher scores indicate poor cognitive function. One study reported this outcome (<a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a>). </p> </section> <section id="CD007964-sec-0136"> <h6 class="title">6.5 Quality of life</h6> <p>Ten trials reported on this important outcome (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a>; <a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>). </p> <section id="CD007964-sec-0137"> <p><b><i>6.5.1 Quality of life scales reporting useful data</i> </b></p> <p> <ul id="CD007964-list-0063"> <li> <p>European Quality of Life Questionnaire ‐ EuroQOL. (<a href="./references#CD007964-bbs2-0212" title="DolanP . Modeling valuations for EuroQol health states. Medical Care1997;35:1095‐108. ">Dolan 1997</a>) </p> </li> </ul> </p> <p>This is also known as the EuroQoL or the EQ‐5D. This is a self‐rated measure of five dimensions of health‐related quality of life (mobility, self care, usual activities, pain/discomfort, anxiety/depression). One trial reported data from this scale (<a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>). </p> <p> <ul id="CD007964-list-0064"> <li> <p>General Quality of Life Inventory‐74 ‐ GQOLI‐74 (<a href="./references#CD007964-bbs2-0279" title="WangXD , WangXL , MaH . Handbook of Rating Scales for Mental Health. Chinese Mental Health Journal, 1999. ">Wang 1999</a>) </p> </li> </ul> </p> <p>GQOLI‐74 is a 74‐item quality of life assessment scale. It contains four subscales that assess physical functioning, psychological functioning, social functioning, and standard of living. High scores indicate better quality of life. One trial reported data from this scale (<a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>). </p> <p> <ul id="CD007964-list-0065"> <li> <p>Quality of Life Scale ‐ QLS (<a href="./references#CD007964-bbs2-0234" title="HeinrichsDW , HanlonTE , CarpenterWT . The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin1984;10:388‐98. ">Heinrichs 1984</a>) </p> </li> </ul> </p> <p>QLS consists of 10 items. High scores indicate better quality of life. Two trials (<a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>) reported data from this scale. </p> <p> <ul id="CD007964-list-0066"> <li> <p>Social Disability Screening Schedule ‐ SDSS (<a href="./references#CD007964-bbs2-0284" title="WuWY . Manual of Psychiatric Rating Scales. 2nd Edition. Hunan Changsa: Hunan Science and Technology Press, 1998. ">Wu 1998</a>) </p> </li> </ul> </p> <p>SDSS consists of 10 items. High scores indicate poor quality of life. One trial (<a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>) reported data from this scale. </p> <p> <ul id="CD007964-list-0067"> <li> <p>Short Form (36) Health Survey ‐ SF‐36 (<a href="./references#CD007964-bbs2-0253" title="McHorneyCA , Ware Jr.JE , et al. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care1993;31:247‐63. ">McHorney 1993</a>) </p> </li> </ul> </p> <p>SF‐36 is a 36‐item, patient‐reported survey of patient health. High scores indicate better quality of life. One trial (<a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a>) reported data from this scale. </p> <p> <ul id="CD007964-list-0068"> <li> <p>Schizophrenia Quality of Life Scale ‐ SQLS (<a href="./references#CD007964-bbs2-0283" title="WilkinsonG , HesdonB , WildD , CooksonR , FarinaC , SharmaV . Self‐report quality of life measure for people with schizophrenia: the SQLS. British Journal of Psychiatry2000;177:42‐6. ">Wilkinson 2000</a>) </p> </li> </ul> </p> <p>SQLS consists of three subscales ('psychosocial', 'motivation and energy', and 'symptoms and side‐effects') with 30 items. High scores indicate poor quality of life. Two trials (<a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a>; <a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a>) reported data from this scale. </p> <p> <ul id="CD007964-list-0069"> <li> <p>World Health Organization Quality of Life ‐ Brief ‐ WHOQOL‐BREF (<a href="./references#CD007964-bbs2-0282" title="WHOQOL Group. Development of the World Health Organization WHOQOL‐BREF quality of life assessment.. Psychological Medicine1998;28:551‐8. ">WHOQOL Group 1998</a>) </p> </li> </ul> </p> <p>WHOQOL‐BREF consists of 26 items measuring the following domains of quality of life: physical health, psychological health, social relationships, and environment. Higher scores indicate better quality of life. Three trials reported data on this scale (<a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>). </p> </section> </section> <section id="CD007964-sec-0138"> <h6 class="title">6.6 Satisfaction with treatment</h6> <p>None of the trials directly measured satisfaction with treatment. Leaving the study early was used as an indirect measure for this important outcome. </p> <section id="CD007964-sec-0139"> <p><b>6.6.1 Leaving the study early.</b></p> <p>Thirty trials (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a>; <a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a>; <a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a>; <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>; <a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a>; <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a>; <a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a>; <a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a>; <a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a>) reported attrition data. </p> </section> </section> <section id="CD007964-sec-0140"> <h6 class="title">6.7 Engagement with services</h6> <section id="CD007964-sec-0141"> <p><b>6.7.1 Compliance to treatment/medication</b></p> <p>Six trials reported binary data for participant compliance to medication (<a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a>; <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>; <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>). </p> <p>Two trials reported binary data for participants refusing treatment (<a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a>; <a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a>). </p> <p>Two trials used scales to measure compliance, reporting continuous data for this outcome (<a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>). </p> </section> <section id="CD007964-sec-0142"> <p><b>6.7.2 Compliance scales reporting useful data</b></p> <p> <ul id="CD007964-list-0070"> <li> <p>Medication Adherence Rating Scale ‐ MARS (<a href="./references#CD007964-bbs2-0273" title="ThompsonK , KulkamiJ , SergejewAA . Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research2000;42:241‐47. ">Thompson 2000</a>) </p> </li> </ul> </p> <p>MARS is a 10‐item scale measuring medication adherence. Higher scores indicate better medication adherence. Two trials reported data on this scale (<a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>). </p> </section> </section> <section id="CD007964-sec-0143"> <h6 class="title">6.8 Economic outcomes</h6> <p>No study reported data for economic outcomes such as direct and indirect costs of care. </p> </section> </section> </section> <section id="CD007964-sec-0144"> <h4 class="title">Excluded studies</h4> <p>We excluded 103 trials (116 references) from this review.</p> <section id="CD007964-sec-0145"> <h5 class="title">1. Issues relating to methods</h5> <p>A total of 19 trials with 20 references were not randomised controlled trials (<a href="./references#CD007964-bbs2-0062" title="AgiusM , ShahS , RamkissonR , MurphyS , ZamanR . Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Final results. Psychiatria Danubina2007;19(3):130‐8. ">Agius 2007</a>; <a href="./references#CD007964-bbs2-0066" title="BechdolfA , VeithaV , SchwarzerD , SchormannM , StammE , JanssenB , et al. Cognitive‐behavioral therapy in the pre‐psychotic phase: an exploratory study. Psychiatry Research2005;136:251–5. ">Bechdolf 2005b</a>; <a href="./references#CD007964-bbs2-0069" title="ByerlyMJ , FisherR , CramodyT , RushAJ . A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry2005;66(8):997‐1001. ">Byerly 2005</a>; <a href="./references#CD007964-bbs2-0073" title="ChenR . The analysis of cognitive‐behavioral psychological intervention on the rehabilitation of chronic schizophrenia [认知行为心理干预对慢性精神分裂症康复作用分析]. Guide of China Medicine [中国医药指南]2012, (11):57‐8. ">Chen 2012</a>; <a href="./references#CD007964-bbs2-0082" title="FengY , SongH , WangX . The effect of venlafaxine plus cognitive therapy for depression after the treatment of schizophrenia: a controlled study [文拉法辛合并认知疗法治疗精神分裂症后抑郁的对照研究]. Yi Xue Li Lun Yu Shi Jian [医学理论与实践]2013, (15):2014‐5. ">Feng 2013</a>; <a href="./references#CD007964-bbs2-0086" title="HangRH , ChengWL , WuMF , FengLP . Cognitive training for geriatric chronic schizophrenia patients [认知训练对老年慢性精神分裂症患者认知功能的影响]. Chinese Journal of Gerontology [中国老年学杂志]2014;34:2678‐80. ">Hang 2014</a>; <a href="./references#CD007964-bbs2-0090" title="HuangS , WangJ . The application of cognitive therapy in 120 cases of patients with schizophrenia [认知治疗在120例精神分裂症缓解期患者中的应用分析]. Guide of China Medicine [中国医药指南]2014;12:115‐6. ">Huang 2014</a>; <a href="./references#CD007964-bbs2-0091" title="IbrahimWE , El‐BilshaMA , AbeldayemSM . Effect of cognitive behavior therapy (CBT) on depression among schizophrenic patients with low self esteem. Middle East Journal of Psychiatry and Alzheimers2012;3(4):3‐10. ">Ibranhim 2012</a>; <a href="./references#CD007964-bbs2-0096" title="JacksonH , McGorryP , EdwardsJ , HulbertC , HenryL , FranceyS , et al. Cognitively‐oriented psychotherapy for early psychosis (COPE). Preliminary results. British Journal Psychiatry1998;172(33 suppl):93‐100. JacksonH , McGorryP , EdwardsJ , HulbertC , HenryL , HarriganS , et al. A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four‐year follow‐up readmission data. Psychological Medicine2005;35(9):1295‐306. JacksonH , McGorryP , HenryL , EdwardsJ , HulbertC , HarriganS , et al. Cognitively oriented psychotherapy for early psychosis (COPE): a 1‐year follow‐up. British Journal Clinical Psychology2001;40(Pt 1):57‐70. ">Jackson 1998</a>; <a href="./references#CD007964-bbs2-0103" title="KongLJ , ZuoXY , ZhouYB , JiaoF . The effect of cognitive behavioural therapy for quality of life in patients with schizophrenia. Journal of Yangtze University (Natural Science Edition)2015;12(30):70‐2. ">Kong 2015</a>; <a href="./references#CD007964-bbs2-0111" title="LiY , YangY , WeiZ , YinY . The influence of cognitive behavior intervention on olanzapine induced weight gain in schizophrenia [认知行为干预对奥氮平致精神分裂症患者体质量增加的影响]. Journal of Clinical Psychosomatic Diseases [临床心身疾病杂志]2015;21:29‐31. ">Li 2015c</a>; <a href="./references#CD007964-bbs2-0120" title="MoY , LiX , FuC , HeR , CaiY , MoT . Effects of cognitive‐behavioral intervention on mental status in homeless schizophrenia patients [认知行为干预对流浪精神疾病患者心理状态的影响]. China Modern Medicine [中国现代药物应用]2015; Vol. 9, issue 1:201‐2. ">Mo 2015</a>; <a href="./references#CD007964-bbs2-0131" title="O'DriscollC , MasonO , BradyF , SmithB , SteelC . Process analysis of trauma‐focused cognitive behavioural therapy for individuals with schizophrenia. Psychology and Psychotherapy2016;89(2):117‐32. ">O'Driscoll 2015</a>; <a href="./references#CD007964-bbs2-0132" title="OwenM , SellwoodW , KanS , MurrayJ , SarsamM . Group CBT for psychosis: a longitudinal, controlled trial with inpatients. Behaviour Research and Therapy2015;65:76‐85. ">Owen 2015</a>; <a href="./references#CD007964-bbs2-0137" title="QiHM , LiuHY . Cognitive behavioral therapy for schizophrenia. Hebei Medical Journal2012;34(21):3229‐31. ">Qi 2012</a>; <a href="./references#CD007964-bbs2-0157" title="XieW , XieY , XiaoY , WangH , XiaoB . The application of multimedia in cognitive intervention to enhance its effect in patients with schizophrenia [精神分裂症患者应用多媒体加强认知干预的效果研究]. Journal of Nursing [护理学报]2013;20(4B):57‐9. ">Xie 2013</a>; <a href="./references#CD007964-bbs2-0158" title="XuM . Effects of cognitive behavioral social work team on anxiety in schizophrenia inpatients [认知行为社工小组对住院精神分裂症患者焦虑情绪的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(1):23‐4. ">Xu 2014</a>; <a href="./references#CD007964-bbs2-0161" title="ZhangJ . Cognitive behavioral therapy for rehabilitation of schizophrenic patients with anxiety [认知行为疗法对康复期精神分裂患者焦虑情绪的影响]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2005;26(9):1010‐1. ">Zhang 2005</a>). </p> </section> <section id="CD007964-sec-0146"> <h5 class="title">2. Issues relating to participants</h5> <p>Participants in 10 trials with 12 references did not meet the diagnostic criteria of schizophrenia. <a href="./references#CD007964-bbs2-0121" title="MorrisonAP , TurkingtonD , PyleM , SpencerH , BrabbanA , DunnG , et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic medication: a randomised controlled trial. Lancet2014; Vol. 153:1395‐403. ">Morrison 2014</a>, <a href="./references#CD007964-bbs2-0135" title='PhillipsLJ , LeicesterSB , O’DwyerLE , FranceySM , KoutsogiannisJ , Abdel‐BakiA , et al. The PACE Clinic: identification and management of young people at "ultra" high risk of psychosis. Journal of Psychiatric Practice2002;8(5):255‐9. PhillipsLJ , YungAR , YuenHP , PantelisC , McGorryPD . Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. American Journal of Medical Genetics2002;114(8):929–37. '>Phillips 2002</a> and <a href="./references#CD007964-bbs2-0061" title="ACTRN12606000101583 . Randomised controlled trial of cognitive behaviour therapy to prevent psychosis among people with at‐risk mental states. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=1167 (first received. ">ACTRN12606000</a> included participants who were at high risk of psychosis or schizophrenia. <a href="./references#CD007964-bbs2-0095" title="HazellCM , HaywardM , CavanaghK , JonesAM , StraussC . Guided self‐help cognitive behavioral intervention for VoicEs (GiVE): study protocol for a pilot randomized controlled trial. Trials2016;17(1):351. ISRCTN77762753 . A pilot randomised controlled trial of guided self‐help cognitive behaviour therapy for distressing voices. isrctn.com/search?q=ISRCTN77762753 (first received 23 July 2015). ">ISRCTN77762753</a> and <a href="./references#CD007964-bbs2-0098" title="JennerJA , NienhuisFJ , WiersmaD , Van deWilligeG . Hallucination focused integrative treatment: a randomized controlled trial. Schizophrenia Bulletin2004;30(1):133–45. ">Jenner 2004</a> included participants with auditory hallucinations. <a href="./references#CD007964-bbs2-0094" title="ISRCTN47998710 . PRODIGY: Prevention of long term social disability amongst young people with emerging psychological difficulties ‐ a pilot randomised controlled trial of social recovery cognitive behavioural therapy. isrctn.com/ISRCTN47998710 [Date Accessed: 29 November 2012]. ">ISRCTN47998710</a> included participants with psychological difficulties. <a href="./references#CD007964-bbs2-0079" title="EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive enhancement therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Research2016;161(2‐3):478‐83. ">Eack 2014</a> included participants with substance misuse and schizophrenia. <a href="./references#CD007964-bbs2-0129" title="O'ConnorK , StipE , PelissierMC , AardemaF , GuayS , GaudetteG , et al. Treating delusional disorder: a comparison of cognitive‐behavioural therapy and attention placebo control. Canadian Journal of Psychiatry2007;52(3):182‐90. ">O'Connor 2007</a> included participants with delusional disorders. <a href="./references#CD007964-bbs2-0070" title="CaiS . Effects of cognitive psychotherapy in schizophrenia patients during recovery stage [康复期精神病患者认知心理治疗的效果观察]. World Latest Medicine Information [世界最新医学信息文摘]2014;14:161‐4. ">Cai 2014c</a> and <a href="./references#CD007964-bbs2-0092" title="ISRCTN11889976 . Comparison between extension of specialised early intervention for first episode psychosis and regular care: a randomised controlled trial. isrctn.com/ISRCTN11889976. ">ISRCTN11889976</a> included participants with psychosis and did not state whether they included schizophrenia or not. </p> </section> <section id="CD007964-sec-0147"> <h5 class="title">3. Issues relating to comparison</h5> <p>A total of 21 trials with 26 references did not use standard care as comparator.</p> <p>These trials compared CBT with other psychosocial therapies such as supportive counselling (<a href="./references#CD007964-bbs2-0085" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1998</a>; <a href="./references#CD007964-bbs2-0100" title="JohnsonDP , PennDL , BauerDJ , MeyerP , EvansE . Predictors of the therapeutic alliance in group therapy for individuals with treatment‐resistant auditory hallucinations. British Journal of Clinical Psychology2008;47(Pt. 2):171‐83. ">Johnson 2008</a>; <a href="./references#CD007964-bbs2-0117" title="LuHM , WangXL , TangY , FeiP . The application of cognitive therapy in patients with schizophrenia. Medical Information2014;27:463. ">Lu 2014a</a>; <a href="./references#CD007964-bbs2-0127" title="ACTRN12616000098437 . Staged Treatment in Early Psychosis (STEP): a sequential multistage randomized clinical trial (SMART) of interventions for Ultra High Risk (UHR) of psychosis patients. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=369499 [Date Accessed: 1 February 2016]. NCT02751632 . The Staged Treatment in Early Psychosis Study. clinicaltrials.gov/ct2/show/NCT02751632 [Date Accessed: 26 April 2016]. ">NCT02751632</a>; <a href="./references#CD007964-bbs2-0130" title="O'DonnellC , DonohoeG , SharkeyL , OwensN , MigoneM , HarriesR , et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ2003;327(7419):834. ">O'Donnell 2003</a>; <a href="./references#CD007964-bbs2-0134" title="PennDL , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52–9. ">Penn 2009</a>; <a href="./references#CD007964-bbs2-0136" title="PintoA , PiaSL , MennellaR , GiorgioD , DeSimoneL . Cognitive‐behavioral therapy and clozapine for clients with treatment‐refractory schizophrenia. Psychiatry Service1999;50(7):901–4. ">Pinto 1999</a>; <a href="./references#CD007964-bbs2-0148" title="ValmaggiaLR , Van derGaagM , TarrierN , PijnenborgM , SlooffCJ . Cognitive‐behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. British Journal of Psychiatry2005;186:324‐30. ">Valmaggia 2005</a>), befriending (<a href="./references#CD007964-bbs2-0097" title="BendallS , JacksonHJ , KillackeyE , AllottK , JohnsonT , HarriganS , et al. The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis. Behavioural and Cognitive Psychotherapy2006;34:277‐91. JacksonHJ , McGorryPD , KillackeyE , BendallS , AllottK , DudgeonP , et al. Acute‐phase and 1‐year follow‐up results of a randomized controlled trial of CBT versus befriending for first‐episode psychosis: the ACE project. Psychological Medicine2008;38(5):725‐35. ">Jackson 2008</a>; <a href="./references#CD007964-bbs2-0142" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive‐behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000</a>; <a href="./references#CD007964-bbs2-0147" title="TurkingtonD , SenskyT , ScottJ , BarnesTRE , NurU , SiddleR , et al. A randomized controlled trial of cognitive‐behavior therapy for persistent symptoms in schizophrenia: a five‐year follow‐up. Schizophrenia Research2008;98:1‐7. ">Turkington 2008</a>), psychoeducation (<a href="./references#CD007964-bbs2-0065" title="BechdolfA , KnostB , KuntermannC , SchillerS , KlosterkötterJ , HambrechtM , et al. A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica2004;110:21‐8. BechdolfA , KçhnD , KnostB , PukropR , KlosterkçtterJ . A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica2005;112:173‐9. ">Bechdolf 2004</a>; <a href="./references#CD007964-bbs2-0071" title="CatheraC , PennD , OttoaMW , YovelaI , MuesercKT , GoffDC . A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia. Schizophrenia Research2005;75:201–9. ">Cather 2005</a>; <a href="./references#CD007964-bbs2-0138" title="RectorNA . Cognitive behavioural therapy reduces short term rehospitalisation compared with psychoeducation in inpatients with schizophrenia. Evidence Based Mental Health2005;8(1):8. ">Rector 2005</a>), cognitive remediation therapy (<a href="./references#CD007964-bbs2-0102" title="KlingbergS1 , WittorfA , HerrlichJ , WiedemannG , MeisnerC , BuchkremerG , et al. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. European Archives of Psychiatry and Clinical Neuroscience2009;259(2):149‐54. ">Klingberg 2009</a>; <a href="./references#CD007964-bbs2-0133" title="PenadesR , CatalenR , SalameroM , BogetT , PuigO , GuarchJ , et al. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophrenia Research2006;87:323–31. ">Penades 2006</a>; ), recreation and support (<a href="./references#CD007964-bbs2-0077" title="DruryV , BirchwoodM , CochraneR . Cognitive therapy and recovery from acute psychosis: a controlled trial. III. Five‐year follow‐up. British Journal of Psychiatry2000;177:8‐14. DruryV , BirchwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry1996;169:593‐601. DruryV , BirchwoodM , CochraneR , MacmillanF . Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry1996;169:602‐7. ">Drury 1996</a>), psychological nursing care (<a href="./references#CD007964-bbs2-0155" title="WuL . Application of psychological intervention in nursing care of patients with chronic schizophrenia with negative symptoms [心理干预在慢性精神分裂症阴性症状患者护理中的应用]. Medical Journal of Chinese People's Health [中国民康医学]2013;25(9):81‐2. ">Wu 2013</a>), and problem‐solving (<a href="./references#CD007964-bbs2-0067" title="BradshawW . Structured group work for individuals with schizophrenia: a coping skills approach. Research on Social Work Practice1996;6(2):139‐54. ">Bradshaw 1996</a>). One trial (<a href="./references#CD007964-bbs2-0093" title="ISRCTN34966555 . Active assistance for psychological therapy (Actissist): using mobile technology to deliver cognitive behaviour therapy for psychosis ‐ RCT. isrctn.com/ISRCTN34966555. ">ISRCTN34966555</a>) compared CBT delivered though mobile application (app) with a symptoms monitoring app where the control group was not standard care. The groups in <a href="./references#CD007964-bbs2-0125" title="NCT02420015 . Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia. clinicaltrials.gov/ct2/show/NCT02420015 [Date Accessed: 17 April 2015]. ">NCT02420015</a> received cognitive‐behavioural smoking cessation counselling. </p> </section> <section id="CD007964-sec-0148"> <h5 class="title">4. Issues relating to intervention</h5> <p>A total of 41 trials with 44 references were excluded because the intervention group did not meet our inclusion criteria. </p> <p>Four trials reported CBT interventions as an element of a treatment package where it was not possible to identify the effect of CBT (<a href="./references#CD007964-bbs2-0084" title="GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. ">Granholm 2007</a>; ; <a href="./references#CD007964-bbs2-0113" title="LincolnTM , ZieglerM , MehlS , KestingML , LullmannE , WestermannS , et al. Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: a randomized clinical practice trial. Journal of Consulting and Clinical Psychology2012;80:674‐86. ">Lincoln 2012</a>; <a href="./references#CD007964-bbs2-0122" title="NCT00810355 . Cognitive Behavior Therapy and Work Outcome. clinicaltrials.gov/ct2/show/NCT00810355 [Date Accessed: 18 December 2008]. ">NCT00810355</a>; <a href="./references#CD007964-bbs2-0140" title="RichmondRL , BakerA , HaileM , CarrV , LewinT , WilhelmK , et al. Intervention for tobacco dependence among people with a psychotic illness: randomized controlled trial with one‐year outcome. Nicotine and Tobacco Research2005;7:681. ">Richmond 2005</a>). </p> <p>The remaining 37 trials employed therapeutic strategies which did not meet our criteria for adjunct CBT (<a href="./references#CD007964-bbs2-0063" title="BachP , HayesSC . The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. Journal of Consulting and Clinical Psychology2002;70(5):1129‐39. ">Bach 2002</a>; <a href="./references#CD007964-bbs2-0064" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive‐behavioural therapy for schizophrenia. Randomised controlled trial. British Journal of Psychiatry2006;189:527‐32. ">Barrowclough 2006</a>; <a href="./references#CD007964-bbs2-0072" title="CellaM , ReederC , WykesT . It is all in the factors: effects of cognitive remediation on symptom dimensions. Schizophrenia Research2014;156(1):60‐2. ">Cella 2014</a>; <a href="./references#CD007964-bbs2-0075" title="DengM , DingN . Effects of group CBT on schizophrenia patients during recovery stage [对精神分裂症康复期患者实施团体CBT的效果观察]. Today Nurse [当代护士]2014;10:116‐8. ">Deng 2014</a>; <a href="./references#CD007964-bbs2-0123" title="NCT00960375 . Smoking Cessation for Veterans With Severe and Persistent Mental Illness. clinicaltrials.gov/ct2/show/NCT00960375 [Date Accessed: 17 August 2009]. ">NCT00960375</a>; <a href="./references#CD007964-bbs2-0080" title="FarrenyA , AguadoJ , OchoaS , Huerta‐RamosE , MarsàF , López‐CarrileroR , et al. REPYFLEC cognitive remediation group training in schizophrenia: looking for an integrative approach. Schizophrenia Research2012;142(1‐3):137‐44. ">Farreny 2012</a>; <a href="./references#CD007964-bbs2-0081" title="FavrodJ , RexhajS , BardyS , FerrariP , HayozC , MoritzS , et al. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized‐controlled study. European Psychiatry2014;29(5):275‐81. ">Favrod 2014</a>; <a href="./references#CD007964-bbs2-0083" title="GaudianoBA , HerbertJD . Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. Behavioural Research and Therapy2006;44(3):415‐37. ">Gaudiano 2006</a>; <a href="./references#CD007964-bbs2-0087" title="HerzMI , LambertiJS , MintzJ , ScottR , O'DellSP , McCartanL , et al. A program for relapse prevention in schizophrenia: a controlled study. Archives General Psychiatry2000;57(3):277‐83. ">Hert 2000</a>; <a href="./references#CD007964-bbs2-0088" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS . Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514–24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504–13. ">Hogarty 1997</a>; <a href="./references#CD007964-bbs2-0089" title="HogartyGE , FlesherS , UlrichR , CarterM , GreenwaldD , Pogue‐GeileM . Cognitive enhancement therapy for schizophrenia: effects of a 2‐year randomized trial on cognition and behavior. Archives General Psychiatry2004;61(9):866–76. ">Hogarty 2004</a>; <a href="./references#CD007964-bbs2-0101" title="KiddSA , KaurJ , VirdeeG , GeorgeTP , McKenzieK , HermanY , et al. Cognitive remediation for individuals with psychosis in a supported education setting: a randomized controlled trial. Schizophrenia Research2014;157(1‐3):90‐8. ">Kidd 2014</a>; <a href="./references#CD007964-bbs2-0104" title="KuipersE , HollowayF , Rabe‐HeskethS , TennakoonL , Croydon Outreach and Assertive Support Team (COAST). An RCT of early intervention in psychosis. Social Psychiatry and Psychiatric Epidemiology2004;39(5):358–63. ">Kuipers 2004</a>; <a href="./references#CD007964-bbs2-0106" title="LeclercC , LesageAD , RicardN , LecomteT , CyrM . Assessment of a new rehabilitative coping skills module for persons with schizophrenia. American Journal of Orthopsychiatry2000;70(3):380‐8. ">Leclerc 2000</a>; <a href="./references#CD007964-bbs2-0107" title="LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous Mental Disorders2008;196:866‐75. ">Lecomte 2008</a>; <a href="./references#CD007964-bbs2-0108" title="LiJ , DengX , XieY , LiangL . Effects of cognitive behavioral therapy on cognitive function in patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and Foreign Medical Research [中外医学研究]2013, (24):130‐2. ">Li 2013</a>; <a href="./references#CD007964-bbs2-0109" title="LiX , GuoY , FuC , ChenL , ZhangZ . The effect of group cognitive behavioral therapy for refractory auditory hallucinations in schizophrenia [小组认知行为治疗对精神分裂症顽固性幻听的疗效观察 ]. Chinese Journal of Rehabilitation [中国康复]2013, (4):313‐5. ">Li 2013b</a>; <a href="./references#CD007964-bbs2-0110" title="LiL , HuL , LiangZ , WenZ . Impact of cognitive intervention on quality of living and related factor of patients with chronic schizophrenia [认知干预对慢性精神分裂症患者生活质量及相关因素的影响]. Clinical Medical and Engineering [临床医学工程]2014;21(8):1073‐4. ">Li 2014b</a>; <a href="./references#CD007964-bbs2-0114" title="LiuD , LiuJ , LiS , FengA . Effects of token therapy and cognitive therapy on quality of life in schizophrenia patients [代币疗法与认知治疗对精神分裂症患者生活质量的影响]. China Health Industry [中国卫生产业]2014, (2):107+109. ">Liu 2013</a>; <a href="./references#CD007964-bbs2-0116" title="LuH , LiY , LiF , JiaoX , ShiW , GuoK , et al. Randomized controlled trial on adjunctive cognitive remediation therapy for chronically hospitalised patients with schizophrenia [慢性精神分裂症住院患者辅以认知矫正治疗的随机对照研究]. Shanghai Archives of Psychiatry [上海精神医学]2012;24:149‐54. ">Lu 2012</a>; <a href="./references#CD007964-bbs2-0118" title="DavisLW , LysakerPH , LancasterRS , BrysonGJ , BellMD . The Indianapolis Vocational Intervention Program: a cognitive behavioral approach to addressing rehabilitation issues in schizophrenia. Journal of Rehabilitation Research and Development2005;42(1):35. LysakerPH , DavisLW , BrysonGJ , BellMD . Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participants with schizophrenia spectrum disorders. Schizophrenia Research2009;107:186‐91. ">Lysaker 2009</a>; <a href="./references#CD007964-bbs2-0126" title="NCT02535923 . CBT‐I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes. clinicaltrials.gov/ct2/show/NCT02535923 [Date Accessed: 31 August 2015]. ">NCT02535923</a>; <a href="./references#CD007964-bbs2-0124" title="NCT02105779 . Optimizing Cognitive Remediation Outcomes in Schizophrenia. clinicaltrials.gov/ct2/show/NCT02105779 [Date Accessed: 7 April 2014]. ">NCT02105779</a>; <a href="./references#CD007964-bbs2-0128" title="BertelsenM , JeppesenP , PetersenL , ThorupA , ØhlenschlaegerJ , LeQuachP , et al. Five‐year follow‐up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Archives of General Psychiatry2008;65(7):762‐71. ">Nordentoff 2005</a>; <a href="./references#CD007964-bbs2-0139" title="ReederC , HarrisV , PicklesA , PatelA , CellaM , WykesT , et al. Does change in cognitive function predict change in costs of care for people with a schizophrenia diagnosis following cognitive remediation therapy?. Schizophrenia Bulletin2014;40(6):1472‐81. ">Reeder 2014</a>; <a href="./references#CD007964-bbs2-0141" title="SellwoodW , BarrowcloughC , TarrierN , QuinnJ , MainwaringJ , LewisS . Needs‐based cognitive‐behavioural family intervention for carers of patients suffering from schizophrenia: 12‐month follow‐up. Acta Psychiatrica Scandinavica2001;104(5):346‐55. SellwoodW , WittkowskiA , TarrierN , BarrowcloughC . Needs‐based cognitive‐behavioural family intervention for patients suffering from schizophrenia: 5‐year follow‐up of a randomized controlled effectiveness trial. Acta Psychiatrica Scandinavica2007;116(6):447–52. ">Sellwood 2000</a>; <a href="./references#CD007964-bbs2-0145" title="SongX , LiuY , ZhangY , ZhouL . The effective of cognitive behavioral therapy on negative symptoms of schizophrenia [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. XinLi YiSheng [心理医生]2012;7:30‐1. ">Song 2012</a>; <a href="./references#CD007964-bbs2-0146" title="SongX , LiJ , ZhangY , WangX , WangE . Effects of group CBT on quality of life in schizophrenia patients with auditory hallucination [团体CBT对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News [国际医药卫生导报]2014;20(16):2572‐4. ">Song 2014</a>; <a href="./references#CD007964-bbs2-0149" title="WangC , LiY , ZhaoZ , PanM , FengY , SunF , et al. Controlled study on long‐term effect of cognitive behavior intervention on first episode schizophrenia. Chinese Mental Health Journal2003;7466:200‐2. ">Wang 2003</a>; <a href="./references#CD007964-bbs2-0150" title="WangH , ChenY , XieW , XiaoB , QiuC , XieS . The effect of cognitive treatment on the compliance for treatment of outpatient with schizophrenia [认知治疗对门诊精神分裂症患者治疗依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2013;25(7):16‐8. ">Wang 2013</a>; <a href="./references#CD007964-bbs2-0151" title="WangC , ChengM , ShengM . Cognitive ‐ the existence group therapy for patients with chronic schizophrenia in community [认知‐存在团体对社区慢性精神分裂症患者的干预效果]. China Journal of Health Psychology [中国健康心理学杂志]2013;21:974‐7. ">Wang 2013a</a>; <a href="./references#CD007964-bbs2-0152" title="WangE . Effects of cognitive rehabilitation care on cognitive function impairment in 40 schizophrenia patients [40例认知康复护理对精神分裂症患者认知功能障碍的影响]. Contemporary Medicine [当代医学]2014;20(19):129‐30. ">Wang 2014</a>; <a href="./references#CD007964-bbs2-0153" title="WeiQ , LiJ , WenC . Clinical efficacy of cognitive therapy for schizophrenia and its impact on the social function of patients [认知疗法治疗精神分裂症的临床疗效及对患者社会功能的影响]. Chinese Journal of Medicinal Guide [中国医药导刊]2012;14(11):1910‐1. ">Wei 2012</a>; <a href="./references#CD007964-bbs2-0156" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77(2):201‐10. ">Wykes 2005</a>; <a href="./references#CD007964-bbs2-0159" title="YangX , XiongY . Cognitive psychotherapy efficacy for the prevention of relapse of schizophrenia research [认知心理治疗对预防精神分裂症复发的疗效研究]. China Foreign Medical Treatment [中外医疗]2012, (5):18+20. ">Yang 2012</a>; <a href="./references#CD007964-bbs2-0162" title="ZhaoY , QinF . Risperidone combined with cognitive insight therapy efficacy study of first‐episode schizophrenia [利培酮合并认知领悟治疗对首发精神分裂症疗效研究]. Journal of Mathematical Medicine [数理医药学杂志]2012;25(2):211‐3. ">Zhao 2012</a>; <a href="./references#CD007964-bbs2-0163" title="ZhouJ . Effects of cognitive behavioral therapy on social function and quality of life in schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research [健康研究]2015;35(05):539‐41. ">Zhou 2015b</a>). </p> <p>In particular, <a href="./references#CD007964-bbs2-0063" title="BachP , HayesSC . The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. Journal of Consulting and Clinical Psychology2002;70(5):1129‐39. ">Bach 2002</a> employed a new wave of CBT involving radical acceptance without cognitive or behavioural modifications. The same applied to acceptance and commitment therapy (<a href="./references#CD007964-bbs2-0083" title="GaudianoBA , HerbertJD . Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. Behavioural Research and Therapy2006;44(3):415‐37. ">Gaudiano 2006</a>), which, similarly to CBT, had a focus on cognitions. It, however, aimed to help participants respond differently to their thoughts rather than directly challenge or test out their validity. Participants were encouraged to accept and experience their internal events without judgement and this treatment did not meet our criteria for CBT. Personal therapy (<a href="./references#CD007964-bbs2-0088" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS . Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514–24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504–13. ">Hogarty 1997</a>), like CBT, aims to prevent relapse and promote personal and social adjustment. However, personal therapy differs from CBT in that it consists of psychoeducation awareness of early signs, supportive therapy techniques, social skills training, the teaching of coping strategies, without an explicit focus on beliefs and cognitive restructuring. Thus, this treatment did not meet our criteria for CBT. Nine studies investigated a group‐based CBT intervention which did not meet our criteria <b>(</b><a href="./references#CD007964-bbs2-0064" title="BarrowcloughC , HaddockG , LobbanF , JonesS , SiddleR , RobertsC , et al. Group cognitive‐behavioural therapy for schizophrenia. Randomised controlled trial. British Journal of Psychiatry2006;189:527‐32. ">Barrowclough 2006</a>; <a href="./references#CD007964-bbs2-0075" title="DengM , DingN . Effects of group CBT on schizophrenia patients during recovery stage [对精神分裂症康复期患者实施团体CBT的效果观察]. Today Nurse [当代护士]2014;10:116‐8. ">Deng 2014</a>; <a href="./references#CD007964-bbs2-0107" title="LecomteT , LeclercC , CorbiereM , WykesT , WallaceCJ , SpidelA . Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. Journal of Nervous Mental Disorders2008;196:866‐75. ">Lecomte 2008</a>; <a href="./references#CD007964-bbs2-0108" title="LiJ , DengX , XieY , LiangL . Effects of cognitive behavioral therapy on cognitive function in patients with chronic schizophrenia [认知行为治疗对慢性精神分裂症患者认知功能的影响]. Chinese and Foreign Medical Research [中外医学研究]2013, (24):130‐2. ">Li 2013</a>; <a href="./references#CD007964-bbs2-0109" title="LiX , GuoY , FuC , ChenL , ZhangZ . The effect of group cognitive behavioral therapy for refractory auditory hallucinations in schizophrenia [小组认知行为治疗对精神分裂症顽固性幻听的疗效观察 ]. Chinese Journal of Rehabilitation [中国康复]2013, (4):313‐5. ">Li 2013b</a>; <a href="./references#CD007964-bbs2-0145" title="SongX , LiuY , ZhangY , ZhouL . The effective of cognitive behavioral therapy on negative symptoms of schizophrenia [认知行为治疗对改善精神分裂症病人阴性症状的效果研究]. XinLi YiSheng [心理医生]2012;7:30‐1. ">Song 2012</a>; <a href="./references#CD007964-bbs2-0146" title="SongX , LiJ , ZhangY , WangX , WangE . Effects of group CBT on quality of life in schizophrenia patients with auditory hallucination [团体CBT对精神分裂症幻听患者生存质量的影响]. International Medicine and Health Guidance News [国际医药卫生导报]2014;20(16):2572‐4. ">Song 2014</a>; <a href="./references#CD007964-bbs2-0156" title="WykesT , HaywardP , ThomasN , GreenN , SurguladzeS , FannonD , et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research2005;77(2):201‐10. ">Wykes 2005</a>; <a href="./references#CD007964-bbs2-0163" title="ZhouJ . Effects of cognitive behavioral therapy on social function and quality of life in schizophrenia patients [认知行为疗法对精神分裂症患者社会功能和生活质量的影响]. Health Research [健康研究]2015;35(05):539‐41. ">Zhou 2015b</a>). <a href="./references#CD007964-bbs2-0089" title="HogartyGE , FlesherS , UlrichR , CarterM , GreenwaldD , Pogue‐GeileM . Cognitive enhancement therapy for schizophrenia: effects of a 2‐year randomized trial on cognition and behavior. Archives General Psychiatry2004;61(9):866–76. ">Hogarty 2004</a> reported the use of therapeutic strategies designed to overcome intellectual and memory deficits associated with schizophrenia rather than psychotic symptoms, beliefs, or cognitive distortions. <a href="./references#CD007964-bbs2-0114" title="LiuD , LiuJ , LiS , FengA . Effects of token therapy and cognitive therapy on quality of life in schizophrenia patients [代币疗法与认知治疗对精神分裂症患者生活质量的影响]. China Health Industry [中国卫生产业]2014, (2):107+109. ">Liu 2013</a> investigated a group CBT plus token therapy intervention which did not meet our criteria. </p> </section> <section id="CD007964-sec-0149"> <h5 class="title">5. Issues relating to outcomes</h5> <p>The remaining 12 trials with 12 references did not have usable data for meta‐analysis (<a href="./references#CD007964-bbs2-0068" title="BradshawW . Integrating cognitive behavioural psychotherapy for persons with schizophrenia into a psychiatric rehabilitation programme: results of a three‐year trial. Community Mental Health Journal2000;36(5):491‐500. ">Bradshaw 2000</a>; <a href="./references#CD007964-bbs2-0076" title="DongX . Cognitive behavioural therapy in combination with antipsychotic medication for schizophrenia. Medical Information2015;28(19):324. ">Dong 2015</a>; <a href="./references#CD007964-bbs2-0078" title="DuLN , PeiJZ , LiuQQ . Cognitive behavioural therapy for the rehabilitation of schizophrenia [认知行为疗法治疗精神分裂症的康复效果观察]. 临床合理用药杂志2015;8(16):140. ">Du 2016</a>; <a href="./references#CD007964-bbs2-0099" title="JiangM , ChenH , SunX . Application of cognitive‐behavioral therapy on schizophrenia patients comorbid with diabetes mellitus [认知行为疗法在精神分裂症伴糖尿病患者中的应用]. Journal of Nursing Science [护理学杂志]2014;29(17):69‐70. ">Jiang 2014</a>; <a href="./references#CD007964-bbs2-0105" title="LangY , LiW , WangF , XuX . The effect of cognitive nursing intervention on the rehabilitation in young schizophrenia patients with impaired memory [认知护理干预在儿童精神分裂症记忆损害患儿恢复中的应用]. Nursing Practice and Research [护理实践与研究]2014;11:104‐5. ">Lang 2014</a>; <a href="./references#CD007964-bbs2-0112" title="LinJ . Effects of cognitive‐behavioral therapy for post‐schizophrenic depression [认知行为疗法在精神分裂症后抑郁中的应用效果分析]. Guide of China Medicine [中国医药指南]2014;12(33):174. ">Lin 2014</a>; <a href="./references#CD007964-bbs2-0115" title="LiuJ , YongS , XuX , ZhangJ , XieP , XuC , et al. Influence of CBT on rehabilitation outcome of hospitalized schizophrenics [认知行为治疗对住院精神分裂症患者康复效果的影响]. Journal of Clinical Psychosomatic Diseases [临床心身疾病杂志]2015;21:64‐6. ">Liu 2015</a>; <a href="./references#CD007964-bbs2-0119" title="McLeodT , MorrisM , BirchwoodM , DoveyA . Cognitive behavioural therapy group work with voice hearers. Part 1. British Journal of Nursing2007;16:248‐52. ">McLeod 2007</a>; <a href="./references#CD007964-bbs2-0143" title="ShaoG . Cognitive behavioral therapy used in the treatment of mentally ill [认知行为疗法在精神病康复治疗中的应用]. Guide of China Medicine [中国医药指南]2013, (11):567‐8. ">Shao 2013</a>; <a href="./references#CD007964-bbs2-0144" title="ShiY , JiaoY , JiangL , SunY , BoZ , WuQ , et al. Effects of cognitive‐behavioral therapy on executive function in chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者执行功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2015;15(5):497‐9. ">Shi 2015</a>; <a href="./references#CD007964-bbs2-0154" title="WuS . Cognitive psychotic therapy for depression in patients with schizophrenia [认知心理治疗改善精神分裂症后抑郁的疗效分析]. Journal of Modern Medicine and Health [现代医药卫生]2012;14:2155‐6. ">Wu 2012</a>; <a href="./references#CD007964-bbs2-0160" title="ZengY , LinS , DaiC . Effects of different nursing models on negative symptoms and social function in psychotic patients [不同护理模式干预对精神病患者阴性症状和社会功能的影响]. China Modern Medicine [中国当代医药]2014;21(18):108‐9+112. ">Zeng 2014</a>). </p> </section> <section id="CD007964-sec-0150"> <h5 class="title">Studies awaiting classification</h5> <p>Eight trials (<a href="./references#CD007964-bbs2-0164" title="ChenG . Efficacy of cognitive‐behavioral therapy on schizophrenia patients during recovery stage [认知行为疗法治疗精神分裂症患者康复期的疗效观察]. 14th academic annual meeting of the Committee on Mental Illness of China Association of Traditional Chinese and Western Medicine [中国中西医结合学会精神疾病专业委员会第十四届学术年会暨首届国际中西医结合精神病学研究进展培训班]. 2015:4. ">Chen 2015c</a>; <a href="./references#CD007964-bbs2-0165" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . Capopus. Randomized clinical trial: specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4(Suppl. 1):160. HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4(Suppl. 1):160. ">Fohlmann 2010</a>; <a href="./references#CD007964-bbs2-0166" title="HardyA , SteelC , SmithB , WykesT , RoseS , EnrightS , et al. Cognitive behavioural therapy for the treatment of posttraumatic stress disorder in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience2015;1:S31‐2. ">Hardy 2015</a>; <a href="./references#CD007964-bbs2-0167" title="HassanS , GanguliR , FlettG , SuleimanA , HewittP . Perfectionism and working alliance in a cognitive‐behavioral intervention for weight loss in psychotic illness. Schizophrenia Research2014;153:S166. ">Hassan 2014</a>; <a href="./references#CD007964-bbs2-0168" title="MounV , TripathiA , DalalPK , SinhaPK . Home based cognitive training in patients of schizophrenia. Indian Journal of Psychiatry2015;57:S78. ">Moun 2015</a>; <a href="./references#CD007964-bbs2-0169" title="RizkDN , SalamaH , MolokhiyaT , KassemL . Effectiveness of brief individual cognitive behavioral therapy for auditory hallucinations in a sample of Egyptian patients with schizophrenia. European Psychiatry2016;33(Suppl.):S259‐60. ">Nagui 2016</a>; <a href="./references#CD007964-bbs2-0170" title="TangW , ZhangJ , WenN , PanJ , YangF , JiangS . Effects on prognosis recurrence and efficacy in schizophrenia patients treated with palpiperone palmitate long‐acting injection and cognitive‐behavioral intervention [棕榈酸帕利哌酮长效针剂联合认知行为干预对精神分裂症患者疗效及预后复发的影响]. 30th anniversary of the establishment of China Mental Health Association and the eighth National Academic Conference on Mental Health [中国心理卫生协会成立30周年纪念活动暨第八次全国心理卫生学术大会]. 2015:192. ">Tang 2015</a>; <a href="./references#CD007964-bbs2-0171" title="TecicT , GuttgemannsJ , LehmkuhlG , MuellerK , StoesserD , WiedemannG , et al. Modified cognitive behavioral therapy in adolescents with persistent psychotic symptoms ‐ results of a randomized controlled trial. Schizophrenia Research2012;136:S302. ">Tecic 2012</a>) are awaiting assessment as we currently are unable to access the full‐text report. </p> </section> <section id="CD007964-sec-0151"> <h5 class="title">Ongoing studies</h5> <p>Please refer to <a href="./references#CD007964-sec-0456" title="">Characteristics of ongoing studies</a> for more details. </p> <p>We identified 15 ongoing trials that started between 2003 and 2016, but results had not been published<i>.</i> Three of these trials (<a href="./references#CD007964-bbs2-0174" title="ISRCTN12668007 . The nightmare intervention study. www.isrctn.com/ISRCTN12668007 [Date Accessed: 20 November 2015]. ">ISRCTN12668007</a>; <a href="./references#CD007964-bbs2-0184" title="NCT02787122 . Pilot‐trial of emotion‐focused cognitive behavior therapy for patients with schizophrenia. clinicaltrials.gov/ct2/show/NCT02787122 [Date Accessed: 1 June 2016]. ">NCT02787122</a>; <a href="./references#CD007964-bbs2-0185" title="NCT02787135 . Efficacy and mechanisms of change of an emotion‐oriented version of cognitive‐behavioral therapy for psychosis. clinicaltrials.gov/ct2/show/NCT02787135 [Date Accessed: 1 June 2016]. ">NCT02787135</a>) were still in the recruiting phase. </p> </section> </section> </section> <section id="CD007964-sec-0152"> <h3 class="title">Risk of bias in included studies</h3> <p>The summary of risk of bias in included trials was presented in <a href="#CD007964-fig-0002">Figure 2</a> and <a href="#CD007964-fig-0003">Figure 3</a> </p> <div class="figure" id="CD007964-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007964-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007964-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007964-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD007964-sec-0153"> <h4 class="title">Allocation</h4> <p>Thirty‐two included trials (32/60, 53.3%) were rated as having low risk of bias from randomisation as they described adequate random sequence generation. The methods used for sequence generation were computer‐generated random numbers, programme or web‐based randomisation system, block randomisation, random number table, and tossing coins. The remaining trials were rated as having unclear risk for selection bias as they did not describe the method of sequence generation. </p> <p>Seventeen trials (17/60, 28.3<b>%</b>) were rated as having low risk of bias from allocation concealment as they reported that the randomisation was conducted by staff independent of the research team or was conducted centrally, therefore, these trials had good allocation concealment. However, most of the included trials did not state the methods used to keep allocation concealed, and they were rated as having unclear risk of bias. One trial clearly stated that it did not conceal the group assignment regimen (<a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>) and this was rated as having a high risk of this selection bias. </p> </section> <section id="CD007964-sec-0154"> <h4 class="title">Blinding</h4> <p>All trials were all rated as having high risk of performance bias as CBT therapy cannot be 'masked' and is very different to standard care. It is very likely that all staff providing the care during the trial would know the group assignment. </p> <p>As for the blinding of outcome assessors, 31 trials (28/60, 46.7%) were rated as having low risk of detection bias as they blinded the outcomes assessors fromr group assignment. Twenty‐two trials did not state whether they keep the outcome assessors blinded, therefore, they were rated as having unclear risk of detection bias. The remaining three trials (<a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>) revealed that the outcomes assessors were not blinded, hence they were rated as having high risk of detection bias. </p> </section> <section id="CD007964-sec-0155"> <h4 class="title">Incomplete outcome data</h4> <p>Nearly 83% (50/60) of the included trials were rated as having low risk of attrition bias, as they had no missing data, a low proportion of participants left the trial early, or an intention‐to‐treat (ITT) analysis was used to deal with the missing data. Four trials (<a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>) had a relatively low proportion of missing data and the authors did not report the cause of withdrawal, so we rated these trials as having unclear risk for attrition bias. Another trial did not report the number of withdrawals, but reported an intention‐to‐treat analysis was used to deal with the missing data (<a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>). Therefore, this trial was also rated as having unclear risk of attrition bias. Five trials (<a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a>; <a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a>; <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a>; <a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a>) were rated as having high risk of attrition bias due to a high proportion of missing data. </p> </section> <section id="CD007964-sec-0156"> <h4 class="title">Selective reporting</h4> <p>A majority of included trials (50/60, 83%) were rated as having low risk of selective reporting as they reported data for all measured outcomes. Only ten trials (<a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a>;<a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a>; <a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a>; <a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a>; <a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a>; <a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>; <a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a>) were rated as having high risk of selective reporting for failure to report results of several prespecified outcomes. </p> </section> <section id="CD007964-sec-0157"> <h4 class="title">Other potential sources of bias</h4> <p>We did not think there was a high risk of other potential sources of bias within the included trials. </p> </section> </section> <section id="CD007964-sec-0158"> <h3 class="title" id="CD007964-sec-0158">Effects of interventions</h3> <p>See: <a href="./full#CD007964-tbl-0001"><b>Summary of findings for the main comparison</b> COMPARISON 1: CBT+ STANDARD CARE compared to STANDARD CARE ALONE for people with schizophrenia</a> </p> <section id="CD007964-sec-0159"> <h4 class="title">COMPARISON 1: CBT plus standard care versus standard care alone</h4> <section id="CD007964-sec-0160"> <h5 class="title">1.1 Global state: 1a. Relapse</h5> <p>Eighteen trials reported data on relapse (<a href="./references#CD007964-fig-0004" title="">Analysis 1.1</a>). </p> <section id="CD007964-sec-0161"> <h6 class="title">1.1.1 Short term</h6> <p>Two trials reported short‐term relapse data. There was not a clear difference between CBT plus standard care and standard care alone groups (RR 0.22, 95% CI 0.04 to 1.24; participants = 92; studies = 2). </p> </section> <section id="CD007964-sec-0162"> <h6 class="title">1.1.2 Medium term</h6> <p>Five trials reported medium‐term data. There was a clear difference, favouring CBT plus standard care (RR 0.53, 95% CI 0.39 to 0.72; participants = 667; studies = 5). </p> </section> <section id="CD007964-sec-0163"> <h6 class="title">1.1.3 Long term</h6> <p>Thirteen trials reported long‐term data. There was no clear difference between CBT plus standard care and standard care alone groups (RR 0.78, 95% CI 0.61 to 1.00; participants = 1538; studies = 13, low‐quality evidence). This result was presented in the SOF table as an outcome of importance. The quality of evidence was low due to significant heterogeneity (Chi<sup>2</sup> = 25.21; df = 12; P = 0.01; I<sup>2</sup> = 52%) and the wide confidence interval which included both appreciable benefit and harm. Removing outliers from this analysis did not alter the result. </p> </section> </section> <section id="CD007964-sec-0164"> <h5 class="title">1.2 Global state: 1b. Relapse ‐ number (skewed data)</h5> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> reported relapse data, however, these data were presented as 'Other data' because of marked skew, which makes it difficult to interpret (<a href="./references#CD007964-fig-0005" title="">Analysis 1.2</a>) </p> </section> <section id="CD007964-sec-0165"> <h5 class="title">1.3 Global state: 2. Clinically important change (no improvement) ‐ defined by individual studies </h5> <p>Three trials provided data at the medium and long term (<a href="./references#CD007964-fig-0006" title="">Analysis 1.3</a>). </p> <section id="CD007964-sec-0166"> <h6 class="title">1.3.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> found no clear difference between CBT plus standard care and standard care alone groups (RR 1.01, 95% CI 0.61 to 1.66; participants = 48; study = 1). </p> </section> <section id="CD007964-sec-0167"> <h6 class="title">1.3.2 Long term</h6> <p>Two trials provided useful long‐term data. There was a favourable effect for CBT plus standard care compared to standard care alone (RR 0.57, 95% CI 0.39 to 0.84; participants = 82; studies = 2; very low‐quality evidence). This result was presented in the SOF table as an outcome of importance. The quality of the evidence for this result was very low due to high risk of bias across several domains and the small number of trials with small sample size and very low number of events contributing data to this result. </p> </section> </section> <section id="CD007964-sec-0168"> <h5 class="title">1.4 Global state: 3a. Rehospitalisation</h5> <p>Eight trials reported data on rehospitalisation (<a href="./references#CD007964-fig-0007" title="">Analysis 1.4</a>). </p> <section id="CD007964-sec-0169"> <h6 class="title">1.4.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> reported short‐term data. There was no clear difference between CBT plus standard care and standard care alone groups (RR 1.00, 95% CI 0.07 to 14.55; participants = 30; study = 1). </p> </section> <section id="CD007964-sec-0170"> <h6 class="title">1.4.2 Long term</h6> <p>Six trials reported long‐term data. There was no clear difference between CBT plus standard care and standard care alone groups (RR 0.79, 95% CI 0.60 to 1.04; participants = 648; studies = 6). </p> </section> </section> <section id="CD007964-sec-0171"> <h5 class="title">1.5 Global state: 3b. Hospitalisation ‐ number of admissions (skewed data)</h5> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> reported 'number of admissions', however these data were presented in Other data tables because of marked skew which makes it difficult to interpret (<a href="./references#CD007964-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD007964-sec-0172"> <h5 class="title">1.6 Global state: 4. Average endpoint total score CGI, high = poor</h5> <p>Three trials (<a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>, <a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>) reported global state data as endpoint scores on the CGI. They reported short‐, medium‐ and long‐term follow‐up (<a href="./references#CD007964-fig-0009" title="">Analysis 1.6</a>). </p> <section id="CD007964-sec-0173"> <h6 class="title">1.6.1 Short term</h6> <p>Short‐term data showed a clear difference, favouring CBT plus standard care (MD ‐0.32, 95% CI ‐0.63 to ‐0.01; participants = 128; studies = 3). </p> </section> <section id="CD007964-sec-0174"> <h6 class="title">1.6.2 Medium term</h6> <p>Medium‐term data showed a clear difference, favouring CBT plus standard care (MD ‐0.52, 95% CI ‐0.89 to ‐0.15; participants = 80; studies = 2). </p> </section> <section id="CD007964-sec-0175"> <h6 class="title">1.6.3 Long term</h6> <p>Only <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported useful long‐term data. Data showed a clear difference, favouring CBT plus standard care (MD ‐0.67, 95% CI ‐1.07 to ‐0.27; participants = 32; study = 1). </p> </section> </section> <section id="CD007964-sec-0176"> <h5 class="title">1.7 Mental state: 1. General ‐ clinically important change (no improvement)</h5> <p>Eleven trials reported clinically important change in general mental state as 'no improvement'. Seven trials reported short‐term follow‐up, and five at the long term (<a href="./references#CD007964-fig-0010" title="">Analysis 1.7</a>). </p> <section id="CD007964-sec-0177"> <h6 class="title">1.7.1 Short term</h6> <p>Short‐term data showed a favourable effect for CBT plus standard care compared to standard care alone (RR 0.44, 95% CI 0.21 to 0.92; participants = 680; studies = 7). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 20.26, df = 6, P = 0.006, I<sup>2</sup> = 70%). The statistical heterogeneity was not significant after removing <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a> from the meta‐analysis. With <a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a> removed, a clear effect favouring CBT group was still observed (RR 0.70 95% CI 0.55 to 0.90). </p> </section> <section id="CD007964-sec-0178"> <h6 class="title">1.7.2 Long term</h6> <p>Long‐term data showed no difference between the treatment groups (RR 0.81, 95% CI 0.65 to 1.02; participants = 501; studies = 5, very low‐quality of evidence). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 7.26, df = 3, P = 0.06, I<sup>2</sup> = 59%, very low‐quality evidence). The quality of evidence was very low due to serious risk of bias of the included studies, significant heterogeneity, and low number of events.The statistical heterogeneity was not significant after removing <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> from the meta‐analysis. With <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> removed, no clear difference between the compared groups was still observed (RR 0.87 95% CI 0.73 to 1.03). </p> </section> </section> <section id="CD007964-sec-0179"> <h5 class="title">1.8 Mental state: 2a. General (average total endpoint score BPRS, high = poor)</h5> <p>Eight trials reported general mental state using BPRS total scores (<a href="./references#CD007964-fig-0011" title="">Analysis 1.8</a>). </p> <section id="CD007964-sec-0180"> <h6 class="title">1.8.1 Short term</h6> <p>Five trials reported short‐term data. There was a clear difference between the treatment groups, favouring CBT plus standard care (MD ‐5.09 CI ‐8.44 to ‐1.74; participants = 541; studies = 5). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 26.08; df = 4; P &lt; 0.0001; I<sup>2</sup> = 85%).The statistical heterogeneity was still significant after successively removing outliers. We could not find the source of the heterogeneity. </p> </section> <section id="CD007964-sec-0181"> <h6 class="title">1.8.2 Medium‐term</h6> <p>Three trials reported medium‐term data. There was no clear difference between CBT plus standard care and standard care alone groups (MD ‐2.57, 95% CI ‐5.73 to 0.60; participants = 199; studies = 3). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0182"> <h6 class="title">1.8.3 Long term</h6> <p>Three trials reported long term data . There was a clear difference between the treatment groups, favouring CBT plus standard care ((MD ‐8.77, 95% CI ‐14.08 to ‐3.46, <a href="./references#CD007964-fig-0011" title="">Analysis 1.8</a>). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 16.17; df = 2; P = 0.02; I<sup>2</sup> = 73%). The statistical heterogeneity was reduced to I<sup>2</sup> = 0% after removing <a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> from the meta‐analysis with the positive effect for CBT remaining (MD ‐6.14, 95% CI ‐9.47 to ‐2.80; participants = 110; studies = 2). </p> </section> </section> <section id="CD007964-sec-0183"> <h5 class="title">1.9 Mental state: 2b.General (average total endpoint score PANSS, high = poor)</h5> <p>Twenty‐two trials reported general mental stated using PANSS total scores (<a href="./references#CD007964-fig-0012" title="">Analysis 1.9</a>) . </p> <section id="CD007964-sec-0184"> <h6 class="title">1.9.1 Short term</h6> <p>Eleven trials reported short‐term data. There was a clear difference between the treatment groups, favouring CBT plus standard care (MD ‐7.21, 95% CI ‐10.12 to ‐4.30, participants = 962; studies = 11). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 51.61; df = 11; P &lt; 0.00001; I<sup>2</sup> = 81%). The statistical heterogeneity was still significant after successively removing outliers. We could not find the source of this heterogeneity. </p> </section> <section id="CD007964-sec-0185"> <h6 class="title">1.9.2 Medium term</h6> <p>Eleven relevant trials reported medium‐term data. There was a clear difference between the treatment groups, favouring CBT plus standard care (MD ‐3.68, 95% CI ‐6.12 to ‐1.24; participants = 963; studies = 11). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 30.35; df = 14; P = 0.0008; I<sup>2</sup> = 67%). The statistical heterogeneity was not significant after removing <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> from the meta‐analysis and the positive effect for CBT remained (MD ‐2.64, 95% CI ‐4.71 to ‐ 0.58). Accordingly, the treatment effect was robust to heterogeneity amongst the studies. </p> </section> <section id="CD007964-sec-0186"> <h6 class="title">1.9.3 Long term</h6> <p>Twelve trials provided reported long‐term data. There was a clear difference between the treatment groups, favouring CBT plus standard care (MD ‐3.74, 95% CI ‐6.46 to ‐1.02; participants = 1284; studies = 12). This subgroup also had important levels of heterogeneity (Chi<sup>2</sup> = 34.88; df = 11; P = 0.0003; I<sup>2</sup> = 68%). The statistical heterogeneity was still significant after successively removing outliers. We could not find the source of this heterogeneity. </p> </section> </section> <section id="CD007964-sec-0187"> <h5 class="title">1.10 Mental state: 2c. General (average total endpoint score PSYRATS, high = poor)</h5> <p>One trial (<a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a>) reported medium‐ and long‐term data for this outcome (<a href="./references#CD007964-fig-0013" title="">Analysis 1.10</a>). </p> <section id="CD007964-sec-0188"> <h6 class="title">1.10.1 Medium term</h6> <p>There was no clear difference between CBT plus standard care and standard care groups at the medium term (MD 1.05, 95% CI ‐1.20 to 3.30; participants = 197; studies = 1). </p> </section> <section id="CD007964-sec-0189"> <h6 class="title">1.10.2 Long term</h6> <p>There was no clear difference between CBT plus standard care and standard care groups at the long term (MD 0.63, 95% CI ‐1.48 to 2.74; participants = 197; studies = 1). </p> </section> </section> <section id="CD007964-sec-0190"> <h5 class="title">1.11 Mental State: 2d. General (average total change score, various scales)</h5> <p>Two trials reported change scores from mental state scales (<a href="./references#CD007964-fig-0014" title="">Analysis 1.11</a>) </p> <section id="CD007964-sec-0191"> <h6 class="title">1.11.1 CHOICE ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> reported change score from CHOICE at the short term. There was a favourable effect for CBT plus standard care compared to standard care alone (MD 9.10, 95% CI 1.74 to 16.46, participants = 136, study = 1). </p> </section> <section id="CD007964-sec-0192"> <h6 class="title">1.11.2 CPRS ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> reported change score from the CPRS at the medium term. There was no clear difference between CBT plus standard care and standard care alone groups (MD 1.32, 95% CI ‐0.97 to 3.61, participants = 336, study = 1). </p> </section> </section> <section id="CD007964-sec-0193"> <h5 class="title">1.12 Mental State: 2e. General (average total change score SCL‐90, high = poor)</h5> <p><a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a> reported average change scores from the SCL‐90. As these data showed significant skew, they were presented as 'Other data' (<a href="./references#CD007964-fig-0015" title="">Analysis 1.12</a>). </p> </section> <section id="CD007964-sec-0194"> <h5 class="title">1.13 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>Seventeen trials reported PANSS subscale scores for positive symptoms (<a href="#CD007964-tbl-0004">Table 3</a>). </p> <div class="table" id="CD007964-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Data added into generic inverse variance outcome (1.14)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>483</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>696</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>651</p> </td> </tr> </tbody> </table> </div> <p>One trial reported short‐term data for this outcome as SEs. We used the RevMan calculator to convert data presented in <a href="#CD007964-tbl-0004">Table 3</a> into SE for use in <a href="./references#CD007964-fig-0016" title="">Analysis 1.13</a>. </p> <section id="CD007964-sec-0195"> <h6 class="title">1.13.1 Short term</h6> <p>Short term data showed an effect favouring CBT (MD ‐3.11, 95% CI ‐4.97 to ‐1.24; studies = 11). For this outcome, heterogeneity was high (Chi<sup>2</sup> = 10.4; df = 1.0; P = 0.0; I<sup>2</sup> = 90%). The statistical heterogeneity was not significant after removing the outliers <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a> and <a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> from the meta‐analysis and the positive effect for CBT remained. Accordingly, the treatment effect was robust to heterogeneity amongst the studies. We could not identify a cause for this heterogeneity. </p> </section> <section id="CD007964-sec-0196"> <h6 class="title">1.13.2 Medium term</h6> <p>Medium‐term data showed an effect favouring CBT (MD ‐1.23, 95% CI ‐1.90 to ‐0.55; studies = 12). </p> </section> <section id="CD007964-sec-0197"> <h6 class="title">1.13.3 Long term</h6> <p>Long‐term data showed an effect favouring CBT (MD ‐0.98, 95% CI ‐1.63 to ‐0.34; studies = 12). </p> </section> </section> <section id="CD007964-sec-0198"> <h5 class="title">1.14 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score BPSR/SAPS, high = poor) </h5> <p>Two trials reported scores from various other scales that measured positive symptoms (<a href="./references#CD007964-fig-0017" title="">Analysis 1.14</a>). </p> <section id="CD007964-sec-0199"> <h6 class="title">1.14.1 BPRS ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> reported BPRS scores. An effect favouring CBT plus standard care was observed (MD ‐1.84 95% CI ‐3.4 to ‐0.27; participants = 48; study = 1). </p> </section> <section id="CD007964-sec-0200"> <h6 class="title">1.14.2 SAPS ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported SAPS scores. An effect favouring CBT plus standard care was observed (MD ‐1.83 95% CI ‐3.61 to ‐0.05; participants = 64; study = 1). </p> </section> </section> <section id="CD007964-sec-0201"> <h5 class="title">1.15 Mental state: 4a. Specific ‐ hallucination ‐ clinically important change ‐ no improvement (&lt; 3 point improvement BPRS ‐ hallucination severity) </h5> <p><a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> reported clinically important change as 'no improvement' which was measured as 'less than 3‐point improvement in hallucination severity scores' on the BPRS (<a href="./references#CD007964-fig-0018" title="">Analysis 1.15</a>). </p> <section id="CD007964-sec-0202"> <h6 class="title">1.15.1 Short term</h6> <p>An effect favouring CBT plus standard care was observed at the short term (RR 0.09 95% CI 0.03 to 0.27; participants = 65; study = 1). </p> </section> <section id="CD007964-sec-0203"> <h6 class="title">1.15.2 Long term</h6> <p>An effect favouring CBT plus standard care was observed at the long term (RR 0.08 95% CI 0.03 to 0.26; participants = 65; study = 1). </p> </section> </section> <section id="CD007964-sec-0204"> <h5 class="title">1.16 Mental state: 4b. Specific ‐ hallucination (average endpoint score various scales, high = poor) </h5> <p>Six trials reported hallucination scores from various scales at the short, medium and long term (<a href="./references#CD007964-fig-0019" title="">Analysis 1.16</a>). </p> <section id="CD007964-sec-0205"> <h6 class="title">1.16.1 AHRS ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> used the AHRS to measure 'hallucination'. At short‐term follow‐up, there was a clear difference between treatment groups, favouring CBT plus standard care (MD ‐3.60, 95% CI ‐6.74 to ‐0.46; participants = 50; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0206"> <h6 class="title">1.16.2 PANSS ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> used the PANSS to measure 'hallucination'. At short‐term follow‐up, there was a clear difference between treatment groups, favouring CBT plus standard care (MD ‐0.48, 95% CI ‐0.92 to ‐0.04; participants = 60; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0207"> <h6 class="title">1.16.3 AHRS ‐ medium term</h6> <p>Medium‐term data from the AHRS did not show a clear difference between CBT plus standard care and standard care alone groups (MD ‐2.57, 95% CI ‐7.07 to 1.93; participants = 128; studies = 2). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 4.75; df = 1; P = 0.03; I<sup>2</sup> = 79%) and the source of this heterogeneity remained unidentified. </p> </section> <section id="CD007964-sec-0208"> <h6 class="title">1.16.4 PANSS ‐ medium term</h6> <p>Medium‐term data from PANSS showed no clear difference between CBT plus standard care and standard care alone groups (MD ‐0.33, 95% CI ‐0.79 to 0.13; participants = 197; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0209"> <h6 class="title">1.16.5 Malevolence ‐ BAVQ ‐ medium term</h6> <p>Medium‐term data from BAVQ also showed no clear difference between CBT plus standard care and standard care alone groups (MD 1.00, 95% CI ‐5.26 to 7.26; participants = 29; study = 1). </p> </section> <section id="CD007964-sec-0210"> <h6 class="title">1.16.6 Omniscience ‐ BAVQ ‐ medium term</h6> <p>Medium‐term data from BAVQ also showed no clear difference between CBT plus standard care and standard care alone groups (MD ‐0.90, 95% CI ‐3.47 to 1.67; participants = 29; study = 1). </p> </section> <section id="CD007964-sec-0211"> <h6 class="title">1.16.7 VPD ‐ medium term</h6> <p>Medium‐term data from the VPD scale showed a clear difference, between treatment groups, favouring CBT plus standard care (MD ‐11.10, 95% CI ‐15.73 to ‐6.47; participants = 29; study = 1). </p> </section> <section id="CD007964-sec-0212"> <h6 class="title">1.16.8 AHRS ‐ long term</h6> <p>Long‐term data from the AHRS did not show a clear difference between CBT plus standard care and standard care alone groups (MD ‐4.40, 95% CI ‐6.60 to ‐2.20; participants = 78; study = 1). </p> </section> <section id="CD007964-sec-0213"> <h6 class="title">1.16.9 PANSS ‐ long term</h6> <p>Long‐term data from the PANSS did not show a clear difference between CBT plus standard care and standard care alone groups (MD 0.14, 95% CI ‐0.3 to 0.58; participants = 197; study = 1). </p> </section> <section id="CD007964-sec-0214"> <h6 class="title">1.16.10 BPRS ‐ long term</h6> <p>Long‐term data from the BPRS showed a clear difference between treatment groups, favouring CBT plus standard care (MD ‐2.82, 95% CI ‐3.74 to ‐1.90; participants = 65; study = 1). </p> </section> </section> <section id="CD007964-sec-0215"> <h5 class="title">1.17 Mental state: 4c. Specific ‐ hallucinations (average endpoint score PsyRATs, high = poor) </h5> <section id="CD007964-sec-0216"> <h6 class="title">1.17.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a> and <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> reported SE data for hallucinations using PsyRATs. However, significant heterogeneity was observed (Chi<sup>2</sup> = 24.87, df = 1 P &lt; 0.00001, I<sup>2</sup> = 96%). As there were only two studies contributing to this outcome, it was not possible to reduce heterogeneity and we decided not to combine these data within the meta‐analysis (<a href="./references#CD007964-fig-0020" title="">Analysis 1.17</a>). </p> </section> <section id="CD007964-sec-0217"> <h6 class="title">1.17.2 Medium term</h6> <p>Only <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> reported medium‐term data. There was no clear difference between CBT plus standard care and standard care alone groups (MD ‐1.17, 95% CI ‐3.26 to 0.92; participants = 422; study = 1). Results were unaltered when applying the fixed‐effect model (<a href="./references#CD007964-fig-0020" title="">Analysis 1.17</a>). </p> </section> </section> <section id="CD007964-sec-0218"> <h5 class="title">1.18 Mental state: 4d. Specific ‐ hallucinations (average endpoint score, various scales, high = poor) (skewed data) </h5> <p><a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a>; <a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a>; <a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a>; and <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a> also presented scale scores for 'hallucination'. These data were presented as 'Other data' because of the presence of excessive skew (<a href="./references#CD007964-fig-0021" title="">Analysis 1.18</a>). </p> </section> <section id="CD007964-sec-0219"> <h5 class="title">1.19 Mental state: 5a. Specific ‐ delusions (average endpoint score PsyRATs, high = poor) </h5> <p>Five studies reported short‐term data for delusions using PsyRATs. <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a>; <a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a>; and <a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a> reported data for this outcome as SEs. We used the RevMan calculator to convert data reported by <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> and <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> (presented in <a href="#CD007964-tbl-0005">Table 4</a>) into SE for use in Analysis 1.19 . </p> <div class="table" id="CD007964-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Data added into generic inverse variance outcome (1.17)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> </tr> </tbody> </table> </div> <section id="CD007964-sec-0220"> <h6 class="title">1.19.1 Short term</h6> <p>At the short term, a positive effect for CBT was observed (MD ‐4.33, 95% CI ‐7.58 to ‐1.08; studies = 5) </p> <p>This outcome had important levels of heterogeneity (Chi<sup>2</sup> = 16.35; df = 2.0; P = 0.0003; I<sup>2</sup> = 90%), which were reduced to I<sup>2</sup> &lt; 50 % when the outliers <a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a> and <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> were excluded, retaining a positive effect for CBT. </p> </section> </section> <section id="CD007964-sec-0221"> <h5 class="title">1.20 Mental state: 5b. Specific ‐ delusions (average endpoint score PANSS, high = poor) </h5> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> reported delusion scores using the PANSS (<a href="./references#CD007964-fig-0023" title="">Analysis 1.20</a>). </p> <section id="CD007964-sec-0222"> <h6 class="title">1.20.1 Short term</h6> <p>There was a single trial in this subgroup. For this outcome, within this subgroup, we did find evidence that CBT was clearly different in its effects compared with 'standard care alone' (MD ‐0.64 95% CI ‐1.16 to ‐0.12; participants = 60; study = 1). </p> </section> <section id="CD007964-sec-0223"> <h6 class="title">1.20.2 Medium term</h6> <p>There was a single trial in this subgroup. For this outcome, within this subgroup, we did not find evidence that CBT was clearly different in its effects compared with 'standard care alone' (MD ‐0.30 95% CI ‐0.71 to 0.11; participants = 197; study = 1). </p> </section> <section id="CD007964-sec-0224"> <h6 class="title">1.20.3 Long term</h6> <p>We found one trial to be relevant to this subgroup. For this outcome, within this subgroup, we found no evidence that CBT was different in its effects compared with 'standard care alone' (MD ‐0.10 95% CI ‐0.53 to 0.33; participants = 197; study = 1). </p> </section> </section> <section id="CD007964-sec-0225"> <h5 class="title">1.21. Mental state: 5c. Specific ‐ delusions (average change score PsyRATs, high = poor) </h5> <section id="CD007964-sec-0226"> <h6 class="title">1.21.1 Medium term</h6> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> reported change scores. There was no evidence of a clear difference between CBT and standard care within this subgroup (MD ‐0.43 95% CI ‐1.82 to 0.96; participants = 336; study = 1) (<a href="./references#CD007964-fig-0024" title="">Analysis 1.21</a>). </p> </section> </section> <section id="CD007964-sec-0227"> <h5 class="title">1.22 Mental state: 5d. Specific ‐ delusions (average endpoint score PSYRATs high = poor) (skewed data) </h5> <p>These data were presented in Other data tables because of excessive skew in the data (<a href="./references#CD007964-fig-0025" title="">Analysis 1.22</a>). </p> </section> <section id="CD007964-sec-0228"> <h5 class="title">1.23 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>Twenty‐one studies reported negative symptom scores using PANSS subscale at the short, medium and long term. Two trials reported short‐term data for this outcome as SEs. We used the RevMan calculator to convert data reported by the other trials (see <a href="#CD007964-tbl-0006">Table 5</a>) into SE to enable use in (Analysis 1.23) (<a href="./references#CD007964-fig-0026" title="">Analysis 1.23</a>). </p> <div class="table" id="CD007964-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Data added into generic inverse variance outcome (1.23)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>356</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>528</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>740</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>696</p> </td> </tr> </tbody> </table> </div> <section id="CD007964-sec-0229"> <h6 class="title">1.23.1 Short term</h6> <p>Short‐term data from 12 trials showed a positive effect for the CBT group (MD ‐3.35, 95% CI ‐3.84 to ‐2.85; studies = 12). </p> </section> <section id="CD007964-sec-0230"> <h6 class="title">1.23.2 Medium term</h6> <p>Medium‐term data from 13 trials showed a positive effect for the CBT group (MD ‐3.35, 95% CI ‐3.84 to ‐2.85; studies = 12) </p> </section> <section id="CD007964-sec-0231"> <h6 class="title">1.23.3 Long term</h6> <p>Long‐term data from 13 trials showed a positive effect for the CBT group (MD ‐1.47, 95% CI ‐1.94 to ‐0.99; studies = 13). </p> <p>All three subgroups had very high heterogeneity (I<sup>2</sup> &gt; 75%), and removing outliers did not alter the result. We could not identify a cause for the heterogeneity. </p> </section> </section> <section id="CD007964-sec-0232"> <h5 class="title">1.24 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score SANS, high = poor) </h5> <p>Four trials reported negative symptoms using SANS (<a href="./references#CD007964-fig-0027" title="">Analysis 1.24</a>). </p> <section id="CD007964-sec-0233"> <h6 class="title">1.24.1 Short term</h6> <p>Four trials reported short‐term data. There was no clear difference between CBT plus standard care and standard care groups (MD ‐4.11 95% CI ‐10.40 to 2.17; participants = 231; studies = 4). This subgroup had important levels of heterogeneity (Chi<sup>2</sup> = 61.03; df = 3; P &lt; 0.00001; I<sup>2</sup> = 95%). The statistical heterogeneity was not significant after removing <a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a> from the meta‐analysis and there was still no clear difference between the treatment groups (MD ‐0.59, 95% CI ‐1.99 to 0.80). Accordingly, the treatment effect was robust to heterogeneity amongst the studies. </p> </section> <section id="CD007964-sec-0234"> <h6 class="title">1.24.2 Long term</h6> <p>One trial reported long‐term data. There was no clear difference between CBT plus standard care and standard care groups (MD ‐1.07 95% CI ‐3.29 to 1.15; participants = 49; study = 1). This result was the same when using a fixed‐effect model. </p> </section> </section> <section id="CD007964-sec-0235"> <h5 class="title">1.25 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score NSRS, high = poor) ‐ medium term </h5> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> reported data. There was no clear difference between the two treatments groups (MD 0.60, 95% CI ‐0.05 to 1.25; participants = 336; study = 1) (<a href="./references#CD007964-fig-0028" title="">Analysis 1.25</a>). </p> </section> <section id="CD007964-sec-0236"> <h5 class="title">1.26 Mental state: 7a. Specific ‐ affective symptoms (average endpoint score PANSS sub scale, high = poor) </h5> <p>Seventeen studies reported affective symptoms using the PANSS subscale. Two trials reported short‐term data for this outcome as SEs. We used the RevMan calculator to convert data reported by the other trials (<a href="#CD007964-tbl-0007">Table 6</a> ) into SEs to enable use in Analysis 1.26 (<a href="./references#CD007964-fig-0029" title="">Analysis 1.26</a>). </p> <div class="table" id="CD007964-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Data added into generic inverse variance outcome (1.26)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>273</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>435</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>647</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>601</p> </td> </tr> </tbody> </table> </div> <section id="CD007964-sec-0237"> <h6 class="title">1.26.1 Short term</h6> <p>Short‐term data from ten trials showed a positive effect for CBT (MD ‐4.86, 95% CI ‐5.75 to ‐3.96; studies = 10). </p> </section> <section id="CD007964-sec-0238"> <h6 class="title">1.26.2 Medium term</h6> <p>There was no clear difference between treatment groups at medium term (MD ‐0.80, 95% CI ‐1.70 to 0.09; studies = 10). </p> </section> <section id="CD007964-sec-0239"> <h6 class="title">1.26.3 Long term</h6> <p>Long‐term data from ten trials showed a positive effect for CBT(MD ‐1.00, 95% CI ‐1.82 to ‐0.18; studies = 10) </p> <p>Heterogeneity was high for all three subgroups (I<sup>2</sup> &gt; 60%). The positive effect for CBT remained when outliers were removed. We could not identify the cause of heterogeneity. </p> </section> </section> <section id="CD007964-sec-0240"> <h5 class="title">1.27 Mental state: 8. Specific ‐ distress (average endpoint score PsyRATs/SADS, high = poor) </h5> <p>Three trials reported stress scores (<a href="./references#CD007964-fig-0030" title="">Analysis 1.27</a>). </p> <section id="CD007964-sec-0241"> <h6 class="title">1.27.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> reported short‐term data. There was a clear difference, favouring CBT plus standard care (MD ‐1.10 95% CI ‐1.77 to ‐0.43; participants = 140; study = 1). These results remained the same when using the fixed‐effect model. </p> </section> <section id="CD007964-sec-0242"> <h6 class="title">1.27.2 Medium term</h6> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> and <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a> reported medium‐term data. There was no clear difference between CBT plus standard care and standard care alone (MD 0.08, 95% CI ‐0.50 to 0.66; participants = 226; studies = 2). For this outcome, heterogeneity was high (Chi<sup>2</sup> = 2.26; df = 1.0; P = 0.13; I<sup>2</sup> = 56%). We failed to find the source of the heterogeneity. </p> </section> <section id="CD007964-sec-0243"> <h6 class="title">1.27.3 Long term</h6> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> found no clear difference between treatment groups in the long term (MD ‐0.10, 95% CI ‐0.47 to 0.27; participants = 197; study = 1). This result remained the same when using the fixed‐effect model. </p> </section> </section> <section id="CD007964-sec-0244"> <h5 class="title">1.28 Mental state: 9. Specific ‐ anxiety (average endpoint score various scales, high = poor) </h5> <p>Ten trials used a variety of measuring scales to report anxiety scores (<a href="./references#CD007964-fig-0031" title="">Analysis 1.28</a>). </p> <section id="CD007964-sec-0245"> <h6 class="title">1.28.1 BAI ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> and <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> reported short‐term scores from the BAI. There was no clear difference between the two treatments groups (MD ‐0.32, 95% CI ‐5.40 to 4.77; participants = 105; studies = 2). </p> </section> <section id="CD007964-sec-0246"> <h6 class="title">1.28.2 SAS ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a> and <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a> reported short‐term scores from the SAS. There was a clear difference between groups with a favourable effect for CBT plus standard care (MD ‐6.21, 95% CI ‐7.36 to ‐5.05; participants = 188; studies = 2). </p> </section> <section id="CD007964-sec-0247"> <h6 class="title">1.28.3 HAMA ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a> reported short‐term scores from the HAMA. There was a clear difference between groups, favouring CBT plus standard care (MD ‐1.79, 95% CI ‐2.29 to ‐1.29; participants = 75; study = 1). </p> </section> <section id="CD007964-sec-0248"> <h6 class="title">1.28.4 SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported short‐term scores from the SCL‐90. There was a clear difference between groups, favouring CBT plus standard care (MD ‐1.43, 95% CI ‐1.53 to ‐1.33; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0249"> <h6 class="title">1.28.5 BAI ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> and <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> reported medium‐term scores from the BAI. There was no clear difference between CBT plus standard care and standard care groups (MD ‐1.34, 95% CI ‐6.55 to 3.87; participants = 108; studies = 2). </p> </section> <section id="CD007964-sec-0250"> <h6 class="title">1.28.6 BAI ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a>; <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> and <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> reported long‐term scores from the BAI. There was no clear difference between CBT plus standard care and standard care groups (MD 1.5, 95% CI ‐1.19 to 4.19; participants = 335; studies = 3). </p> </section> <section id="CD007964-sec-0251"> <h6 class="title">1.28.7 HADS ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> reported long‐term scores from the HADS. There was no clear difference between CBT plus standard care and standard care groups (MD 0.66, 95% CI ‐1.22 to 2.54; participants = 92; study = 1). </p> </section> </section> <section id="CD007964-sec-0252"> <h5 class="title">1.29 Mental state: 10a. Specific ‐ depression ‐ clinically important change (no improvement = reduction HAMD score &lt; 25%) ‐ short term </h5> <p><a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> measured clinically important change in depression, defining 'no improvement' as less than 25% reduction of the HAMD score. Similar numbers of participants from both groups showed 'no improvement' ‐ i.e. no advantage for CBT was observed (RR 0.67, 95% CI 0.21 to 2.15; participants = 68; study = 1) (<a href="./references#CD007964-fig-0032" title="">Analysis 1.29</a>). </p> </section> <section id="CD007964-sec-0253"> <h5 class="title">1.30 Mental state: 10b. Specific ‐ depression (average endpoint score various scales, high = poor) ‐ short term </h5> <p>Eight trials reported depression scores at the short term from various scales (<a href="./references#CD007964-fig-0033" title="">Analysis 1.30</a>). </p> <section id="CD007964-sec-0254"> <h6 class="title">1.30.1 BDI</h6> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> and <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> reported BDI scores. There was no clear difference between CBT plus standard care and standard care groups (MD ‐1.11, 95% CI ‐4.25 to 2.03; participants = 78; studies = 2). </p> </section> <section id="CD007964-sec-0255"> <h6 class="title">1.30.2 SDS</h6> <p><a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a> and <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a> reported SDS scores. There was a clear difference between treatment groups with a favourable effect for CBT plus standard care (MD ‐3.29, 95% CI ‐4.4 to ‐2.19; participants = 188; studies = 2). </p> </section> <section id="CD007964-sec-0256"> <h6 class="title">1.30.3 HAMD ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a> and <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> reported HAMD scores. There was a clear difference between treatment groups with a favourable effect for CBT plus standard care (MD ‐4.95, 95% CI ‐6.69 to ‐3.2; participants = 143; studies = 2). </p> </section> <section id="CD007964-sec-0257"> <h6 class="title">1.30.4 SCL‐90</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported SCL‐90 scores. At the short term, there was a clear difference between treatment groups with a favourable effect for CBT plus standard care (MD ‐0.58, 95% CI ‐0.65 to ‐0.51; participants = 90; study = 1). </p> </section> </section> <section id="CD007964-sec-0258"> <h5 class="title">1.31 Mental state: 10c. Specific ‐ depression (average change score MADRS, high = poor) ‐ medium term </h5> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> reported MADRS change scores. At the medium term, there was no clear difference between the two treatments (MD 0.15, 95% CI ‐1.26 to 1.56; participants = 336; studies = 1) (<a href="./references#CD007964-fig-0034" title="">Analysis 1.31</a>). </p> </section> <section id="CD007964-sec-0259"> <h5 class="title">1.32 Mental state: 10d. Specific ‐ depression (average endpoint score various scales, high = poor) </h5> <p>Several other trials presented scores from various scales for depression. They were presented as 'Other data' due to excess skew (<a href="./references#CD007964-fig-0035" title="">Analysis 1.32</a>). </p> </section> <section id="CD007964-sec-0260"> <h5 class="title">1.33 Mental state: 11a. Specific ‐ self‐esteem (average endpoint score ‐ various scales, high = good) </h5> <p>Ten trials reported self‐esteem scores from various scales (<a href="./references#CD007964-fig-0036" title="">Analysis 1.33</a>). </p> <section id="CD007964-sec-0261"> <h6 class="title">1.33.1 RSES ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> used the RSES scale to measure self‐esteem. At short‐term follow‐up, there was no clear difference between the treatment groups (MD 0.40, 95% CI ‐1.43 to 2.23; participants = 144; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0262"> <h6 class="title">1.33.2 SES ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a> and <a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a> used the SES to measure self‐esteem. At short‐term follow‐up, there was a clear difference between treatment groups, favouring CBT plus standard care (MD 3.29, 95% CI 2.43 to 4.16; participants = 188; studies = 2). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0263"> <h6 class="title">1.33.3 RSCQ ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> and <a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> used the RSCQ to measure self‐esteem. At short‐term follow‐up, there was a clear difference between the two treatment groups (MD 8.29, 95% CI ‐0.08 to 16.66; participants = 95; studies = 2). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0264"> <h6 class="title">1.33.4 GSES ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a> used the GSES to measure self‐esteem. At short‐term follow‐up, there was a clear difference between treatment groups, favouring CBT plus standard care (MD 1.48 95% CI 0.05 to 2.91; participants = 190; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0265"> <h6 class="title">1.33.5 RSES ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> reported medium‐term data from the RSES. There was not a clear difference between treatment groups (MD 0.90, 95% CI ‐0.79 to 2.59; participants = 144; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0266"> <h6 class="title">1.33.6 RSCQ ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a> reported medium‐term data from the RSCQ. There was not a clear difference between treatment groups (MD 0.40, 95% CI ‐7.46 to 8.26; participants = 66; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0267"> <h6 class="title">1.33.7 SERS ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> used the SERS to measure self‐esteem. At medium‐term follow‐up, there was a clear difference between treatment groups, favouring CBT plus standard care (MD 16.9, 95% CI 1.25 to 32.55; participants = 35; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0268"> <h6 class="title">1.33.8 GSES ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a> reported medium‐term data from the GSES. There was a clear difference between treatment groups, favouring CBT plus standard care (MD 0.76, 95% CI 0.53 to 0.99; participants = 104; study = 1). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0269"> <h6 class="title">1.33.9 RSES ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> and <a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> reported long‐term data from the RSES. There was no clear difference between treatment groups (MD ‐0.33, 95% CI ‐1.79 to 1.14; participants = 236; studies = 2). This result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0270"> <h6 class="title">1.33.10 RSCQ ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> and <a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a> reported long‐term data from the RSCQ. There was no clear difference between treatment groups (MD 6.23, 95% CI ‐8.56 to 21.03; participants = 131; studies = 2). For this outcome, heterogeneity was high (Chi<sup>2</sup> = 6.05; df = 1; P = 0.01; I<sup>2</sup> = 83%). We failed to find the source of the heterogeneity. </p> </section> </section> <section id="CD007964-sec-0271"> <h5 class="title">1.34 Mental state: 11b. Specific ‐ self‐esteem (average endpoint score various scales) ‐ short term (skewed data) </h5> <p>These data are presented in Other data tables because of a marked skew in the data which makes it difficult to interpret the findings (<a href="./references#CD007964-fig-0037" title="">Analysis 1.34</a>). </p> </section> <section id="CD007964-sec-0272"> <h5 class="title">1.35 Mental state: 12a. Specific ‐ insight (average endpoint score various scales, high = good) </h5> <p>Four trials reported insight scores using various scales (<a href="./references#CD007964-fig-0038" title="">Analysis 1.35</a>). </p> <section id="CD007964-sec-0273"> <h6 class="title">1.35.1 ITAQ ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a> used the ITAQ to measure insight. At the short term, there was a clear difference between treatment groups, favouring CBT plus standard care (MD 4.92, 95% CI 3.19 to 6.65; participants = 75; study = 1). </p> </section> <section id="CD007964-sec-0274"> <h6 class="title">1.35.2 BCIS ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> used the BCIS to measure insight. At medium‐term follow‐up, there was no clear difference between treatment groups (MD 1.33, 95% CI ‐1.24 to 3.90; participants = 65; study = 1). </p> </section> <section id="CD007964-sec-0275"> <h6 class="title">1.35.3 ITAQ ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a> used the ITAQ to measure insight. At medium‐term follow‐up, there was no clear difference between treatment groups (MD ‐0.10, 95% CI ‐2.97 to 2.77; participants = 74; study = 1). </p> </section> <section id="CD007964-sec-0276"> <h6 class="title">1.35.4 SRIS ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> used the SRIS to measure insight. At the long term, there was not a clear difference between treatment groups (MD 0.02, 95% CI ‐1.3 to 1.34; participants = 92; study = 1). </p> </section> <section id="CD007964-sec-0277"> <h6 class="title">1.35.5 BCIS ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> reported long‐term scores from the BCIS. There was no clear difference between the two treatments (MD ‐0.54, 95% CI ‐3.7 to 2.62; participants = 64; study = 1). </p> </section> <section id="CD007964-sec-0278"> <h6 class="title">1.35.6 ITAQ ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a> reported long‐term scores from the ITAQ.. There was not a clear difference between the treatment groups (MD 0.40, 95% CI ‐2.2 to 3.0; participants = 74; study = 1). </p> </section> </section> <section id="CD007964-sec-0279"> <h5 class="title">1.36 Mental state: 12b. Specific ‐ insight (average endpoint score SAI, high = good)</h5> <p>One trial reported short‐term SEs for this outcome and two other trials reported mean and SD. We used the RevMan calculator to convert relevant data presented in <a href="#CD007964-tbl-0008">Table 7</a> into SE for use in <a href="./references#CD007964-fig-0039" title="">Analysis 1.36</a>. </p> <div class="table" id="CD007964-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Data added into generic inverse variance outcome (1.36)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> </tbody> </table> </div> <section id="CD007964-sec-0280"> <h6 class="title">1.36.1 Short term</h6> <p>A favourable effect for CBT was found at the short term (MD 6.50, 95% CI 5.84 to 7.16; studies = 3). </p> </section> <section id="CD007964-sec-0281"> <h6 class="title">1.36.2 Medium term</h6> <p>No clear difference between treatment groups was observed at the medium term (MD 1.60, 95% CI ‐0.19 to 3.39; studies = 1). </p> </section> <section id="CD007964-sec-0282"> <h6 class="title">1.36.3 Long term</h6> <p>A favourable effect for CBT was found at the long term (MD 2.90, 95% CI 0.96 to 4.84; studies = 1) </p> </section> </section> <section id="CD007964-sec-0283"> <h5 class="title">1.37 Mental state: 12c. Specific ‐ insight (average change score SAI, high = good) ‐ medium term </h5> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> reported SAI change scores for insight. At medium‐term follow‐up, there was no clear difference between treatment groups (MD ‐0.69, 95% CI ‐1.41 to 0.03; participants = 336; study = 1) (<a href="./references#CD007964-fig-0040" title="">Analysis 1.37</a>). </p> </section> <section id="CD007964-sec-0284"> <h5 class="title">1.38 Mental state: 13. Specific ‐ well‐being (average endpoint WEMW score, high = good) ‐ short term </h5> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> and <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> reported short‐term scores for well being. There was a favourable effect for CBT plus standard care (MD 4.08, 95% CI 0.90 to 7.26; participants = 170; studies = 2) (<a href="./references#CD007964-fig-0041" title="">Analysis 1.38</a>). </p> </section> <section id="CD007964-sec-0285"> <h5 class="title">1.39 Mental state: 14a. Specific ‐ various other symptoms (average endpoint score, high = poor) </h5> <p>Six trials reported on a variety of other specific mental state symptoms, using various scales (<a href="./references#CD007964-fig-0042" title="">Analysis 1.39</a>). </p> <section id="CD007964-sec-0286"> <h6 class="title">1.39.1 Psychotic symptoms ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐0.58, 95% CI ‐0.72 to ‐0.44; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0287"> <h6 class="title">1.39.2 Somatisation ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐1.86, 95% CI ‐1.98 to ‐1.74; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0288"> <h6 class="title">1.39.3 Sensitivity of interpersonal relationship ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐1.1, 95% CI ‐1.19 to ‐1.01; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0289"> <h6 class="title">1.39.4 Obsessive‐compulsive disorder ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐1.29, 95% CI ‐1.36 to ‐1.22; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0290"> <h6 class="title">1.39.5 Hostility ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐0.84, 95% CI ‐1.0 to ‐0.68; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0291"> <h6 class="title">1.39.6 Phobia ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐0.51, 95% CI ‐0.61 to ‐0.41; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0292"> <h6 class="title">1.39.7 Paranoia ‐ SCL‐90 ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐0.7, 95% CI ‐0.8 to ‐0.6; participants = 90; study = 1). </p> </section> <section id="CD007964-sec-0293"> <h6 class="title">1.39.8 Paranoia ‐ GPTS ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> and <a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐13.32, 95% CI ‐22.97 to ‐3.68; participants = 170; studies = 2). For this outcome, heterogeneity was low (Chi<sup>2</sup> = 0.01; df = 1; P = 0.93; I<sup>2</sup> = 0%). </p> </section> <section id="CD007964-sec-0294"> <h6 class="title">1.39.9 Worry ‐ PSWQ ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐3.70, 95% CI ‐7.12 to ‐0.28; participants = 141; study = 1). </p> </section> <section id="CD007964-sec-0295"> <h6 class="title">1.39.10 Rumination ‐ PTQ ‐ short term</h6> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> reported data for this outcome. There was a favourable effect for CBT plus standard care (MD ‐5.40, 95% CI ‐8.96 to ‐1.84; participants = 135; study = 1). </p> </section> <section id="CD007964-sec-0296"> <h6 class="title">1.39.11 Hopelessness ‐ BHS ‐ medium term</h6> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> and <a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> reported data for this outcome. There was no clear difference between treatment groups (MD ‐0.56, 95% CI ‐1.93 to 0.82; participants = 232; studies = 2). </p> </section> <section id="CD007964-sec-0297"> <h6 class="title">1.39.12 Hopelessness ‐ BHS ‐ long term</h6> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> and <a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> reported data for this outcome. There was no clear difference between treatment groups (MD 0.74, 95% CI ‐0.54 to 2.01; participants = 268; studies = 2). </p> </section> </section> <section id="CD007964-sec-0298"> <h5 class="title">1.40 Mental state: 14b. Specific ‐ various other symptoms (average endpoint score SCL‐90, high = poor) ‐ long term </h5> <p><a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a> reported on a variety of other specific mental state symptoms, using the SCL‐90, however these data were skewed and were presented as 'Other data' (<a href="./references#CD007964-fig-0043" title="">Analysis 1.40</a>). </p> </section> <section id="CD007964-sec-0299"> <h5 class="title">1.41 Adverse effect/event(s): 1a. General ‐ any adverse event</h5> <p><a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a> and <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> reported incidence of 'any adverse event'. There was a clear difference between treatment groups with fewer reports of adverse events in the CBT plus standard care groups (RR 0.44, 95% CI 0.27 to 0.72; participants = 146; studies = 2; very low‐quality evidence). This result was presented in the SOF table as an outcome of importance. The quality of evidence was very low due to serious risk of bias of the included studies, very small sample size, and a very low number of events (<a href="./references#CD007964-fig-0044" title="">Analysis 1.41</a>). </p> </section> <section id="CD007964-sec-0300"> <h5 class="title">1.42 Adverse effect/event(s): 1b. General (average total endpoint score TESS, high = poor) ‐ medium term </h5> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> and <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> reported TESS scores. At medium‐term follow‐up, there was no clear difference between treatment groups (MD 0.24, 95% CI ‐1.43 to 1.9; participants = 109; studies = 2, <a href="./references#CD007964-fig-0045" title="">Analysis 1.42</a>). </p> </section> <section id="CD007964-sec-0301"> <h5 class="title">1.43 Adverse effect/event(s): 2a. Specific ‐ various effects</h5> <p><a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a> reported incidence of various specific adverse effects (<a href="./references#CD007964-fig-0046" title="">Analysis 1.43</a>). </p> <section id="CD007964-sec-0302"> <h6 class="title">1.43.1 Drowsiness</h6> <p>There was no clear difference between treatment groups for this outcome (RR 0.53, 95% CI 0.05 to 5.57; participants = 78; study = 1). </p> </section> <section id="CD007964-sec-0303"> <h6 class="title">1.43.2 Headache</h6> <p>There was no clear difference between treatment groups for this outcome (RR 1.05, 95% CI 0.07 to 16.24; participants = 78; study = 1). </p> </section> <section id="CD007964-sec-0304"> <h6 class="title">1.43.3 Mild lactation</h6> <p>There was no clear difference between treatment groups for this outcome (RR 0.15, 95% CI 0.01 to 2.81; participants = 78; study = 1). </p> </section> <section id="CD007964-sec-0305"> <h6 class="title">1.43.4 Opsomenorrhea</h6> <p>There was no a clear difference between treatment groups for this outcome (RR 0.21, 95% CI 0.01 to 4.24; participants = 78; study = 1). </p> </section> </section> <section id="CD007964-sec-0306"> <h5 class="title">1.44. Adverse effect/event(s): 2b. Specific ‐ suicide attempt</h5> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> and <a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a> reported suicide attempts. There was no clear difference between the CBT plus standard care and standard care groups (RR 1.84, 95% CI 0.84 to 4.04; participants = 323; studies = 2) (<a href="./references#CD007964-fig-0047" title="">Analysis 1.44</a>). </p> </section> <section id="CD007964-sec-0307"> <h5 class="title">1.45 Adverse effect/event(s): 2c. Specific ‐ death</h5> <section id="CD007964-sec-0308"> <h6 class="title">1.45.1 Any cause</h6> <p>Nine trials reported deaths (any cause). There was no clear difference between the CBT plus standard care and standard care groups (RR 0.78, 95% CI 0.38 to 1.58; participants = 1341; studies = 9) (<a href="./references#CD007964-fig-0048" title="">Analysis 1.45</a>). </p> </section> </section> <section id="CD007964-sec-0309"> <h5 class="title">1.46 Functioning: 1. General (average endpoint score GAF, high = good)</h5> <p>Six trials reported GAF general functioning scores (<a href="./references#CD007964-fig-0049" title="">Analysis 1.46</a>). </p> <section id="CD007964-sec-0310"> <h6 class="title">1.46.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> reported short‐term data. There was no clear difference between treatment groups (MD ‐0.68, 95% CI ‐5.82 to 4.47; participants = 72; study = 1). The result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0311"> <h6 class="title">1.46.2 Medium term</h6> <p>Five trials reported medium‐term data. There was no clear difference between treatment groups (MD 3.37, 95% CI ‐1.66 to 8.41; participants = 482; studies = 5). For this outcome heterogeneity was high (Chi<sup>2</sup> = 11.12; df = 4; P = 0.03; I<sup>2</sup> = 64%). The statistical heterogeneity was not significant after removing <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a> from the meta‐analysis (MD 1.19, 95% CI ‐3.02 to 5.40). Accordingly, the treatment effect was robust to heterogeneity amongst the studies. </p> </section> <section id="CD007964-sec-0312"> <h6 class="title">1.46.3 Long term</h6> <p>Five trials reported long‐term data. There was no clear difference between treatment groups (MD 1.79, 95% CI ‐1.95 to 5.53; participants = 446; studies = 5). For this subgroup, heterogeneity was moderately high (Chi<sup>2</sup> = 8.13; df = 4.0; P = 0.09; I<sup>2</sup> = 51%). The statistical heterogeneity was not significant after removing <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a> from the meta‐analysis (MD ‐0.15, 95% CI ‐2.38 to 2.07). Accordingly, the treatment effect was robust to heterogeneity amongst the studies. </p> </section> </section> <section id="CD007964-sec-0313"> <h5 class="title">1.47 Functioning: 2a. Social (average endpoint ILSS, high = good)</h5> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> reported data for social functioning using the ILSS (<a href="./references#CD007964-fig-0050" title="">Analysis 1.47</a>). </p> <section id="CD007964-sec-0314"> <h6 class="title">1.47.1 Medium term</h6> <p>No clear difference between treatment groups was observed at the medium term (MD 0.04, 95% CI ‐0.02 to 0.09; participants = 61; studies = 1). </p> </section> <section id="CD007964-sec-0315"> <h6 class="title">1.47.2 Long term</h6> <p>No clear difference between treatment groups was observed at the long term (MD 0.05, 95% CI 0.00 to 0.11; participants = 63; studies = 1). </p> </section> </section> <section id="CD007964-sec-0316"> <h5 class="title">1.48 Functioning: 2b. Social (average endpoint SFS, high = good)</h5> <p>Two trials (<a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> and <a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a>) reported social functioning data from the SFS (<a href="./references#CD007964-fig-0051" title="">Analysis 1.48</a>). </p> <section id="CD007964-sec-0317"> <h6 class="title">1.48.1 Medium term</h6> <p>A clear difference between treatment groups, favouring CBT plus standard care, was observed at the medium term (MD 7.23, 95% CI 2.91 to 11.55; participants = 92; studies = 2). </p> </section> <section id="CD007964-sec-0318"> <h6 class="title">1.48.2 Long term</h6> <p>A clear difference between treatment groups, favouring CBT plus standard care, was observed at the long term (MD 6.88, 95% CI 1.99 to 11.76; participants = 103; studies = 2). </p> </section> </section> <section id="CD007964-sec-0319"> <h5 class="title">1.49 Functioning: 2c. Social (average endpoint SOFAS, high = good)</h5> <p>Four trials reported social functioning data using the SOFAS (<a href="./references#CD007964-fig-0052" title="">Analysis 1.49</a>). </p> <section id="CD007964-sec-0320"> <h6 class="title">1.49.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> reported short‐term data. No clear difference between treatment groups was observed (MD 0.98, 95% CI ‐4.40 to 6.36; participants = 48; studies = 1). </p> </section> <section id="CD007964-sec-0321"> <h6 class="title">1.49.1 Medium term</h6> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> reported medium‐term data. No clear difference between treatment groups was observed (MD ‐1.00, 95% CI ‐8.02 to 6.02; participants = 81; studies = 1). </p> </section> <section id="CD007964-sec-0322"> <h6 class="title">1.49.2 Long term</h6> <p><a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> and <a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> reported long‐term data. No clear difference between treatment groups was observed (MD 0.56, 95% CI ‐2.64 to 3.76; participants = 295; studies = 2; very low‐quality evidence). This result was presented as an 'important outcome' in the SOF table. The quality of evidence for this result was very low due to high risk of bias across several domains, a low number of studies with a low sample size, and low number of events contributing data. These data are also scale data and did not measure a clinically important change in social functioning. </p> </section> </section> <section id="CD007964-sec-0323"> <h5 class="title">1.50 Functioning: 2d. Social (average endpoint PSP, high = good)</h5> <p>Two trials (<a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a>; <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a>) reported social functioning data from PSP at the short, medium and long term (<a href="./references#CD007964-fig-0053" title="">Analysis 1.50</a>). </p> <section id="CD007964-sec-0324"> <h6 class="title">1.50.1 Short term</h6> <p>A clear difference between treatment groups, favouring CBT plus standard care, was observed at the short term (MD 7.96, 95% CI 3.15 to 12.78; participants = 92; studies = 2). </p> </section> <section id="CD007964-sec-0325"> <h6 class="title">1.50.2 Medium term</h6> <p>A clear difference between treatment groups, favouring CBT plus standard care, was observed at the medium term (MD 7.23, 95% CI 2.91 to 11.55; participants = 92; studies = 2). </p> </section> <section id="CD007964-sec-0326"> <h6 class="title">1.50.3 Long term</h6> <p>A clear difference between treatment groups, favouring CBT plus standard care, was observed at the long term (MD 12.66, 95% CI 8.65 to 16.67; participants = 92; studies = 2). </p> </section> </section> <section id="CD007964-sec-0327"> <h5 class="title">1.51 Functioning: 2e. Social (average endpoint UPSA, high = good)</h5> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> reported social functioning data using the UPSA (<a href="./references#CD007964-fig-0054" title="">Analysis 1.51</a>). </p> <section id="CD007964-sec-0328"> <h6 class="title">1.51.1 Medium term</h6> <p>No clear difference between treatment groups was observed at the medium term (MD ‐0.01, 95% CI ‐0.10 to 0.08; participants = 64; studies = 1). </p> </section> <section id="CD007964-sec-0329"> <h6 class="title">1.51.2 Long term</h6> <p>No clear difference between treatment groups was observed at the long term (MD 0.02, 95% CI ‐0.07 to 0.11; participants = 58; studies = 1). </p> </section> </section> <section id="CD007964-sec-0330"> <h5 class="title">1.52 Functioning: 3. Life skills (average endpoint score LSP, high = poor)</h5> <section id="CD007964-sec-0331"> <h6 class="title">1.52.1 Long term</h6> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> reported endpoint scores at the long term for life skills using the LSP. No clear difference between treatment groups was observed (MD ‐3.32, 95% CI ‐8.40 to 1.76; participants = 92; studies = 1) (<a href="./references#CD007964-fig-0055" title="">Analysis 1.52</a>). </p> </section> </section> <section id="CD007964-sec-0332"> <h5 class="title">1.53 Functioning: 4a. Cognitive ‐ overall (average total endpoint score WCST, high = poor) </h5> <p><a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a> reported cognitive functioning data from the WCST (<a href="./references#CD007964-fig-0056" title="">Analysis 1.53</a>). </p> <section id="CD007964-sec-0333"> <h6 class="title">1.53.1 Medium term</h6> <p>No clear difference between treatment groups was observed at the medium term (MD ‐0.30, 95% CI ‐8.89 to 8.29; participants = 100; studies = 1). </p> </section> <section id="CD007964-sec-0334"> <h6 class="title">1.53.2 Long term</h6> <p>A clear difference between treatment groups, favouring CBT plus standard care, was observed at the long term (MD ‐9.80, 95% CI ‐17.76 to ‐1.84; participants = 100; studies = 1). </p> </section> </section> <section id="CD007964-sec-0335"> <h5 class="title">1.54 Functioning: 4b. Cognitive ‐ memory (average endpoint score WMS, high = good)</h5> <section id="CD007964-sec-0336"> <h6 class="title">1.54.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a> reported short‐term data from the WMS, and a favourable effect for CBT plus standard care was observed (MD 9.33, 95% CI 1.54 to 17.12; participants = 100; studies = 1). </p> </section> </section> <section id="CD007964-sec-0337"> <h5 class="title">1.55 Functioning: 4c. Cognitive ‐ memory (average endpoint score CMS, high = good)</h5> <p><a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a> reported scores from the CMS (<a href="./references#CD007964-fig-0058" title="">Analysis 1.55</a>). </p> <section id="CD007964-sec-0338"> <h6 class="title">1.55.1 Medium term</h6> <p>No clear difference between treatment groups was observed at the medium term (MD 0.40, 95% CI ‐7.42 to 8.22; participants = 100; studies = 1). </p> </section> <section id="CD007964-sec-0339"> <h6 class="title">1.55.2 Long term</h6> <p>No clear difference between treatment groups was observed at the long term (MD 0.90, 95% CI ‐6.24 to 8.04; participants = 100; studies = 1). </p> </section> </section> <section id="CD007964-sec-0340"> <h5 class="title">1.56 Functioning: 4d. Congitive ‐ various (average endpoint score MCCB, high = poor) ‐ medium term </h5> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> reported medium‐term MCCB scores for various aspects of cognitive functioning (<a href="./references#CD007964-fig-0059" title="">Analysis 1.56</a>). </p> <section id="CD007964-sec-0341"> <h6 class="title">1.56.1 Continuous performance</h6> <p>A favourable effect for CBT plus standard care was observed (MD ‐44.10, 95% CI ‐52.40 to ‐35.80; participants = 79; studies = 1). </p> </section> <section id="CD007964-sec-0342"> <h6 class="title">1.56.2 Mood management</h6> <p>A favourable effect for CBT plus standard care was observed (MD ‐1.60, 95% CI ‐2.15 to ‐1.05; participants = 79; studies = 1). </p> </section> <section id="CD007964-sec-0343"> <h6 class="title">1.56.3 Sematic influencing</h6> <p>A favourable effect for CBT plus standard care was observed (MD ‐2.40, 95% CI ‐4.63 to ‐0.17; participants = 79; studies = 1). </p> </section> <section id="CD007964-sec-0344"> <h6 class="title">1.56.4 Verbal memory</h6> <p>A favourable effect for CBT plus standard care was observed (MD ‐2.80, 95% CI ‐5.06 to ‐0.54; participants = 79; studies = 1). </p> </section> <section id="CD007964-sec-0345"> <h6 class="title">1.56.5 Visual memory</h6> <p>No clear difference between treatment groups was observed (MD ‐2.60, 95% CI ‐5.64 to 0.44; participants = 79; studies = 1). </p> </section> </section> <section id="CD007964-sec-0346"> <h5 class="title">1.57 Functioning: 5. Intelligence (average endpoint score WAIS, high = good)</h5> <p><a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a> reported WAIS 'intelligence' scores (<a href="./references#CD007964-fig-0060" title="">Analysis 1.57</a>). </p> <section id="CD007964-sec-0347"> <h6 class="title">1.57.1 Short term</h6> <p>At the short term, no clear difference between treatment groups was observed (MD 4.89, 95% CI ‐2.43 to 12.21; participants = 100; studies = 1). </p> </section> <section id="CD007964-sec-0348"> <h6 class="title">1.57.2 Medium term</h6> <p>At the medium term, a clear effect, favouring CBT plus standard care was observed (MD 11.83, 95% CI 9.27 to 14.39; participants = 80; studies = 1). </p> </section> </section> <section id="CD007964-sec-0349"> <h5 class="title">1.58 Functioning: 6. Disability (SE data, WHODAS, high = poor)</h5> <p><a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a> reported SE from the WHODAS and found a clear difference between treatment groups, favouring CBT plus standard care ( (MD ‐10.52, 95% CI ‐14.65 to ‐6.39; studies = 1) (<a href="./references#CD007964-fig-0061" title="">Analysis 1.58</a>). </p> </section> <section id="CD007964-sec-0350"> <h5 class="title">1.59 Quality of life: 1a. General (average total endpoint score various scales, high = good) ‐ short term </h5> <p>Two trials reported scores for general quality of life at short‐term follow‐up (<a href="./references#CD007964-fig-0062" title="">Analysis 1.59</a>). </p> <section id="CD007964-sec-0351"> <h6 class="title">1.59.1 QLS</h6> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> reported scores from QLS. No clear difference between treatment groups was observed (MD ‐1.90, 95% CI ‐10.63 to 6.83; participants = 48; studies = 1). </p> </section> <section id="CD007964-sec-0352"> <h6 class="title">1.59.2 WHOQOL‐BREF</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported scores from WHOQOL‐BREF. No clear difference between treatment groups was observed (MD 6.64, 95% CI ‐1.36 to 14.64; participants = 28; studies = 1). </p> </section> </section> <section id="CD007964-sec-0353"> <h5 class="title">1.60 Quality of life: 1b. General (average total endpoint score various scales, high = good) ‐ medium term </h5> <section id="CD007964-sec-0354"> <h6 class="title">1.60.1 WHOQOL‐BREF</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> also reported medium term scores from WHOQOL‐BREF. A clear difference between treatment groups, favouring CBT plus standard care, was observed (MD 8.20, 95% CI 0.66 to 15.74; participants = 28; studies = 1). </p> </section> </section> <section id="CD007964-sec-0355"> <h5 class="title">1.61 Quality of life: 1c. General (average total endpoint score various scales, high = good) ‐ long term </h5> <p>Four trials reported long‐term scores from various scales for general quality of life (<a href="./references#CD007964-fig-0064" title="">Analysis 1.61</a>). </p> <section id="CD007964-sec-0356"> <h6 class="title">1.61.1 QLS</h6> <p><a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> used the QLS. No clear difference between treatment groups was observed (MD ‐3.60, 95% CI ‐11.32 to 4.12; participants = 71; studies = 1; very low‐quality evidence).This result was used in the SOF table but given a grading of very low‐quality evidence due to very small sample size and the data reported were not clinically important changes in quality of life. </p> </section> <section id="CD007964-sec-0357"> <h6 class="title">1.61.2 GQOLI‐74</h6> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> reported GQOLI‐74 scores. A favourable effect for CBT plus standard care was observed (MD 2.82, 95% CI 1.62 to 4.02; participants = 80; studies = 1). </p> </section> <section id="CD007964-sec-0358"> <h6 class="title">1.61.3 WHOQOL‐BREF</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported WHOQOL‐BREF scores. A favourable effect for CBT plus standard care was observed (MD 8.85, 95% CI 1.01 to 16.69; participants = 28; studies = 1). </p> </section> <section id="CD007964-sec-0359"> <h6 class="title">1.61.4 EuroQOL</h6> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> reported EuroQOL scores. No clear difference between treatment groups was observed (MD ‐4.50, 95% CI ‐10.65 to 1.65; participants = 190; studies = 1). </p> </section> </section> <section id="CD007964-sec-0360"> <h5 class="title">1.62 Quality of life: 1d. General (average total endpoint score SQLS, high = poor)</h5> <section id="CD007964-sec-0361"> <h6 class="title">1.62.1 Medium term</h6> <p><a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a> reported SQLS scores. A favourable effect for CBT plus standard care was observed (MD ‐29.50, 95% CI ‐40.28 to ‐18.72; participants = 104; studies = 1) (<a href="./references#CD007964-fig-0065" title="">Analysis 1.62</a>). </p> </section> </section> <section id="CD007964-sec-0362"> <h5 class="title">1.63 Quality of life: 2a. Specific ‐ physical (average endpoint score WHQOL‐BREF, high = good) </h5> <p>Two trials reported data for physical quality of life using WHQOL‐BREF (<a href="./references#CD007964-fig-0066" title="">Analysis 1.63</a>). </p> <section id="CD007964-sec-0363"> <h6 class="title">1.63.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported short‐term scores. No clear difference between treatment groups was observed (MD 1.71, 95% CI ‐1.01 to 4.43; participants = 28; studies = 1). </p> </section> <section id="CD007964-sec-0364"> <h6 class="title">1.63.2 Medium term</h6> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> and <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported medium‐term scores. A favourable effect for CBT plus standard care was observed (MD 2.60, 95% CI 0.20 to 5.00; participants = 109; studies = 2). </p> </section> <section id="CD007964-sec-0365"> <h6 class="title">1.63.3 Long term</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported long‐term scores. A favourable effect for CBT plus standard care was observed (MD 2.71, 95% CI 0.11 to 5.31; participants = 28; studies = 1). </p> </section> </section> <section id="CD007964-sec-0366"> <h5 class="title">1.64 Quality of life: 2b. Specific ‐ physical (average endpoint score GQOLI‐74, high = good) </h5> <section id="CD007964-sec-0367"> <h6 class="title">1.64.1 Long term</h6> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> reported GQOLI‐74 scores and observed a favourable effect for CBT plus standard care at the long term (MD 13.69, 95% CI 9.62 to 17.76; participants = 80; studies = 1). </p> </section> </section> <section id="CD007964-sec-0368"> <h5 class="title">1.65 Quality of life: 3a. Specific ‐ psychological (average endpoint score WHQOL‐BREF, high = good) </h5> <p>Two trials reported psychological scores from the WHQOL‐BREF (<a href="./references#CD007964-fig-0068" title="">Analysis 1.65</a>). </p> <section id="CD007964-sec-0369"> <h6 class="title">1.65.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported short‐term scores. A favourable effect for CBT plus standard care was observed (MD 2.22, 95% CI 0.28 to 4.16; participants = 28; studies = 1). </p> </section> <section id="CD007964-sec-0370"> <h6 class="title">1.65.2 Medium term</h6> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> and <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported medium‐term scores. A favourable effect for CBT plus standard care was observed (MD 2.52, 95% CI 0.71 to 4.33; participants = 109; studies = 2). </p> </section> <section id="CD007964-sec-0371"> <h6 class="title">1.65.3 Long term</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported long‐term scores. A favourable effect for CBT plus standard care was observed (MD 2.37, 95% CI 0.56 to 4.18; participants = 28; studies = 1). </p> </section> </section> <section id="CD007964-sec-0372"> <h5 class="title">1.66 Quality of life: 3b. Specific ‐ psychological (average endpoint score GQOL‐74, high = good) </h5> <section id="CD007964-sec-0373"> <h6 class="title">1.66.1 Long term</h6> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> reported long‐term psychological scores from the GQOL‐74. A favourable effect for CBT plus standard care was observed (MD 17.03, 95% CI 13.07 to 20.99; participants = 80; studies = 1) (<a href="./references#CD007964-fig-0069" title="">Analysis 1.66</a>). </p> </section> </section> <section id="CD007964-sec-0374"> <h5 class="title">1.67 Quality of life: 3c. Specific ‐ psychological (average endpoint score SQLS, high = poor) </h5> <section id="CD007964-sec-0375"> <h6 class="title">1.67.1 Medium term</h6> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> used the SQLS and reported medium‐term psychological scores. No clear difference between treatment groups was observed (MD ‐1.26, 95% CI ‐5.19 to 2.67; participants = 50; studies = 1) (<a href="./references#CD007964-fig-0070" title="">Analysis 1.67</a>). </p> </section> </section> <section id="CD007964-sec-0376"> <h5 class="title">1.68 Quality of life: 4a. Specific ‐ various other aspects (average endpoint score WHQOL‐BREF, high = good) ‐ short term </h5> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported short‐term WHQOL‐BREF scores for various other aspects of quality of life (<a href="./references#CD007964-fig-0071" title="">Analysis 1.68</a>). </p> <section id="CD007964-sec-0377"> <h6 class="title">1.68.1 Environment</h6> <p>No clear difference between treatment groups was observed (MD 1.82, 95% CI ‐1.71 to 5.35; participants = 28; studies = 1). </p> </section> <section id="CD007964-sec-0378"> <h6 class="title">1.68.2 Social relationship</h6> <p>No clear difference between treatment groups was observed (MD 0.87, 95% CI ‐0.62 to 2.36; participants = 28; studies = 1). </p> </section> </section> <section id="CD007964-sec-0379"> <h5 class="title">1.69 Quality of life: 4b. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ medium term </h5> <p>Three trials reported medium‐term scores from WHOQOL‐BREF and SF‐36 for various other aspects of quality of life (<a href="./references#CD007964-fig-0072" title="">Analysis 1.69</a>). </p> <section id="CD007964-sec-0380"> <h6 class="title">1.69.1 Environment (WHOQOL‐BREF)</h6> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> and <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported WHOQOL‐BREF environment scores. No clear difference between treatment groups was observed (MD 2.56, 95% CI ‐0.21 to 5.34; participants = 109; studies = 2). </p> </section> <section id="CD007964-sec-0381"> <h6 class="title">1.69.2 Physical functioning (SF‐36)</h6> <p><a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a> reported SF‐36 physical functioning scores. A favourable effect for CBT plus standard care was observed (MD 22.30, 95% CI 17.65 to 26.95; participants = 89; studies = 1). </p> </section> <section id="CD007964-sec-0382"> <h6 class="title">1.69.3 Role emotional (SF‐36)</h6> <p><a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a> reported SF‐36 role emotional scores. A favourable effect for CBT plus standard care was observed (MD 26.90, 95% CI 19.74 to 34.06; participants = 89; studies = 1). </p> </section> <section id="CD007964-sec-0383"> <h6 class="title">1.69.4 Role Physcial (SF‐36)</h6> <p><a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a> reported SF‐36 role physical scores. A favourable effect for CBT plus standard care was observed (MD 31.20, 95% CI 25.94 to 36.46; participants = 89; studies = 1). </p> </section> <section id="CD007964-sec-0384"> <h6 class="title">1.69.5 Social Relationship (WHOQOL‐BREF)</h6> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> and <a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported WHOQOL‐BREF social relationship scores. No clear difference between treatment groups was observed (MD 0.90, 95% CI ‐0.60 to 2.39; participants = 109; studies = 2). </p> </section> </section> <section id="CD007964-sec-0385"> <h5 class="title">1.70 Quality of life: 4c. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ long term </h5> <p>Two trials reported long‐term data on various other aspects of quality of life (<a href="./references#CD007964-fig-0073" title="">Analysis 1.70</a>). </p> <section id="CD007964-sec-0386"> <h6 class="title">1.70.1 Environment (WHOQOL‐BREF)</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported WHOQOL‐BREF environment scores. No clear difference between treatment groups was observed (MD 2.76, 95% CI ‐0.31 to 5.83; participants = 28; studies = 1). </p> </section> <section id="CD007964-sec-0387"> <h6 class="title">1.70.2 Social function (GQOLI‐74)</h6> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> reported GQOLI‐74 social function scores. A favourable effect for CBT plus standard care was observed (MD 16.19, 95% CI 11.72 to 20.66; participants = 80; studies = 1). </p> </section> <section id="CD007964-sec-0388"> <h6 class="title">1.70.3 Social relationship (WHOQOL‐BREF)</h6> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> reported WHOQOL‐BREF social relationship scores. No clear difference between treatment groups was observed (MD 1.02, 95% CI ‐0.55 to 2.59; participants = 28; studies = 1). </p> </section> </section> <section id="CD007964-sec-0389"> <h5 class="title">1.71 Quality of life: 4d. Specific ‐ various other aspects (average endpoint score various scales, high = poor) ‐ long term </h5> <p>Three trials used the SQLS and SDSS to report various other aspects of quality of life at long‐term follow‐up (<a href="./references#CD007964-fig-0074" title="">Analysis 1.71</a>). </p> <section id="CD007964-sec-0390"> <h6 class="title">1.71.1 Insight/treatment attitude (SQLS)</h6> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> reported SQLS insight/treatment attitude scores. A favourable effect for standard care was observed (MD 3.14, 95% CI 1.96 to 4.32; participants = 50; studies = 1). </p> </section> <section id="CD007964-sec-0391"> <h6 class="title">1.71.2 Motivation/vitality (SQLS)</h6> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> and <a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a> reported SQLS motivation/vitality scores. A favourable effect for CBT plus standard care was observed (MD ‐3.43, 95% CI ‐5.45 to ‐1.40; participants = 154; studies = 2). </p> </section> <section id="CD007964-sec-0392"> <h6 class="title">1.71.3 Social function (SDSS)</h6> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> reported SDSS social function scores. A favourable effect for CBT plus standard care was observed (MD ‐1.51, 95% CI ‐2.34 to ‐0.68; participants = 59; studies = 1). </p> </section> <section id="CD007964-sec-0393"> <h6 class="title">1.71.4 Symptoms/side effects (SQLS)</h6> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> reported SQLS symptoms/side effects scores. No difference between treatment groups was observed (MD ‐0.25, 95% CI ‐2.76 to 2.26; participants = 50; studies = 1). </p> </section> </section> <section id="CD007964-sec-0394"> <h5 class="title">1.72 Quality of life: 5a. Specific ‐ psychological (average endpoint score SQLS, high = poor) ‐ medium term data (skewed data) </h5> <p>Data for this outcome were presented as Other data because of marked skew (<a href="./references#CD007964-fig-0075" title="">Analysis 1.72</a>), which makes it difficult to interpret the findings. </p> </section> <section id="CD007964-sec-0395"> <h5 class="title">1.73 Quality of life: 5b. Specific ‐ role functioning (average endpoint score QLS, high = good) ‐ long term (skewed data) </h5> <p>Data for this outcome were presented as Other data because of marked skew (<a href="./references#CD007964-fig-0076" title="">Analysis 1.73</a>), which makes it difficult to interpret the findings. </p> </section> <section id="CD007964-sec-0396"> <h5 class="title">1.74 Quality of life: 5c. Specific ‐ symptoms/side effects (average endpoint score SQLS, high = poor) ‐ medium term (skewed data) </h5> <p>Data for this outcome were presented as Other data because of marked skew (<a href="./references#CD007964-fig-0077" title="">Analysis 1.74</a>), which makes it difficult to interpret the findings. </p> </section> <section id="CD007964-sec-0397"> <h5 class="title">1.75 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason</h5> <p>We were able to collect leaving the study data from 35 trials (<a href="./references#CD007964-fig-0078" title="">Analysis 1.75</a>). </p> <section id="CD007964-sec-0398"> <h6 class="title">1.75.1 Short term</h6> <p>Short‐term data from 12 trials showed no clear difference between treatment groups (RR 1.02, 95% CI 0.77 to 1.35; participants = 1214; study = 12). </p> </section> <section id="CD007964-sec-0399"> <h6 class="title">1.75.2 Medium term</h6> <p>Medium‐term data from 11 trials showed no clear difference between treatment groups (RR 0.91, 95% CI 0.74 to 1.11; participants = 1402; studies = 11). </p> </section> <section id="CD007964-sec-0400"> <h6 class="title">1.75.3 Long term</h6> <p>Long‐term data from 19 trials showed no clear difference between treatment groups (RR 0.93, 95% CI 0.77 to 1.12; participants = 1945; studies = 19; moderate‐quality evidence). This result was presented in the SOF table and was graded as moderate quality as leaving the study early data are a 'proxy measure' for predicting satisfaction with treatment. </p> </section> </section> <section id="CD007964-sec-0401"> <h5 class="title">1.76 Engagement with services: 1a. Compliance to medication</h5> <p>Six trials reported numbers of participants compliant with medication (<a href="./references#CD007964-fig-0079" title="">Analysis 1.76</a>). </p> <section id="CD007964-sec-0402"> <h6 class="title">1.76.1 Short term</h6> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a>; <a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a>; <a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a>; and <a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a> reported short‐term data. No clear difference between treatment groups was observed (RR 1.45, 95% CI 0.81 to 2.60; participants = 261; studies = 4). For this subgroup, heterogeneity was high (Chi<sup>2</sup> = 38.64; df = 3.0; P = 0.0003; I<sup>2</sup> = 81%). The statistical heterogeneity was still significant after leaving out trials one by one. We failed to find the source of the heterogeneity. </p> </section> <section id="CD007964-sec-0403"> <h6 class="title">1.76.2 Medium term</h6> <p><a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> and <a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> reported medium‐term data. A favourable effect for CBT plus standard care was observed (RR 1.23, 95% CI 1.02 to 1.49; participants = 128; studies = 2). The result remained the same when using a fixed‐effect model. </p> </section> <section id="CD007964-sec-0404"> <h6 class="title">1.76.3 Long term</h6> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> and <a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> reported long‐term data. A favourable effect for CBT plus standard care was observed (RR 1.35, 95% CI 1.1 to 1.65; participants = 148; studies = 2). The result remained the same when using a fixed‐effect model (Chi<sup>2</sup> = 0.63; df = 1.0; P = 0.43; I<sup>2</sup> = 0%). </p> </section> </section> <section id="CD007964-sec-0405"> <h5 class="title">1.77 Engagment with services: 1b. Refusing treatment</h5> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> and <a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a> reported the number of participants refusing treatment at the short term. No clear difference between treatment groups was observed (RR 0.49, 95% CI 0.18 to 1.38; participants = 190; studies = 2) (<a href="./references#CD007964-fig-0080" title="">Analysis 1.77</a>). </p> </section> <section id="CD007964-sec-0406"> <h5 class="title">1.78 Engagement with services: 1c. Compliance with medication (average endpoint score MARS, high = good) </h5> <p>Two trials measured compliance with medication using MARS (<a href="./references#CD007964-fig-0081" title="">Analysis 1.78</a>). </p> <p><b>1.78.1 Medium term</b> </p> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> reported medium‐term data. No clear difference between treatment groups was observed (MD ‐0.60, 95% CI ‐1.41 to 0.21; participants = 81; study = 1). </p> <p><b>1.78.2 Long term</b> </p> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> reported long‐term data. A favourable effect for CBT plus standard care was observed (MD 38.02, 95% CI 33.48 to 42.56; participants = 90; study = 1). </p> </section> </section> <section id="CD007964-sec-0407"> <h4 class="title">2. Sensitivity analyses</h4> <p>Where relevant, we carried out sensitivity analyses.</p> <section id="CD007964-sec-0408"> <h5 class="title">2.1. Blinding</h5> <p>Sensitivity analysis showed that there was no substantial difference between results including trials with non‐blind outcome assessment and results excluding trials with non‐blind outcome assessment (<a href="./references#CD007964-fig-0082" title="">Analysis 2.1</a>; <a href="./references#CD007964-fig-0083" title="">Analysis 2.2</a>). </p> </section> <section id="CD007964-sec-0409"> <h5 class="title">2.3 Well‐defined CBT versus less‐well‐defined CBT</h5> <p>After removing trials with less‐well‐defined CBT, there was not a clear difference between CBT and standard care for relapse rate at the medium term (<a href="./references#CD007964-fig-0084" title="">Analysis 3.1</a>) and global state improvement at the long term (<a href="./references#CD007964-fig-0086" title="">Analysis 3.3</a>). No clear difference in results was found when trials with less‐well‐defined CBT were excluded from the meta‐analyses of the other primary outcomes (<a href="./references#CD007964-fig-0085" title="">Analysis 3.2</a>; <a href="./references#CD007964-fig-0087" title="">Analysis 3.4</a>). </p> </section> <section id="CD007964-sec-0410"> <h5 class="title">2.4 Therapist experience</h5> <p>After removing trials with less experienced therapists of CBT, there was not a clear difference between CBT and standard care for global state improvement at the long term (<a href="./references#CD007964-fig-0090" title="">Analysis 4.3</a>) and mental state improvement at the short term (<a href="./references#CD007964-fig-0091" title="">Analysis 4.4</a>). No clear difference in results were found when trials with less experienced therapists are excluded from the meta‐analyses of the primary outcome (<a href="./references#CD007964-fig-0088" title="">Analysis 4.1</a>; <a href="./references#CD007964-fig-0089" title="">Analysis 4.2</a>; <a href="./references#CD007964-fig-0092" title="">Analysis 4.5</a>). </p> </section> <section id="CD007964-sec-0411"> <h5 class="title">2.5 Assumptions for lost binary data</h5> <p>No clear difference in results was found between results derived from completers only and results with an assumption for missing data (<a href="./references#CD007964-fig-0093" title="">Analysis 5.1</a>; <a href="./references#CD007964-fig-0094" title="">Analysis 5.2</a>). </p> </section> <section id="CD007964-sec-0412"> <h5 class="title">2.6. Imputed values</h5> <p>Only one trial was a cluster‐randomised controlled trial (<a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a>), which contributed data for relapse at the short term. No clear difference in results was found when the trial with imputed values was excluded from the meta‐analyses of the primary outcome (<a href="./references#CD007964-fig-0095" title="">Analysis 6.1</a>). </p> </section> <section id="CD007964-sec-0413"> <h5 class="title">2.7. Fixed‐ and random‐effects</h5> <p>No substantive difference in results was found when we combined data using a random‐effects model for the primary outcome (<a href="./references#CD007964-fig-0096" title="">Analysis 7.1</a>). </p> </section> </section> <section id="CD007964-sec-0414"> <h4 class="title">3. Subgroup analysis</h4> <section id="CD007964-sec-0415"> <h5 class="title">3.1 Standard care including antipsychotics as opposed to standard care not including antipsychotics </h5> <p>In 60 trials, CBT was added to standard care where it was clear that standard care included prescription antipsychotics. For six trials (<a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a>; <a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a>; <a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a>; <a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a>; <a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a>), it was not clear if antipsychotics were part of standard care during the trial period. No trial clearly stated that standard care did not include antipsychotics, so we were unable to conduct a subgroup analysis. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007964-sec-0416" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007964-sec-0416"></div> <section id="CD007964-sec-0417"> <h3 class="title" id="CD007964-sec-0417">Summary of main results</h3> <p>This review now includes 60 trials comparing CBT plus standard care with standard care alone. Prespecified outcomes were included in the <a href="./full#CD007964-tbl-0001">summary of findings Table for the main comparison</a> and, where those outcomes were not available, the finding that we judged closest to the first pre‐stipulated one was used. </p> <section id="CD007964-sec-0418"> <h4 class="title">1. Global state: Relapse ‐ long term; clinically important change</h4> <p>We chose to measure this outcome at the long term as we thought this was likely to be the most clinically important. Considerable investment is made within CBT therapy and any benefit, therefore, should be expected not to be transient. The trialists also seemed to concur with this by reporting data for the important outcome of 'relapse' over various but protracted periods that fell into our category of 'long term' (13 RCTs, 1538 people). We could only grade the evidence as 'low quality' and there is not a clear difference between groups (RR 0.78, 95% CI 0.61 to 1.00). However, no clear evidence of effect is not the same as evidence of no effect and these data are compatible with an important degree of relapse reduction across a year. However, taking the point estimate of these figures as correct, assuming more data would only increase the precision of the result, around 12 people would need to be treated in order to avoid one relapse. This could suggest that CBT may have something to offer over and above standard care, in unblinded trials, largely undertaken by those who were very skilled CBT practitioners ‐ but not that much to offer, and at considerable expense. The second global state outcome (clinically important change) was rarely reported (2 RCTs, 82 participants), and although this was more favourable for the CBT group, the quality of data had to be graded as 'very low'. </p> </section> <section id="CD007964-sec-0419"> <h4 class="title">2. Mental state: General ‐ clinically important change</h4> <p>Although not statistically significant, this finding does concur with the global findings in that there is some support for CBT having some positive effect. The quality of evidence had to be graded as 'very low' for the reasons specified in the <a href="./full#CD007964-tbl-0001">summary of findings Table for the main comparison</a>, and any effect, even if it should really exist, is modest. By now, with the maturity of this question and the trials being undertaken addressing this question, findings should really be of higher quality, and greater precision. Despite every effort to bring mental state measures together, the trials in this review reported on this outcome in 38 different ways. Many results based on endpoint or change scores did favour the CBT group. With a 'glass‐half‐full' approach, this could be seen as encouraging; with a 'glass‐half‐empty' approach, it could be seen as a wasteful chaos of measurement of outcomes of unclear clinical meaning, and opening opportunities for inclusion of bias. </p> </section> <section id="CD007964-sec-0420"> <h4 class="title">3. Adverse events: General: any adverse event</h4> <p>Adverse effects of the talking therapies are rarely reported and talking therapy approaches can have adverse consequences (McMurran 2016); the studies included in this review are no exception to the poor reporting trend in this area of care. However, there are some data on adverse events and these very‐low quality data do favour the CBT groups (RR 0.44, 95% CI 0.27 to 0.72). This is important, albeit from very few data. If CBT does help people avoid adverse events ‐ such as self‐harm ‐ this might be further investigated but probably in qualitative work. Replicating this finding within more trials could be prohibitively expensive as the sample size would have be large, and the eventual investment for self‐harm saved painfully high. </p> </section> <section id="CD007964-sec-0421"> <h4 class="title">4. Functioning: Social ‐ clinically important change in social functioning</h4> <p>We were surprised that no trial reported this outcome so we had to employ a proxy measure for the <a href="./full#CD007964-tbl-0001">summary of findings Table for the main comparison</a>. Future trials could just ask a binary question to clarify this important issue. The average endpoint score on the relevant scale (SOFAS) was not clearly different between the groups. We are unclear of the clinical meaning of changes on the SOFAS, but scales tend to measure fine‐grained changes ‐ and even with that, no real effect was identified. Although all data were of very low quality, the fact that this important aspect of functioning is seemingly unaffected by CBT is a clinical disappointment. It would seem that this is a highly important outcome for the families of people with schizophrenia. </p> </section> <section id="CD007964-sec-0422"> <h4 class="title">5. Quality of life: General ‐ clinically important change</h4> <p>The same issue applies to this outcome as it did for the functioning measure above. Surprisingly, we had to employ a proxy measure, this fine‐grained measure provided equivocal very low‐quality data, and again with no suggestion of any effect. It would seem likely that this is an outcome of major importance to people with schizophrenia. </p> </section> <section id="CD007964-sec-0423"> <h4 class="title">6. Satisfaction with treatment: Leaving the study early ‐ long term</h4> <p>These studies were good at retaining people across the long term with &lt; 20% leaving by around one year. There was no clear difference between the two groups (19 RCTs, 1945 people, moderate‐quality evidence). CBT seems not to be off‐putting to people ‐ but nor does it keep any more in care. </p> </section> </section> <section id="CD007964-sec-0424"> <h3 class="title" id="CD007964-sec-0424">Overall completeness and applicability of evidence</h3> <section id="CD007964-sec-0425"> <h4 class="title">1. Completeness</h4> <p>For the completeness of the evidence, the completeness of participants and interventions was good<b>,</b> but the outcomes were not. Reporting on outcomes of key importance was patchy, and only 28% of the included studies reported our primary outcomes. In addition, very few studies reported clinically important data on adverse events, function, and quality of life. There were no good economic data at all. Most data we do have was of low quality and we remain unsure of the effects of CBT for things so fundamental as people's quality of life. It is easy to say in hindsight but there appeared to be a chaos of reporting in these studies, leading to production of low‐quality evidence. This could be reduced by trialists agreeing together on the measures and timings that are clinically meaningful and relevant to clinicians and patients. The research waste evidenced in these studies is difficult to justify. </p> </section> <section id="CD007964-sec-0426"> <h4 class="title">2. Applicability</h4> <p>There was a relatively complete representation of the population. The participants within the trials did seem 'recognisable' for everyday care. There was a wide age range, with a good gender balance and from inpatient and community settings. Ages ranged from 16 years to 78 years and a majority of the trials involved working age adults, which is also the most prevalent age of schizophrenia. There was a good gender balance and setting (inpatients and community patients) across all the included trials. The length of illness ranged from one month to 30.1 years, and most trials involved people who had the condition for over 12 months, hence the current evidence is more applicable to people with chronic schizophrenia. For most trials, the CBT intervention was not mixed with other active psychotherapies and for all trials, CBT was given in combination with the standard care intervention of the trial which typically included antipsychotic medication and psychiatric care. </p> <p>However, about half of the trials (48%) employed qualified CBT therapists and only 15% supported less specialised staff delivering the CBT (other trials did not specify). We are therefore unclear about the effect of CBT delivered by 'usual' healthcare professionals and this is important in terms of applicability. Few mental healthcare services can afford an experienced and trained CBT therapist in addition to other staff. </p> </section> </section> <section id="CD007964-sec-0427"> <h3 class="title" id="CD007964-sec-0427">Quality of the evidence</h3> <p>The current body of evidence available does not allow for robust conclusions regarding the effects of adding CBT to standard care for people with schizophrenia. This is mainly due to the risk of bias among included trials, imprecision of the effect estimate, and heterogeneity. Although the review included 60 trials, not all trials reported data on all prespecified outcomes, hence, often there are only a handful of small trials contributing data to any given outcome. Consequently, the pooled summary effects of a majority of outcomes is either with wide confidence intervals or below the threshold of optimal information size. The heterogeneity was substantial and we failed to explain the source of heterogeneity by sensitivity analysis. </p> <p>Considering the maturity of trials in this area, the quality of evidence available is embarrassingly low. The veracity of the findings of the trials is threatened by biases, uncollaborative working, and poor reporting. These issues will have led to much research waste ‐ of funding, and opportunity for researchers, carers, and recipients of care. </p> </section> <section id="CD007964-sec-0428"> <h3 class="title" id="CD007964-sec-0428">Potential biases in the review process</h3> <p>We performed comprehensive searches of all relevant databases with no language, date, or publication status restrictions. Although every effort was made to minimise bias in the review process, the potential risk of missing trials cannot be completely eliminated. </p> <p>The data screening and extraction process was strictly adhered to the Cochrane recommended procedures and standards. Nevertheless, unlike pharmaceutical therapies, CBT is comparatively more difficult to identify due to its nature as a talking therapy. We used strict measures to improve screening accuracy and consulted content experts, where necessary, however, the risk of missing identified trials is not entirely unlikely. </p> <p>Several review authors for this review are authors of the original Cochrane review (<a href="./references#CD007964-bbs2-0242" title="JonesC , CormacI , MotaJ , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524.pub2] ">Jones 2004</a>) and are familiar with many of the trials in this review from past work. This could have biased us ‐ but we trust the rigorous Cochrane methods and replication we have undertaken in this review protect data from that potential. </p> </section> <section id="CD007964-sec-0429"> <h3 class="title" id="CD007964-sec-0429">Agreements and disagreements with other studies or reviews</h3> <p>There are many reviews of CBT for people with schizophrenia and they do differ. Fully providing possible reasons for this would be an interesting but impossibly time‐consuming addition to this review. We feel a key difference across reviews is the openness and clarity of method. Cochrane's methods have been robust to criticism and can be again. Methods for Cochrane reviews do evolve and become even more rigorous across time. However, this review has ‐ slowly ‐ moved across time from the original version (<a href="./references#CD007964-bbs2-0242" title="JonesC , CormacI , MotaJ , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524.pub2] ">Jones 2004</a>) and split to become one of a family of CBT reviews for people with schizophrenia (<a href="./references#CD007964-bbs2-0244" title="JonesC , HackerD , MeadenA , CormacI , IrvingCB , XiaJ , et al. Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Cochrane Database of Systematic Reviews2018, Issue 11. [DOI: 10.1002/14651858.CD008712.pub3] ">Jones 2018</a>; <a href="./references#CD007964-bbs2-0243" title="JonesC , CormacI , CampbellC , MeadenA , HackerD , IrvingCB . Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007965] ">Jones 2009a</a>). Essentially, the findings of these comprehensive updates do not differ from the original findings of <a href="./references#CD007964-bbs2-0242" title="JonesC , CormacI , MotaJ , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524.pub2] ">Jones 2004</a>. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007964-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for 2017 search" data-id="CD007964-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram for 2017 search</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007964-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007964-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 1 Global state: 1a. Relapse." data-id="CD007964-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 1 Global state: 1a. Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0005"> <p> <div class="table" id="CD007964-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>161</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>161</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>161</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 2 Global state: 1b. Relapse (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0005">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 3 Global state: 2. Clinically important change (no improvement) ‐ defined by individual studies." data-id="CD007964-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 3 Global state: 2. Clinically important change (no improvement) ‐ defined by individual studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 4 Global state: 3a. Rehospitalisation." data-id="CD007964-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 4 Global state: 3a. Rehospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0008"> <p> <div class="table" id="CD007964-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 5 Global state: 3b. Hospitalisation ‐ number of admissions (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0008">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 6 Global state: 4. Average endpoint total score CGI, high = poor." data-id="CD007964-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 6 Global state: 4. Average endpoint total score CGI, high = poor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 7 Mental state: 1. General ‐ clinically important change (no improvement)." data-id="CD007964-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 7 Mental state: 1. General ‐ clinically important change (no improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 8 Mental state: 2a. General (average total endpoint score BPRS, high = poor)." data-id="CD007964-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 8 Mental state: 2a. General (average total endpoint score BPRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 9 Mental state: 2b. General (average total endpoint score PANSS, high = poor)." data-id="CD007964-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 9 Mental state: 2b. General (average total endpoint score PANSS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 10 Mental state: 2c. General (average total endpoint score PsyRAT, high = poor)." data-id="CD007964-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 10 Mental state: 2c. General (average total endpoint score PsyRAT, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 11 Mental state: 2d. General (average total change score, various scales)." data-id="CD007964-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 11 Mental state: 2d. General (average total change score, various scales). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0015"> <p> <div class="table" id="CD007964-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 12 Mental state: 2e. General (average total endpoint score SCL‐90, high = poor) ‐ long term. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0015">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 13 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS subscale, high = poor)." data-id="CD007964-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 13 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 14 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score BPRS/SAPS, high = poor) ‐ short term." data-id="CD007964-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 14 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score BPRS/SAPS, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 15 Mental state: 4a. Specific ‐ hallucination ‐ clinically important change (no improvement ‐ &lt; 3 point improvement BPRS (hallucination severity score))." data-id="CD007964-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 15 Mental state: 4a. Specific ‐ hallucination ‐ clinically important change (no improvement ‐ &lt; 3 point improvement BPRS (hallucination severity score)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 16 Mental state: 4b. Specific ‐ hallucination (average endpoint score various scales, high = poor)." data-id="CD007964-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 16 Mental state: 4b. Specific ‐ hallucination (average endpoint score various scales, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 17 Mental state: 4c. Specific ‐ hallucinations (average endpoint score, PsyRATs, high = poor)." data-id="CD007964-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 17 Mental state: 4c. Specific ‐ hallucinations (average endpoint score, PsyRATs, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0021"> <p> <div class="table" id="CD007964-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>PsyRATs ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>PsyRATs ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>BPRS ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>England 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>England 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>VCS ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trower 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trower 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>VCS ‐ medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trower 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trower 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 18 Mental state: 4d. Specific ‐ hallucinations (average endpoint score various scales, high = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0021">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 19 Mental state: 5a. Specific ‐ delusions (average endpoint score, PsyRATs , high = poor)) ‐ short term." data-id="CD007964-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 19 Mental state: 5a. Specific ‐ delusions (average endpoint score, PsyRATs , high = poor)) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 20 Mental state: 5b. Specific ‐ delusions (average endpoint score PANSS, high = poor)." data-id="CD007964-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 20 Mental state: 5b. Specific ‐ delusions (average endpoint score PANSS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 21 Mental state: 5c. Specific ‐ delusions (average change score PsyRATs, high = poor)." data-id="CD007964-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 21 Mental state: 5c. Specific ‐ delusions (average change score PsyRATs, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0025"> <p> <div class="table" id="CD007964-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care (Liverpool)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 22 Mental state: 5d. Specific ‐ delusions (average endpoint score PsyRATS, high = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0025">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 23 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score, PANSS subscale, high = poor)." data-id="CD007964-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 23 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score, PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 24 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score SANS, high = poor)." data-id="CD007964-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 24 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score SANS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 25 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score NSRS, high = poor) ‐ medium term." data-id="CD007964-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 25 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score NSRS, high = poor) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 26 Mental state: 7a. Specific ‐ affective symptoms (average enpoint score, PANSS subscale, high = poor)." data-id="CD007964-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 26 Mental state: 7a. Specific ‐ affective symptoms (average enpoint score, PANSS subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 27 Mental state: 8. Specific ‐ distress (average endpoint score PsyRATs/SADS, high = poor)." data-id="CD007964-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 27 Mental state: 8. Specific ‐ distress (average endpoint score PsyRATs/SADS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 28 Mental state: 9. Specific ‐ anxiety (average endpoint score various scales, high = poor)." data-id="CD007964-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 28 Mental state: 9. Specific ‐ anxiety (average endpoint score various scales, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 29 Mental state: 10a. Specific ‐ depression ‐ clinically important change (no improvement = reduction HAMD score &lt; 25%) ‐ short term." data-id="CD007964-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 29 Mental state: 10a. Specific ‐ depression ‐ clinically important change (no improvement = reduction HAMD score &lt; 25%) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 30 Mental state: 10b. Specific ‐ depression (average endpoint score various scales, high = poor) ‐ short term." data-id="CD007964-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 30 Mental state: 10b. Specific ‐ depression (average endpoint score various scales, high = poor) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 31 Mental state: 10c. Specific ‐ depression (average change score MADRS, high = poor)." data-id="CD007964-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 31 Mental state: 10c. Specific ‐ depression (average change score MADRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0035"> <p> <div class="table" id="CD007964-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>CDS ‐ short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>CDS ‐ medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Birchwood 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Birchwood 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jackson 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jackson 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trower 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trower 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>BDI ‐ medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rector 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rector 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>HAMD ‐ medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Granholm 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Granholm 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>MADRS ‐ medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gleeson 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gleeson 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>BDI ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fowler 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fowler 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Garety 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.3075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Garety 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.4155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.4444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rector 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rector 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>CDS ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Birchwood 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Birchwood 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jackson 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jackson 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>HADS ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Farhall 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Farhall 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>HAMD ‐ long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Granholm 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Granholm 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 32 Mental state: 10d. Specific ‐ depression (average endpoint score various scales, high = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0035">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 33 Mental state: 11a. Specific ‐ self esteem (average endpoint score various scales, high = good)." data-id="CD007964-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 33 Mental state: 11a. Specific ‐ self esteem (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0037"> <p> <div class="table" id="CD007964-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>SCS (high = good)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>754.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>406.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>636.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>311.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>positive self ‐ BCSS (high = good)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>negative self ‐ BCSS (high = poor)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 34 Mental state: 11b. Specific ‐ self esteem (average endpoint score various scales) ‐ short term (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0037">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 35 Mental state: 12a. Specific ‐ insight (average endpoint score various scales, high = good)." data-id="CD007964-fig-0038" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 35 Mental state: 12a. Specific ‐ insight (average endpoint score various scales, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 36 Mental state: 12b. Specific ‐ insight (average endpoint score SAI, high = good) ‐ short term." data-id="CD007964-fig-0039" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 36 Mental state: 12b. Specific ‐ insight (average endpoint score SAI, high = good) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 37 Mental state: 12c. Specific ‐ insight (average change score SAI, high = good)." data-id="CD007964-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 37 Mental state: 12c. Specific ‐ insight (average change score SAI, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 38 Mental state: 13. Specific ‐ well‐being (average endpoint score WEMWS, high = good) ‐ short term." data-id="CD007964-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 38 Mental state: 13. Specific ‐ well‐being (average endpoint score WEMWS, high = good) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 39 Mental state: 14a. Specific ‐ various other symptoms (average endpoint score various scales high = poor)." data-id="CD007964-fig-0042" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 39 Mental state: 14a. Specific ‐ various other symptoms (average endpoint score various scales high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0043"> <p> <div class="table" id="CD007964-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>anxiety</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>depression</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>psychotic symptom</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>somatization</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>sensitivity of interpersonal relationship</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>obsessive‐compulsiive</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>hostility</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>paranoid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>phobia</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Li 2015a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 40 Mental state: 14b. Specific ‐ various other symptoms (average endpoint score SCL‐90, high = poor) ‐ long term (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0043">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 41 Adverse effect/event(s): 1a. General ‐ any adverse event." data-id="CD007964-fig-0044" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 41 Adverse effect/event(s): 1a. General ‐ any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 42 Adverse effect/event(s): 1b. General (average total endpoint score TESS, high = poor) ‐ medium term." data-id="CD007964-fig-0045" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 42 Adverse effect/event(s): 1b. General (average total endpoint score TESS, high = poor) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 43 Adverse effect/event(s): 2a. Specific ‐ various effects." data-id="CD007964-fig-0046" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 43 Adverse effect/event(s): 2a. Specific ‐ various effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 44 Adverse effect/event(s): 2b. Specific ‐ suicide attempt." data-id="CD007964-fig-0047" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 44 Adverse effect/event(s): 2b. Specific ‐ suicide attempt. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 45 Adverse effect/event(s): 2c. Specific ‐ death." data-id="CD007964-fig-0048" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 45 Adverse effect/event(s): 2c. Specific ‐ death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 46 Functioning: 1. General (average endpoint score GAF, high = good)." data-id="CD007964-fig-0049" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 46 Functioning: 1. General (average endpoint score GAF, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 47 Functioning: 2a. Social (average endpoint score ILSS, high = good)." data-id="CD007964-fig-0050" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 47 Functioning: 2a. Social (average endpoint score ILSS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 48 Functioning: 2b. Social (average endpoint score SFS, high = good)." data-id="CD007964-fig-0051" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 48 Functioning: 2b. Social (average endpoint score SFS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 49 Functioning: 2c. Social (average endpoint score SOFAS, high = good)." data-id="CD007964-fig-0052" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.49</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 49 Functioning: 2c. Social (average endpoint score SOFAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 50 Functioning: 2d. Social (average endpoint score PSP, high = good)." data-id="CD007964-fig-0053" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.50</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 50 Functioning: 2d. Social (average endpoint score PSP, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 51 Functioning: 2e. Social (average endpoint score UPSA, high = good)." data-id="CD007964-fig-0054" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.51</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 51 Functioning: 2e. Social (average endpoint score UPSA, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 52 Functioning: 3. Life skills (average endpoint score LSP, high = poor)." data-id="CD007964-fig-0055" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.52</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 52 Functioning: 3. Life skills (average endpoint score LSP, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-52.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-53" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-53.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 53 Functioning: 4a. Cognitive ‐ overall (average total endpoint score WCST, high = poor)." data-id="CD007964-fig-0056" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-53.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.53</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 53 Functioning: 4a. Cognitive ‐ overall (average total endpoint score WCST, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-53.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-54" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-54.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 54 Functioning: 4b. Cognitive ‐ memory (average endpoint score WMS, high = good)." data-id="CD007964-fig-0057" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-54.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.54</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 54 Functioning: 4b. Cognitive ‐ memory (average endpoint score WMS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-54.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-55" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-55.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 55 Functioning: 4c. Cognitive ‐ memory (average endpoint score CMS, high = good)." data-id="CD007964-fig-0058" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-55.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.55</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 55 Functioning: 4c. Cognitive ‐ memory (average endpoint score CMS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-55.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-56" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-56.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 56 Functioning: 4d. Cognitive ‐ various (average endpoint score MCCB, high = poor) ‐ medium term." data-id="CD007964-fig-0059" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-56.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.56</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 56 Functioning: 4d. Cognitive ‐ various (average endpoint score MCCB, high = poor) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-56.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-57" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-57.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 57 Functioning: 5. Intelligence (average endpoint score WAIS, high = good)." data-id="CD007964-fig-0060" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-57.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.57</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 57 Functioning: 5. Intelligence (average endpoint score WAIS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-57.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-58" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-58.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 58 Functioning: 6. Disability (average endpoint score WHODAS, high = poor)." data-id="CD007964-fig-0061" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-58.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.58</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 58 Functioning: 6. Disability (average endpoint score WHODAS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-58.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-59" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-59.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 59 Quality of life: 1a. General (average total endpoint score various scales, high = good) ‐ short term." data-id="CD007964-fig-0062" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-59.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.59</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 59 Quality of life: 1a. General (average total endpoint score various scales, high = good) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-59.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-60" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-60.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 60 Quality of life: 1b. General (average total endpoint score various scales, high = good) ‐ medium term." data-id="CD007964-fig-0063" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-60.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.60</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 60 Quality of life: 1b. General (average total endpoint score various scales, high = good) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-60.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-61" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-61.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 61 Quality of life: 1c. General (average total endpoint score various scales, high = good) ‐ long term." data-id="CD007964-fig-0064" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-61.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.61</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 61 Quality of life: 1c. General (average total endpoint score various scales, high = good) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-61.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-62" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-62.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 62 Quality of life: 1d. General (average total endpoint score SQLS, high = poor)." data-id="CD007964-fig-0065" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-62.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.62</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 62 Quality of life: 1d. General (average total endpoint score SQLS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-62.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-63" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-63.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 63 Quality of life: 2a. Specific ‐ physical (average endpoint score WHOQOL‐BREF, high = good)." data-id="CD007964-fig-0066" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-63.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.63</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 63 Quality of life: 2a. Specific ‐ physical (average endpoint score WHOQOL‐BREF, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-63.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-64" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-64.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 64 Quality of life: 2b. Specific ‐ physical (average endpoint score GQOLI‐74, high = good)." data-id="CD007964-fig-0067" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-64.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.64</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 64 Quality of life: 2b. Specific ‐ physical (average endpoint score GQOLI‐74, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-64.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-65" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-65.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 65 Quality of life: 3a. Specific ‐ psychological (average endpoint score WHOQOL‐BREF, high = good)." data-id="CD007964-fig-0068" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-65.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.65</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 65 Quality of life: 3a. Specific ‐ psychological (average endpoint score WHOQOL‐BREF, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-65.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-66" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-66.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 66 Quality of life: 3b. Specific ‐ psychological (average endpoint score GQOL‐74, high = good)." data-id="CD007964-fig-0069" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-66.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.66</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 66 Quality of life: 3b. Specific ‐ psychological (average endpoint score GQOL‐74, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-66.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-67" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-67.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 67 Quality of life: 3c. Specific ‐ psychological (average endpoint score SQLS, high = poor)." data-id="CD007964-fig-0070" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-67.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.67</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 67 Quality of life: 3c. Specific ‐ psychological (average endpoint score SQLS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-67.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-68" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-68.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 68 Quality of life: 4a. Specific ‐ various other aspects (average endpoint score WHQOL‐BREF, high = good) ‐ short term." data-id="CD007964-fig-0071" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-68.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.68</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 68 Quality of life: 4a. Specific ‐ various other aspects (average endpoint score WHQOL‐BREF, high = good) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-68.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-69" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-69.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 69 Quality of life: 4b. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ medium term." data-id="CD007964-fig-0072" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-69.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.69</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 69 Quality of life: 4b. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-69.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-70" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-70.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 70 Quality of life: 4c. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ long term." data-id="CD007964-fig-0073" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-70.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.70</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 70 Quality of life: 4c. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-70.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-71" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-71.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 71 Quality of life: 4d. Specific ‐ various aspects (average endpoint score various scales, high = poor) ‐ medium term." data-id="CD007964-fig-0074" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-71.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.71</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 71 Quality of life: 4d. Specific ‐ various aspects (average endpoint score various scales, high = poor) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-71.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0075"> <p> <div class="table" id="CD007964-tblf-0009"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lu 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lu 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.72</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 72 Quality of life: 5a. Specific ‐ psychological (average endpoint score SQLS, high = poor) ‐ medium term (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0075">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0076"> <p> <div class="table" id="CD007964-tblf-0010"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fowler 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fowler 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.73</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 73 Quality of life: 5b. Specific ‐ role functioning (average endpoint score QLS, high = good) ‐ long term (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0076">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0077"> <p> <div class="table" id="CD007964-tblf-0011"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lu 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lu 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.74</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 74 Quality of life: 5c. Specific ‐ symptoms/side effects (average endpoint score SQLS, high = poor) ‐ medium term (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0077">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007964-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-75" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-75.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 75 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason." data-id="CD007964-fig-0078" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-75.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.75</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 75 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-75.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-76" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-76.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 76 Engagement with services: 1a. Compliance to medication." data-id="CD007964-fig-0079" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-76.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.76</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 76 Engagement with services: 1a. Compliance to medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-76.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-77" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-77.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 77 Engagement with services: 1b. Refusing treatment." data-id="CD007964-fig-0080" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-77.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.77</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 77 Engagement with services: 1b. Refusing treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-77.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-001-78" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-001-78.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 78 Engagement with services: 1c. Compliance with medication (average endpoint score MARS, high = good)." data-id="CD007964-fig-0081" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-78.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.78</div> <div class="figure-caption"> <p>Comparison 1 COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE, Outcome 78 Engagement with services: 1c. Compliance with medication (average endpoint score MARS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-001-78.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SENSITIVITY ANALYSIS 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE (NON‐BLIND OUTCOME ASSESSMENT), Outcome 1 Global state: 1. Relapse ‐ long term." data-id="CD007964-fig-0082" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 SENSITIVITY ANALYSIS 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE (NON‐BLIND OUTCOME ASSESSMENT), Outcome 1 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SENSITIVITY ANALYSIS 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE (NON‐BLIND OUTCOME ASSESSMENT), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term." data-id="CD007964-fig-0083" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 SENSITIVITY ANALYSIS 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE (NON‐BLIND OUTCOME ASSESSMENT), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 1 Global state: 1. Relapse ‐ medium term." data-id="CD007964-fig-0084" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 1 Global state: 1. Relapse ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 2 Global state: 1. Relapse ‐ long term." data-id="CD007964-fig-0085" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 2 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 3 Global state: 2. Clinically important change (no improvement) ‐ long term." data-id="CD007964-fig-0086" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 3 Global state: 2. Clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term." data-id="CD007964-fig-0087" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 1 Global state: 1. Relapse ‐ medium term." data-id="CD007964-fig-0088" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 1 Global state: 1. Relapse ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 2 Global state: 1. Relapse ‐ long term." data-id="CD007964-fig-0089" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 2 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 3 Global state: 2. Clinically important change (no improvement) ‐ long term." data-id="CD007964-fig-0090" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 3 Global state: 2. Clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term." data-id="CD007964-fig-0091" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 5 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term." data-id="CD007964-fig-0092" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST), Outcome 5 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SENSITIVITY ANALYSIS 4: CBT+ STANDARD CARE versus STANDARD CARE ALONE (ASSUMATPION FOR MISSING DATA), Outcome 1 Global state: 1. Relapse ‐ long term." data-id="CD007964-fig-0093" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 SENSITIVITY ANALYSIS 4: CBT+ STANDARD CARE versus STANDARD CARE ALONE (ASSUMATPION FOR MISSING DATA), Outcome 1 Global state: 1. Relapse ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SENSITIVITY ANALYSIS 4: CBT+ STANDARD CARE versus STANDARD CARE ALONE (ASSUMATPION FOR MISSING DATA), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term." data-id="CD007964-fig-0094" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 SENSITIVITY ANALYSIS 4: CBT+ STANDARD CARE versus STANDARD CARE ALONE (ASSUMATPION FOR MISSING DATA), Outcome 2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 SENSITIVITY ANALYSIS 5: CBT+ STANDARD CARE versus STANDARD CARE ALONE (IMPUTED VALUES), Outcome 1 Global state: 1a. Relapse ‐ short term." data-id="CD007964-fig-0095" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 SENSITIVITY ANALYSIS 5: CBT+ STANDARD CARE versus STANDARD CARE ALONE (IMPUTED VALUES), Outcome 1 Global state: 1a. Relapse ‐ short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007964-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/urn:x-wiley:14651858:media:CD007964:CD007964-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_t/tCD007964-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SENSITIVITY ANALYSIS 6: CBT+ STANDARD CARE versus STANDARD CARE ALONE (RANDOM EFFECT MODEL), Outcome 1 Global state: 2. Clinically important change (no improvement)." data-id="CD007964-fig-0096" src="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 SENSITIVITY ANALYSIS 6: CBT+ STANDARD CARE versus STANDARD CARE ALONE (RANDOM EFFECT MODEL), Outcome 1 Global state: 2. Clinically important change (no improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/media/CDSR/CD007964/image_n/nCD007964-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD007964-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Suggested design of study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: randomised, fully explicit description of methods of randomisation and allocation concealment.<br/> Blinding: single, tested.<br/> Setting: community rather than hospital.<br/> Duration: 12 weeks treatment, and then follow‐up to at least 52 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: schizophrenia (ICD).<br/> N = 300.*<br/> Age: adults.<br/> Sex: both. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Cognitive behaviour therapy plus standard care. N = 150.</p> <p>Content:</p> <p> <ul id="CD007964-list-0071"> <li> <p>a discrete psychological intervention, which is in addition to, and separate from, other therapeutic interventions (for example, behavioural family therapy) and </p> </li> <li> <p>recipients establish links between their symptoms, thoughts and beliefs, and consequent distress or problem behaviour, and </p> </li> <li> <p>the re‐evaluation of their perceptions, beliefs or reasoning relating to the target symptoms; this may include the re‐evaluation of specific 'inferential' beliefs or more global 'evaluative' beliefs. </p> </li> </ul> </p> <p>Delivered by: experienced therapists.</p> <p>2. Other psychosocial therapy plus standard care . N = 150.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General: time to all‐cause treatment failure marked by its discontinuation, relapse/rehospitalisation, general impression of clinician (CGI), carer/other, compliance with treatment.<br/> Mental state: BPRS and PANSS.<br/> Global state: CGI (Clinical Global Impression).<br/> Quality of life. QOL (Quality of Life Questionnaire).<br/> Social functioning: return to everyday living for 80% of time.*<br/> Economic outcomes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* Powered to be able to identify a difference of ˜ 20% between groups for primary outcome with adequate degree of certainty. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>BPRS = Brief Psychiatric Rating Scale<br/> CGI = <br/> ICD = International Classification of Diseases<br/> PANSS = Positive and Negative Syndrome Scale<br/> QOL = </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Suggested design of study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007964-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">COMPARISON 1: CBT+ STANDARD CARE compared to STANDARD CARE ALONE for people with schizophrenia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>COMPARISON 1: CBT+ STANDARD CARE compared to STANDARD CARE ALONE for people with schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with schizophrenia<br/> <b>Setting:</b> inpatient and outpatient<br/> <b>Intervention:</b> CBT+ standard care<br/> <b>Comparison:</b> Standard care alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with STANDARD CARE ALONE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with COMPARISON 1: CBT+ STANDARD CARE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: 1a. Relapse ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.78<br/> (0.61 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1538<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>260 per 1,000<br/> (203 to 333) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Global state: 2. Clinically important change (no improvement) ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.57<br/> (0.39 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>82<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>750 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>428 per 1,000<br/> (293 to 630) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mental state: General ‐ clinically important change (no improvement) ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.81<br/> (0.65 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>501<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>423 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>343 per 1,000<br/> (275 to 431) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: General: any adverse event</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.44<br/> (0.27 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>146<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>432 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>190 per 1,000<br/> (117 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functioning: Social (average endpoint score SOFAS, high = good) ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.56 higher<br/> (2.64 lower to 3.76 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>295<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The predefined outcome: 'Functioning: clinically important change in social functioning' was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life: General (average endpoint score QLS, high = good) ‐ long term *</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.6 lower<br/> (11.32 lower to 4.12 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* The predefined outcome of importance: 'Quality of life: clinically important change was not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Satisfaction with treatment: 1. Leaving the study early ‐ long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.77 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1945<br/> (19 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>184 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>171 per 1,000<br/> (141 to 206) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to heterogeneity. </p> <p><sup>2</sup> Downgraded one level due to imprecision: confidence interval of the effect estimation includes both appreciable benefit and harm. </p> <p><sup>3</sup> Downgraded one level due to study limitations: several bias domains were of high or unclear risk, including blinding of trialists and participants (high risk) and random sequence generation and allocation concealment (unclear risk). </p> <p><sup>4</sup> Downgraded two levels due to imprecision: very small sample size and very low number of events </p> <p><sup>5</sup> Downgraded one level due to imprecision: low number of events. </p> <p><sup>6</sup> Downgraded one level due to indirectness: average scale scores used to measure outcome, not clinically important change. </p> <p><sup>7</sup> Downgraded one level due to indirectness: leaving the study early used to predict satisfaction with treatment. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">COMPARISON 1: CBT+ STANDARD CARE compared to STANDARD CARE ALONE for people with schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">More detailed description of interventions in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Cognitive Behavioural Therapy</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Study ID</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>No other active therapies</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Experienced therapists</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Well‐defined CBT</b> </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup><b>Details about CBT</b> </sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content:</p> <p>The interventions began with the motivational interviewing phase and five initial weekly sessions designed to assess and then enhance the patient’s motivation to change. If the patient’s commitment was obtained, changes in substance use were negotiated on an individual basis. With the introduction of the individual cognitive behaviour therapy at week 6 (or earlier, if appropriate), the motivational interviewing style was integrated into subsequent cognitive behaviour therapy sessions. The individual cognitive behaviour therapy took place over approximately 18 weekly sessions, followed by six biweekly sessions (a total of 29 individual sessions, including the motivational interviewing). </p> <p>Six clinicians (five clinical psychologists and one nurse therapist) conducted the cognitive behaviour therapies (individual and family). All had experience in cognitive behaviour therapy work with psychotic patients and were eligible for accreditation as cognitive behaviour therapists with the </p> <p>British Association for Behavioural and Cognitive Psychotherapy. Therapy was detailed in a comprehensive treatment manual (available from CB), and the therapists received weekly supervision based on audiotape sessions to ensure treatment fidelity. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychological therapy consisted of 26 individual sessions delivered over 12 months. Treatment was built around two phases. The first phase used motivational interviewing to reinforce motivation to change. In phase two of the intervention, CBT from both the psychosis and substance misuse evidence base was used to formulate a change plan to help the patients to implement and maintain changes (e.g. strategies for dealing with distressing voices and depressed mood, responding to relapses, and coping with cravings and urges). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: motivation building which is to elicit and understand patients' perspective in relation to life goals, explore and resolve ambivalence so as to facilitate motivation for change; CBT techniques from both the psychosis and substance use evidence base were used to help the patient implement and maintain changes; </p> <p>Delivered by: The trial therapists all had experience in conducting CBT with people with first‐episode psychosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognitive behaviour therapy techniques are used to assess and modify conviction in four beliefs linked to the construct of voice power. Protocol for cognitive therapy for command hallucinations was developed by MB and details are provided in our casebook manuals. </p> <p>Delivered by: cognitive therapists who were supervised in each centre by a lead clinician with expertise in cognitive behaviour therapy for psychosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0005" title="CaoJ , ZhuJ , XuL , LinL , QiaoS , WuS . Study on the effects of cognitive‐behavioral intervention on the rehabilitation of first‐episode schizophrenia [认知行为干预对首发精神分裂症康复效果的追踪调查研究]. Journal of Psychiatry [精神医学杂志]2014;27:297‐9. ">Cao 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The intervention included health education to help patients recognize and correct their wrong beliefs or cognition; behavioural therapy included relaxation training. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0006" title="ChenS , WangH . The effect of cognitive behavioural therapy for depression in patients with schizophrenia [认知疗法对精神分裂症后抑郁的效果观察]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [实用心脑肺血管病杂志]2014;22:85‐6. ">Chen 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation: help for participants to figure out their inappropriate beliefs and attitude; help participants recognize their cognition problems, and rebuild their personality and behaviour. Psychoeducation was given to families. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: the content of CBT was not stated.</p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0008" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerD , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303–11. ">Durham 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: An initial emphasis on engagement, education and building a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; development of a normalising rationale for the patient's psychotic experiences; exploration and enhancement of current coping strategies; acquisition of additional coping strategies for hallucinations and delusions; and focus on accompanying affective symptomatology using relaxation training, personal effectiveness training and problem‐solving, as appropriate. </p> <p>Delivered by: five clinical nurse specialists with extensive professional experience of severe mental disorder. The therapists received training mainly focused on CBT. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0009" title="EdwardsJ , CocksJ , BurnettP , MaudD , WongL , YuenHP , et al. Randomized controlled trial of clozapine and CBT for first‐episode psychosis with enduring positive symptoms: a pilot study. Schizophrenia Research and Treatment2011:394896. ">Edwards 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: A manualised CBT program, the systematic treatment of persistent psychosis (STOPP; Hermann‐Doig 2003). </p> <p>Delivered by: not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0010" title="EnglandM . Efficacy of cognitive nursing intervention for voice hearing. Perspectives in Psychiatric Care2007;43:69‐76. EnglandM . Significance of cognitive intervention for voice hearers. Perspectives in Psychiatric Care2008;44:40‐7. ">England 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT was applied by delivery of 12, 90‐min sessions of individualised counselling to voice hearers over a period of 4 months. CBT consisted of reasoning and decision support, counselling strategies tied to the techniques of Socratic learning, the verbal challenge, or empirical reality trial, homework assignments, and summarisation of the counselling sessions. The counselling sessions were audio‐taped to allow for audit of the nurse's counselling strategies. </p> <p>Delivered by: an experienced psychiatric clinical nurse specialist.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The CBT intervention is based on efficacy trials conducted in the UK (Kuipers 1998). It is similar in scope and content to the therapy outlined by Fowler 1995. </p> <p>Therapists work with patients for 12‐24 sessions on agreed recovery goals using one or more of the following recovery therapy components: </p> <p> <ul id="CD007964-list-0013"> <li> <p>everyday coping,</p> </li> <li> <p>working with symptoms,</p> </li> <li> <p>understanding the experience of psychosis,</p> </li> <li> <p>strengthening adaptive view of self,</p> </li> <li> <p>personal/emotional issues or comorbid disorders,</p> </li> <li> <p>relapse prevention, and</p> </li> <li> <p>family or social reintegration.</p> </li> </ul> </p> <p>Delivered by: 12 clinical psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0012" title="BartonGR , HodgekinsJ , MugfordM , JonesPB , CroudaceT , FowlerD . Cognitive behaviour therapy for improving social recovery in psychosis: cost‐effectiveness analysis. Schizophrenia Research2009;112:158‐63. FowlerD , HodgekinsJ , PainterM , ReillyT , CraneC , MacmillanI , et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis). Psychological Medicine2009;39:1627‐36. ">Fowler 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: An initial emphasis on engagement, education, and building a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; development of a normalising rationale for the patient's psychotic experiences; exploration and enhancement of current coping strategies; acquisition of additional coping strategies for hallucinations and delusions; and focus on accompanying affective symptomatology using relaxation training, personal effectiveness training, and problem‐solving, as appropriate. </p> <p>Delivered by: five clinical nurse specialists with extensive professional experience of severe mental disorder. The therapists received training mainly focused on CBT. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: 1. negative thoughts about the self, 2. positive activities, and 3. positive thoughts about the self. </p> <p>Delivered by: clinical psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The main techniques were psychoeducation about worry, identification and reviewing of positive and negative beliefs about worry, increasing awareness of the initiation of worry and individual triggers, use of worry periods, planning activity at times of worry (whichcould include relaxation), and learning to let go of worry. </p> <p>Delivered by: not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT targeted at relapse prevention, done by exploring people's understanding of triggers and risks of relapse and by developing a new model of disorder emphasising alternatives to delusional thinking; targets often included persistent negative beliefs about self and others, characteristic reasoning styles such as jumping to conclusions and distressing emotional reactions to events and anomalous experiences; administered by skilled practitioners (doctorial level clinical psychologists) and treatment fidelity assessed using the Cognitive Therapy for Psychosis Adherence Scale. </p> <p>Delivered by: five clinical nurse specialists with extensive professional experience of severe mental disorder. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0016" title="GleesonJ , WadeD , CastleD , GeeD , CrispK , PearceT , et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. Journal of Mental Health2008;17:19‐32. GleesonJFM , CottonSM , Alvarez‐JimenezM , WadeD , GeeD , CrispK , et al. A randomized controlled trial of relapse prevention therapy for first‐episode psychosis patients. Journal of Clinical Psychiatry2009;70:477‐86. ">Gleeson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT focused upon relapse prevention although nonadherence to treatment, substance abuse, coping with stress, and comorbid anxiety and depression were also targeted. There were parallel individual CBT sessions and family therapy sessions (based upon cognitive behavioural family therapy for schizophrenia (Falloon, 1988; Mueser &amp; Glynn, 1999). The family therapy focused upon communication skills, psychoeducation regarding relapse risk, and a review of early warning signs and documentation of a relapse prevention plan. </p> <p>Delivered by: individual research therapist, who additionally adopted the role of outpatient cases. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The treatment manual included a patient workbook that contained homework forms. The CBT was developed specifically for patients with schizophrenia; the age‐relevant content modifications were added. To simplify learning and to help patients remember to use cognitive techniques in everyday life, mnemonic aids were provided; there were also behavioural role‐playing exercises and problem‐solving skills. </p> <p>Delivered by: psychologists or senior graduate students who had 2 years of clinical experience. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0018" title="GraweRW , FalloonIR , WidenJH , SkogvollE . Two years of continued early treatment for recent‐onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica2006;114(5):328‐36. [PUBMED: 17022792] ">Grawe 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: integrated treatment provided by multidisciplinary team, including pharmacotherapy and case management. Structured family psychoeducation, cognitive behavioural family education, problem‐solving skills training, individual cognitive behavioural strategies for residue symptoms. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT was divided into two phases. Targeted CBT included identifying and targeting beliefs and behaviours, which increased risk to self or others, identifying and targeting beliefs and behaviours accelerating relapse and developing alternative beliefs and reinforcing those through behaviour change. During the study period, the CBT group received a median(range) of 6 (0–14) outpatient medical consultations and 28.5 (0 – 86) community mental health team contacts. </p> <p>Delivered by: a clinical psychologist.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT procedure was edited according to previous study and guideline (<a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a> and Wright 2010). </p> <p>Delivered by: rehabilitation therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0021" title="HabibN , DawoodS , KingdonD , NaeemF . Preliminary evaluation of Culturally Adapted CBT for psychosis (CA‐CBTp): findings from Developing Culturally‐sensitive CBT Project (DCCP). Behavioural and Cognitive Psychotherapy2015;43(2):200‐8. ">Habib 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Therapy was provided according to a manualised treatment protocol (Kingdon and Turkington, 1994), and was culturally adapted. </p> <p>Delivered by: psychologist who had received training in CBTp.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0022" title="HeX , LiZ , ChenY . Efficacy of cognitive behavioral therapy for anxiety in females with first‐episode paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期焦虑情绪的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;24(6):651‐3. LiZ , HeX , ChenY , LiZ . Control study of the effect of cognitive behavioral therapy combined with on the depression syndromes patients who had been in the recovery status of paranoid schizophrenia [认知行为疗法对首发女性偏执型精神分裂症康复期抑郁情绪疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2012;5:518‐20. ">He 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content:The intervention was based on a cognitive behavioural therapy handbook developed by the investigators. The therapeutic milieu and content was applied according to the handbook. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT and risperidone.</p> <p>Delivered by: six experienced psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0024" title="HuX , PanX . Effects of cognitive behavioral therapy on cognitive function in schizophrenia patients [认知行为治疗对精神分裂症患者认知功能的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(7):8‐9. ">Hu 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The cognitive behavioural therapy included wrong behaviour correction, relaxation, etc. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0025" title="JacksonC , TrowerP , ReidI , SmithJ , HallM , TownendM , et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy2009;47(6):454‐62. ">Jackson 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The cognitive therapy based recovery intervention (CRI) was designed to be delivered on a weekly basis over a 6‐month period (i.e. it was limited to a maximum of 26 sessions) and followed a protocol‐based modular approach. There were three key components: (a) engagement and formulation; (b) trauma processing; and (c) appraisals of psychotic illness (shame, loss, and entrapment). The intervention, therefore, is not just designed for those who could be described as 'traumatised' by their experiences of psychosis. It is intended to be helpful for all first‐episode patients adjusting to and recovering from a first episode of psychosis. </p> <p>Delivered by: four clinical psychologists and a cognitive behavioural psychotherapist. All clinicians had over 4 years experience in the practice of cognitive therapy for early psychosis and received regular case supervision. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Rational thinking training, helping the participant realise his or her inappropriate cognition, behavioural training, diary and health education. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0027" title="JiaoC , WuB , ZhangZ , TangS , ShengC , LiJ , et al. Efficacy of alliance therapy of risperidone and cognitive‐behavioral treatment in schizophrenia patients during recovery stage [联合应用利培酮和认知行为疗法治疗康复期精神分裂症的疗效观察]. Contemporary Medicine Forum [当代医药论丛]2014;12(12):238‐9. ">Jiao 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: to help participants understand their symptoms and strategies to prevent the symptoms, cognitive rebuild, communication with therapists. </p> <p>The dosage of risperidone was 3.8 ± 0.7 mg/day.</p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0028" title="GaretyP , KuipersE , FowlerD , ChamberlainF , DunnG . Cognitive behavioural therapy for drug resistant psychosis. British Journal of Psychiatry1994;67:259‐71. KuipersE , FowlerD , GaretyP , ChisholmD , FreemanD , DunnG , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. British Journal of Psychiatry1998;173:61‐8. KuipersE , GaretyP , FowlerD , DunnG , FreemanD , BebbingtonP , et al. London East‐Anglia randomised controlled trial of cognitive behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry1997;171:319‐27. ">Kuipers 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Initial sessions were focused on facilitating engagement in treatment. Considerable effort was spent on building and maintaining a good basic therapeutic relationship, and this relationship was characterised by considerable flexibility on the part of the therapist. When necessary, treatment was arranged in locations convenient to the client, including home visits and proactive outreach. Behavioural therapy techniques, including activity scheduling, relaxation and skills training. </p> <p>Delivered by: experienced clinical psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The CBT was manual‐based with four stages.</p> <p><i>Stage 1</i>: a cognitive behavioural analysis of how symptoms might relate to cognitions, behaviour and coping strategies. Education about the nature and treatment of psychosis, using a stress vulnerability model to link biological and psychological mechanisms, was used to help engagement. </p> <p><i>Stage 2</i>: a problem list was generated collaboratively with the patient. This was then prioritised according to the degree of distress attached, feasibility and, where relevant, clinical risk involved. Prioritised problems were assessed in detail and a formulation was agreed which included such issues as trigger situations and cognitions. </p> <p><i>Stage 3</i>: Interventions particularly addressed positive psychotic symptoms of delusions and hallucinations, generating alternative hypotheses for abnormal beliefs and hallucinations, identifying precipitating and alleviating factors and reducing associated distress. </p> <p><i>Stage 4</i>: monitoring positive psychotic symptoms of delusions and hallucinations. </p> <p>Delivered by:one of five therapists trained in CBT in psychosis, supervised by experienced cognitive therapists. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: Cognitive therapy was conducted to help participant correct their wrong beliefs or thinking process; establish and intensify the right cognition. </p> <p>Delivered by: not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0031" title="LiX , GuoY , FuC , ChenL . Clinical efficiency and safety of CBT combined with low‐dose risperidone alliance treatment on auditory hallucination in schizophrenia patients [CBT联合小剂量利培酮治疗精神分裂症患者幻听的临床效果及安全性研究]. Sichuan Mental Health [四川精神卫生]2014;27(6):502‐4. ">Li 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation about voice; discuss the content of hallucinations; introduction of the ABC model; discuss the link between voice and behaviour; coping strategies. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0032" title="LiX , GuoY , FuC , ChenL . Effects of CBT combined with low‐dose risperidone alliance treatment on cognitive function in schizophrenia patients: neuropsychological assessment [CBT联合小剂量利培酮对精神分裂症患者认知功能影响的神经心理学评估]. Sichuan Mental Health [四川精神卫生]2015;23(03):211‐4. ">Li 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: building of a therapeutic alliance; functional analysis of key symptoms, leading to a formulation and problem list; scheduling of activity; simulated scene training and case explanation; exploration and enhancement of current coping strategies; homework assignments. </p> <p>Delivered by: therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0033" title="LiH , ShuJ , HuangC , SunH , ZhuY , WangS . Comparative study of the effect of integrated community rehabilitation intervention for the mental health of patients with chronic schizophrenia and their caregivers [社区综合康复对慢性精神分裂症患者的家庭负担及照料者心理健康的对比研究]. Medical Journal of Chinese Peoples Health [中国民康医学]2015;27(9):1‐4+7. ">Li 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: functional analysis of symptoms and negative behaviour, providing treatment therapy, help patients to develop positive attitude, improve cognitive abilities, reduce conflicts with social interactions, improve clinical compliance, reduce negative mood, improve the way of thinking. </p> <p>Delivered by: specially trained therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0034" title="LiuG . Cognitive behavioural therapy for the quality of life and stigma of patients with schizophrenia [认知心理治疗对精神分裂症康复期患者生活质量及病耻感的影响]. Xinli Yisheng [心理医生]2012;8:71. ">Liu 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: rehabilitation training, cognitive and behaviour modification, life skill training, rebuild the link between cognition, behaviour, and psychology. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0035" title="LuJ , MaoZ . Effects of cognitive‐behavioral therapy on quality of life and self‐efficacy in schizophrenia patients [认知行为治疗对慢性精神分裂症患者生活质量和自我效能感的影响]. Journal of Psychiatry [精神医学杂志]2014;27(5):347‐9. ">Lu 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognitive coping strategies, behavioural therapy, etc.</p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0036" title="MaW , ShiS , YuH , ZhaoY . Efficacy of cognitive‐behavioral therapy on quality of life in 190 schizophrenia patients [认知行为治疗对190例精神分裂症患者生活质量的疗效观察]. Medical Journal of Chinese People's Health [中国民康医学]2016;28(02):1‐2+9. ">Ma 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT therapy included a therapeutic alliance building with patients, help to develop personal behaviour control ability, help to correct cognitions in thought, beliefs and attitudes, help patients to aware of the importance of medications. </p> <p>Delivered by: therapists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: A spiritual dimension was included in formulation, understanding and in therapy plan; Urdu equivalents of CBT jargons were used in the therapy; culturally appropriate homework assignments were selected and participants were encouraged to attend even if they were unable to complete their homework; folk stories and examples relevant to the religious beliefs of the local population were used to clarify issues. </p> <p>Delivered by: psychology graduates with more than 5 years experience of working in mental health. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0038" title="NaeemF , JohalR , McKennaC , RathodS , AyubM , LecomteT , et al. Cognitive Behavior Therapy for psychosis based Guided Self‐Help (CBTp‐GSH) delivered by frontline mental health professionals: results of a feasibility study. Schizophrenia Research2016;173(1‐2):69‐74. ">Naeem 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBTp consisted of a total of 17 handouts and eight worksheets, that could be flexibly given by a health professional over 12‐16 sessions. The handouts focused on psychoeducation, dealing with hallucinations, paranoia, changing negative thinking, behavioural activation, problem‐solving, improving relationships and communication skills. Health professionals were trained in formulating and devising a plan to suit the individuals' needs. The intervention was then delivered according to this plan. </p> <p>Frequency: a 15‐30 minutes CBT was conducted in each session.</p> <p>Delivered by: frontline mental health professionals.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0039" title="PanS . Cognitive therapy in the care of schizophrenic depression [认知疗法在精神分裂症伴抑郁障碍护理中的应用]. Xin Li Yisheng [心理医生]2012;7:206‐7. ">Pan 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: not stated.</p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT combined with antipsychotics. CBT involves: 1) establish the consultant connection between participants and investigator; 2) help the participants recognise their wrong beliefs and thinking process; 3) help the participants realize their wrong recognition based on their problematic beliefs and guiding them to the correct recognition style; 4) help the participants realise and correct the inappropriate points in their thinking process. 5) encourage the participant to express his/her own viewpoints and promote his/her introspectiveness. 6) help the participants inspect their external misconceptions and correct the deep cause of misconceptions by demonstration, imitation, or didactic suggestion; 7) help participants consolidate their reestablished conceptions and beliefs. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0041" title="QinC . Effects of cognitive‐behavioral intervention on anxiety and depression in schizophrenia patients during recovery stage [认知行为干预对康复期精神分裂症患者焦虑抑郁症状的影响]. Journal of Clinical Nursing [临床护理杂志]2014;13(2):40‐2. ">Qin 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognition correction and group psychoeducation, training exercise.</p> <p>Delivered by: psychologists or nurse.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: coping strategies and relapse prevention.</p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The CBT approach in this study was guided by the principles and strategies developed by Beck et al. (1979, 1985). The first phase of therapy focused on engagement and assessment. The second phase of therapy aimed to socialise the patient to the cognitive model and to impart cognitive and behavioural coping skills, including self‐monitoring with a thought record and the completion of homework tasks. Overlapping with the first two phases of treatment, a third aspect of treatment focused on providing psychoeducation with a normalising rationale. </p> <p>Delivered by: two doctoral level psychologists and one psychiatrist, all with formal training and practice in cognitive behavioural interventions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0044" title="StartupM , JacksonMC , StartupS . Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease2004;194(10):740‐50. ">Startup 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: This is a highly individualised, needs‐based form of CBT for psychotic disorders and is based on collaborative empiricism and (evolving) cognitive‐behavioural formulations. </p> <p>Delivered by: clinical psychologists who were employed as specialists in serious mental illness and conducted CBT for schizophrenia on a routine basis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0045" title="SunJ , FengN , SunQ , GuoH . Effects of cognitive therapy on cognitive function in first‐episode schizophrenia patients [认知疗法对首发精神分裂症患者认知功能的影响]. Journal of Clinical Psychosomatic Diseases [临床身心疾病杂志]2014;20(1):54‐6, 83. ">Sun 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT included the building of a therapeutic alliance with patients, functional analysis of symptoms, help to deal with hallucinations and delusions, relaxation training, personal effectiveness training and problem‐solving, as appropriate. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0046" title="TarrierN , BeckettR , HarwoodS , BakerA , YusupoffL , UgarteburuI . A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: 1. outcome. British Journal of Psychiatry1993;162:524‐32. TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumpherysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐month follow‐up. British Journal of Psychiatry1999;174:500‐4. TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. ">Tarrier 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: coping strategy enhancement, training in problem‐solving, strategies to reduce relapse plus standard care. </p> <p>Delivered by: three experienced clinical psychologists and followed a protocol manual.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBSPp was based on a treatment manual and was derived from an explanatory model of suicide behaviour; the intervention consisted of three phases: 1) Information processing biases; 2) appraisals of defeat, entrapment, social isolation, emotional dysregulation, and interpersonal problem‐solving. 3) suicide schema. </p> <p>Delivered by: clinical psychologists (JK, JM) who had extensive experience in delivering CBT for psychosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0048" title="TrowerP , BirchwoodM , MeadenA , ByrneS , NelsonA , RossK . Cognitive therapy for command hallucinations: randomised controlled trial. British Journal of Psychiatry2004;184:312‐20. ">Trower 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: four core dysfunctional beliefs (and their functional relation to behaviour and emotion) that define the client ‐ voice (social rank) power relationship. Using the methods of collaborative empiricism and Socratic dialogue, the therapist seeks to engage the client to question, challenge and undermine the power beliefs, then to use behavioural tests to help the client gain disconfirming evidence against the beliefs. These strategies are also used to build clients' alternative beliefs in their own power and status, and finally, where appropriate, to explore the origins of the schema so clients have an explanation for why they developed those beliefs about the voice in the first place. </p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0049" title="RathodS , KingdonD , SmithP , TurkingtonD . Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics ‐ data on a previously published randomised controlled trial. Schizophrenia Research2005;74(2‐3):211‐9. TurkingtonD , KingdonD , RathodS , HammondK , PeltonJ , MehtaR . Outcomes of an effectiveness trial of cognitive‐behavioural intervention by mental health nurses in schizophrenia. British Journal of Psychiatry2006;189:36‐40. TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. ">Tuikington 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: based on same manual used in Turkington 2000, including assessment and engaging, developing explanations, case formulation, symptom management, adherence, working with core beliefs and relapse prevention. </p> <p>Delivered by: nurses receiving 10 days of intensive training.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0050" title="VelliganDI , TaiS , RobertsDL , Maples‐AguilarN , BrownM , MintzJ , et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophrenia Bulletin2015;41(3):597‐603. ">Velligan 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The focus of the sessions was on patient‐identified problems, particularly those that interfered with daily functioning or were distressing, normalising symptoms, and using CBT techniques to develop alternative explanations. </p> <p>Delivered by: master's and doctoral level professionals with &gt; 2 years' experience in assessment and treatment of serious mental illness. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0051" title="WangL , DuX , LiX , GuoY . Control study of cognitive behavioral nursing therapy for chronic schizophrenic [认知行为护理疗法对慢性精神分裂症作用的对照研究]. Medical Journal of Chinese People's Health [中国民康医学]2005;17(9):548‐9. ">Wang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: help patients to understand their symptoms and the impact of symptoms to emotion, realise the relationship between behaviour and disease; strengthened behaviour therapy; cognitive behavioural therapy. </p> <p>Delivered by: unclear.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0053" title="WangC , AnQ . The effect of cognitive behavioural therapy for the compliance behaviour in patients with schizophrenia [认知行为治疗对精神分裂症患者遵医行为的影响]. Seek Medical and Ask the Medicine [求医问药]2012;7:651. ">Wang 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation about symptoms and relapse, coping strategies to hallucination and delusions; cognitive modification. </p> <p>Delivered by: 6 psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: The intervention was based on two published cognitive behavioural therapy handbooks. </p> <p>Delivered by: psychologist who had been trained to conduct CBT.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: establishing therapeutic relationship and collating comprehensive illness history of individual patients. Treatment is divided into psychological and behaviour aspects. Participants were give psychoeducation about schizophrenia symptoms in order to improve treatment compliance, and meanwhile, behavioural intervention was given to reinforce symptom self‐monitoring, relapse prevention, and ways of managing thoughts and actions. Standard care is Risperidol, 0.5 mg/day, increased to 4 mg/day by the second week of intervention and maximum dosage is 6 mg/day. </p> <p>Delivered by: psychologist who had been trained to conduct CBT.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0055" title="YaoL . Nursing interventions on anxiety and depression in schizophrenics during recovery stage [康复期精神分裂症患者焦虑抑郁情绪的护理措施]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):251‐2. ">Yao 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT included: 1) active promotion of social activity; 2) help to deal with hallucinations, paranoia, changing negative thinking; 3) help to self‐regulate psychotic symptoms and improve social recovery from psychosis; 4) psychoeducation; 5) relax training with a duration of 30 minutes; 6) promoting of patients' and guardians' confidence; 7) activity scheduling. </p> <p>Delivered by: qualified doctors and senior nurse.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0056" title="ZhangY . Effects of cognitive behavioral therapy on medication adherence in homeless psychotic patients during recovery stage [认知行为干预对恢复期住院流浪精神病患者服药依从性的影响]. Medical Journal of Chinese People's Health [中国民康医学]2014;26(22):117‐8. ">Zhang 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation and cognition modification.</p> <p>Delivered by: three psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0057" title="ZhangH . The effect of cognitive psychology therapy for patients with psychosis [康复期精神病患者认知心理治疗的护理观察]. World Latest Medicine Information [世界最新医学信息文摘]2015;15(41):191, 19. ">Zhang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: CBT included cognitive therapy and rational‐emotive therapy. Cognitive therapy helped patients to change negative thinking by providing psychoeducation. In rational‐emotive therapy, doctors planned therapy for each patient individually depending on patients' background and symptoms, to help patients to build up confidence and solve emotional problems. The therapies included psycho‐diagnosis, helping patients to understand, analysis of patients' background, implementation and strengthening of therapies. </p> <p>Delivered by: qualified doctors.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0058" title="ZhaoD , ZhaoX , GuoJ , WuL , XuN , HuoX , et al. Effects of cognitive behavioral therapy on social support system in schizophrenia patients [认知行为疗法改善精神分裂症患者社会支持系统的临床研究]. 中外健康文摘2014;5(22):66‐7. ZhaoX , ZhaoD , GuoJ , WuL . Clinical study of cognitive behavioral therapy combined with risperidone for social support system in patients with schizophrenia [认知行为疗法联合利培酮对精神分裂症患者社会支持系统进行干预的临床研究]. Gansu Science and Technology [甘肃科技]2013, (12):117‐20. ">Zhao 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: psychoeducation about symptoms and coping strategies to symptoms; cognition modification, and encouragement of social intercourse. </p> <p>Delivered by: five psychologists.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0059" title="ZhaoS , WangJ . Rehabilitation efficacy of cognitive behavioral therapy on chronic schizophrenia patients [认知行为治疗对慢性精神分裂症患者康复疗效的对照研究]. Chinese Journal of Trauma and Disability Medicine [中国伤残医学]2014;22(8):209‐10. ">Zhao 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: practicing daily life activity, recreation therapy, and cognition modification.</p> <p>Delivered by: not stated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0060" title="ZouH , WangF , LiZ , YaoX , ZhangL , FengY , et al. Cognitive behavioral therapy and exercise intervention for patients taking antipsychotic [认知行为治疗和运动干预对服用抗精神病药物患者影响的效果评价]. Chinese Nursing Management [中国护理管理]2013, (4):33‐6. ">Zou 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>√</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>✗</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Content: cognition modification, psychoeducation about disease, and physical exercise.</p> <p>Delivered by: nurses who had five years experience of CBT.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>√ = criteria fulfilled; ✗ = criteria not fulfilled; ? = unclear.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">More detailed description of interventions in the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcome categories</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These relate to meaningful changes in symptomatology and general clinical condition, recovery and well‐being. These outcomes include relapse, rehospitalisation, healthy days, or other clinical important change in global state. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mental state</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These refer to presence or absence of symptoms of psychosis as well as continuous measures relating to characteristics of such symptoms (e.g. preoccupation; conviction; frequency; duration; intensity, loudness; perceived interference with daily living) and insight. Measures of general affect (e.g. anxiety, depression, shame, hopelessness, anger; self‐esteem) and symptom‐related affect measures (e.g. voice‐related distress; delusional distress) are also considered. The presence or frequency of problematic behaviours (suicide attempts; deliberate self‐harm; violence to others, etc.) and functional and adaptive behaviours (e.g. increased coping strategies) are included. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All health interventions have the capacity for unintended and unwanted side effects. To date, there has been a paucity of studies that have attempted to identify adverse effects of psychological therapies. Such outcomes might include dependency, increased distress, increased family dysfunction, and disengagement from mental health services. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include changes in employment, occupational and educational status, level of received benefits or social welfare, perceived quality of life, and level of social functioning. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include changes in the general quality of life or specific aspects relevant to quality of life. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfaction with treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>These outcomes might include both recipients of care satisfied with treatment and carers' satisfaction with treatment. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Engagement with service</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The measurement of service utilisation and functional outcomes may convey important information regarding health economic benefits, as well as provide indirect markers of personal independence. Such outcomes might include number of acute hospital/inpatient respite days, number of acute hospital admissions or equivalent (e.g. home treatment/crisis team intervention; respite admissions), changes in legal status (MHA 1983), changes in level of care (including accommodation type and intensity of service (Assertive Outreach Team versus Community Mental Health Team)). These outcomes would also include alterations in the degree of compliance with the prescribed medication regimen, as well as alterations to the prescribed medication including changes in type of medication and prescribed dosage. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Economic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Direct costs of care and Indirect costs of care.</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcome categories</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Data added into generic inverse variance outcome (1.14)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>483</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>696</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>651</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Data added into generic inverse variance outcome (1.14)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Data added into generic inverse variance outcome (1.17)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0013" title="FreemanD , PughK , DunnG , EvansN , SheavesB , WaiteF , et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: The potential benefits of enhancing self confidence. Schizophrenia Research2014;160(1‐3):186‐92. ">Freeman 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007964-bbs2-0014" title="FreemanD , DunnG , StartupH , PughK , CordwellJ , ManderH , et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single‐blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry2015;2:305‐13. ">Freeman 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Data added into generic inverse variance outcome (1.17)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Data added into generic inverse variance outcome (1.23)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0026" title="JiaY , LouF , FengM . Cognitive behavioral nursing therapy for patients with schizophrenia. Journal of Nursing Science2005;20:10‐2. ">Jia 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>356</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>528</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0001" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [PUBMED: 11579006] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183:418‐26. [PUBMED: 14594917] ">Barrowclough 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0017" title="GranholmE , McQuaidJR , AuslanderLA , McClureFS . Group cognitive‐behavioral social skills training for older outpatients with chronic schizophrenia. Journal of Cognitive Psychotherapy2004;18:265‐79. GranholmE , McQuaidJR , McClureFS , AuslanderLA , PerivoliotisD , PedrelliP , et al. A randomized, controlled trial of cognitive behavioral social skills training for middle‐aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry2005;162:520‐9. GranholmE , McQuaidJR , McClureFS , LinkPC , PerivoliotisD , GottliebJD , et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12‐month follow‐up. Journal of Clinical Psychiatry2007;68:730‐7. McQuaidJR , GranholmE , McClureFS , RoepkeS , PedrelliP , PattersonTL , et al. Development of an integrated cognitive‐behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research2000;9(3):149‐56. ">Granholm 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0040" title="QianD . Efficacy of cognitive behavioral interventions for the rehabilitation of patients with schizophrenia [认知行为干预对精神分裂症患者康复期的效果观察]. Journal of Medical Theory and Practice [医学理论与实践]2012;25(3):294‐5. ">Qian 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>740</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>696</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Data added into generic inverse variance outcome (1.23)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Data added into generic inverse variance outcome (1.26)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0030" title="李杰 . Cognitive therapy combined with clinical efficacy of ziprasidone treatment of schizophrenia and its impact on treatment compliance [认知疗法联合齐拉西酮治疗精神分裂症的临床疗效及对治疗依从性的影响]. Seek Medical and Ask the Medicine2013;11(6):111‐2. ">Li 2013a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0052" title="WangD , LiX , XuJ , YinG , ChenS . A comparison of clinical study of schizophrenia with and without cognitive behavior therapy [认知行为治疗精神分裂症患者临床对照研究]. China Medical Herald [中国医药导报]2008;5(28):39‐40. ">Wang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>273</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0007" title="ChenL , YaoH , LiX . CBT in the treatment of refractory auditory hallucinations of schizophrenia: a comparative study [CBT治疗精神分裂症顽固性幻听疗效的对照研究]. Journal of Qiqihar Medical College [齐齐哈尔医学院学报]2015;36(14):2063‐5. ">Chen 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0023" title="HuC . Clinical studies of cognitive behavioral therapy combined with medication for residual schizophrenia [认知行为联合药物治疗精神分裂症残留型40例临床研究]. Journal of Community Medicine [社区医学杂志]2013;8:17‐9. ">Hu 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0042" title="QiuL , WangJ , WuY , LiuD , ZhuD . Short‐term efficacy of cognitive‐behavioral therapy in female first‐episode paranoid schizophrenia [认知行为治疗对女性首发偏执型精神分裂症的早期疗效观察]. Journal of Chinese People's Health [中国民康医学]2014;26(5):15‐7. ">Qiu 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0047" title="TarrierN , KellyJ , MaqsoodS , SnelsonN , MaxwellJ , LawH , et al. The cognitive behavioural prevention of suicide in psychosis: a clinical trial. Schizophrenia Research2014;156(2‐3):204‐10. ">Tarrier 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>435</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0002" title="BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviours2009;34(10):859‐66. [PUBMED: 19362429] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical research ed.)2010;341:c6325. [PUBMED: 21106618] BerryK , AllottR , EmsleyR , EnnionS , BarrowcloughC . Perceived empowerment in people with a dual diagnosis of schizophrenia spectrum disorder and substance misuse. Social Psychiatry and Psychiatric Epidemiology2014;49(3):377‐84. [PUBMED: 24141697] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [PUBMED: 25962788] BerryK , GreggL , Vasconcelose Sa D , HaddockG , BarrowcloughC . Staff‐patient relationships and outcomes in schizophrenia: the role of staff attributions. Behaviour Research and Therapy2012;50(3):210‐4. [PUBMED: 22325807] HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: a study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [PUBMED: 22088611] ">Barrowclough 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0003" title="BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. ">Barrowclough 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0004" title="BirchwoodM , MichailM , MeadenA , LewisS , DaviesL , DunnG , et al. The MRC command trial: results of a multi‐centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. Schizophrenia Research2014;153:S74. BirchwoodM , MichailM , MeadenA , TarrierN , LewisS , WykesT , et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet Psychiatry2014;1(1):23‐33. BirchwoodM , PetersE , WykesT , TarrierN , LewisS , DunnG , et al. A multi‐centre randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry2011, (11):155. ISRCTN62304114 . A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations. isrctn.com/ISRCTN62304114 (accessed 27 March 2008). ">Birchwood 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0011" title="FarhallJ , FreemanNC , ShawyerF , TrauerT . An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology2009;48:47‐62. ">Farhall 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0015" title="GaretyPA , FowlerDG , FreemanD , BebbingtonP , DunnG , KuipersE . A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry2008;192:412‐23. KuipersE , Kuipers . The role of CBT in relapse prevention of schizophrenia. Schizophrenia Research2012;136(Suppl.1):S58‐9. ">Garety 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0019" title="DurhamRC , ChambersJA , PowerKG , SharpDM , MacdonaldRR , MajorKA , et al. Long‐term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technology Assessment2005;9(42):1–174. GumleyA , KaratziasA , PowerK , ReillyJ , McNayL , O'GradyM . Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self‐esteem. British Journal of Clinical Psychology2006;45:247‐60. GumleyA , O'GradyM , McNayL , ReillyJ , PowerK , NorrieJ . Early intervention for relapse in schizophrenia: results of a 12‐month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine2003;33:419‐31. ">Gumley 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0029" title="LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry2002;181(S43):S91‐7. TarrierN , HaddockG , LewisS , DrakeR , GreggL . Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research2006;83(1):15‐27. TarrierN , LewisS , HaddockG , BentallR , DrakeR , KindermanP , et al. Cognitive‐behavioural therapy in first‐episode and early schizophrenia. British Journal of Psychiatry2004;184:231‐9. ">Lewis 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0043" title="RectorNA , SeemanMV , SegalZV . Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research2003;63:1‐11. ">Rector 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0054" title="WangZ , GuoZ , HanG , WangJ , LiZ . Efficacy of cognitive‐behavioral therapy in community schizophrenia patients [认知行为治疗对社区精神分裂症患者的疗效]. China Journal of Health Psychology [中国健康心理学杂志]2015;23(1):16‐9. WangZ , GuoZ , WangJ , YanG , HanG , LiZ . Effects of normalized cognitive‐behavioral therapy on quality of life and social function in community residual schizophrenia patients [规范化认知行为治疗对社区残留型精神分裂症患者生活质量和社会功能的影响]. Journal of Neuroscience and Mental Health [神经疾病与精神卫生]2014;14(5):494‐6. ">Wang 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>647</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>601</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Data added into generic inverse variance outcome (1.26)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007964-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Data added into generic inverse variance outcome (1.36)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>CBT group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Standard care group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Short term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0037" title="NaeemF , SaeedS , IrfanM , KiranT , MehmoodN , GulM , et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophrenia Research2015;164(1‐3):143‐8. ">Naeem 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Medium term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Long term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007964-bbs2-0020" title="GuoZ , LiZ , MaY , ZhouY , ChaoW , GuoJ , et al. Short‐term cognitive‐behavioral treatment combined with regular therapy on community schizophrenia patients: preliminary observation of efficacy [短程认知行为治疗联合常规治疗对社区精神分裂症患者疗效的初步观察]. Chinese Journal of Psychiatry [中华精神科杂志]2015;48(6):331‐8. ">Guo 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Data added into generic inverse variance outcome (1.36)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/full#CD007964-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1a. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.04, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.39, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.61, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 1b. Relapse (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 2. Clinically important change (no improvement) ‐ defined by individual studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.61, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.39, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Global state: 3a. Rehospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.60, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Global state: 3b. Hospitalisation ‐ number of admissions (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Global state: 4. Average endpoint total score CGI, high = poor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.63, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐0.89, ‐0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐1.07, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 1. General ‐ clinically important change (no improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.21, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.65, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mental state: 2a. General (average total endpoint score BPRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.09 [‐8.44, ‐1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.57 [‐5.73, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.77 [‐14.08, ‐3.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mental state: 2b. General (average total endpoint score PANSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>962</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.21 [‐10.12, ‐4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>963</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.68 [‐6.12, ‐1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.74 [‐6.46, ‐1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 2c. General (average total endpoint score PsyRAT, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [‐1.20, 3.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [‐1.48, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mental state: 2d. General (average total change score, various scales) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 CHOICE ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.10 [1.74, 16.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 CPRS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [‐0.97, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 2e. General (average total endpoint score SCL‐90, high = poor) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 3a. Specific ‐ positive symptoms (average endpoint score PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.11 [‐4.97, ‐1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.23 [‐1.90, ‐0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.98 [‐1.63, ‐0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mental state: 3b. Specific ‐ positive symptoms (average endpoint score BPRS/SAPS, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 BPRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.84 [‐3.40, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 SAPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐3.61, ‐0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mental state: 4a. Specific ‐ hallucination ‐ clinically important change (no improvement ‐ &lt; 3 point improvement BPRS (hallucination severity score)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.03, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.03, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Mental state: 4b. Specific ‐ hallucination (average endpoint score various scales, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 AHRS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.60 [‐6.74, ‐0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 PANSS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.92, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 AHRS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.57 [‐7.07, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4 PANSS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.79, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.5 Malevolence ‐ BAVQ ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [‐5.26, 7.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.6 Omniscience ‐ BAVQ ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐3.47, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.7 VPD ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.10 [‐15.73, ‐6.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.8 AHRS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.40 [‐6.60, ‐2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.9 PANSS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.30, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.10 BPRS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.82 [‐3.74, ‐1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Mental state: 4c. Specific ‐ hallucinations (average endpoint score, PsyRATs, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Mental state: 4d. Specific ‐ hallucinations (average endpoint score various scales, high = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 PsyRATs ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 PsyRATs ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3 BPRS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.4 VCS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.5 VCS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mental state: 5a. Specific ‐ delusions (average endpoint score, PsyRATs , high = poor)) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.33 [‐7.58, ‐1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Mental state: 5b. Specific ‐ delusions (average endpoint score PANSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.16, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.71, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.53, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Mental state: 5c. Specific ‐ delusions (average change score PsyRATs, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐1.82, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Mental state: 5d. Specific ‐ delusions (average endpoint score PsyRATS, high = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Mental state: 6a. Specific ‐ negative symptoms (average endpoint score, PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.35 [‐3.84, ‐2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.43 [‐1.94, ‐0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.47 [‐1.94, ‐0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Mental state: 6b. Specific ‐ negative symptoms (average endpoint score SANS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.11 [‐10.40, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.07 [‐3.29, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Mental state: 6c. Specific ‐ negative symptoms (average endpoint score NSRS, high = poor) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.05, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Mental state: 7a. Specific ‐ affective symptoms (average enpoint score, PANSS subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.86 [‐5.75, ‐3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.70, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐1.82, ‐0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Mental state: 8. Specific ‐ distress (average endpoint score PsyRATs/SADS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐1.77, ‐0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.50, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.47, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Mental state: 9. Specific ‐ anxiety (average endpoint score various scales, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 BAI ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐5.40, 4.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.2 SAS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.21 [‐7.36, ‐5.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.3 HAMA ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.79 [‐2.29, ‐1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.4 SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.43 [‐1.53, ‐1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.5 BAI ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.34 [‐6.55, 3.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.6 BAI ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [‐1.19, 4.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.7 HADS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [‐1.22, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Mental state: 10a. Specific ‐ depression ‐ clinically important change (no improvement = reduction HAMD score &lt; 25%) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.21, 2.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Mental state: 10b. Specific ‐ depression (average endpoint score various scales, high = poor) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 BDI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.11 [‐4.25, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.2 SDS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.29 [‐4.40, ‐2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.3 HAMD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.95 [‐6.69, ‐3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.4 SCL‐90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐0.65, ‐0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Mental state: 10c. Specific ‐ depression (average change score MADRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐1.26, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Mental state: 10d. Specific ‐ depression (average endpoint score various scales, high = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 CDS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.2 CDS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.3 BDI ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.4 HAMD ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.5 MADRS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.6 BDI ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.7 CDS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.8 HADS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.9 HAMD ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Mental state: 11a. Specific ‐ self esteem (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.1 RSES ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐1.43, 2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.2 SES ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.29 [2.43, 4.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.3 RSCQ ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.29 [‐0.08, 16.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.4 GSES ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.05, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.5 RSES ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐0.79, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.6 RSCQ ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐7.46, 8.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.7 SERS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.90 [1.25, 32.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.8 GSES ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.53, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.9 RSES ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐1.79, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.10 RSCQ ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.23 [‐8.56, 21.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Mental state: 11b. Specific ‐ self esteem (average endpoint score various scales) ‐ short term (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 SCS (high = good)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.2 positive self ‐ BCSS (high = good)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.3 negative self ‐ BCSS (high = poor)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Mental state: 12a. Specific ‐ insight (average endpoint score various scales, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 ITAQ ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.92 [3.19, 6.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 BCIS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [‐1.24, 3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.3 ITAQ ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐2.97, 2.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.4 SRIS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐1.30, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.5 BCIS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐3.70, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.6 ITAQ ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐2.20, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Mental state: 12b. Specific ‐ insight (average endpoint score SAI, high = good) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.50 [5.84, 7.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.6 [‐0.19, 3.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.9 [0.96, 4.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Mental state: 12c. Specific ‐ insight (average change score SAI, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐1.41, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Mental state: 13. Specific ‐ well‐being (average endpoint score WEMWS, high = good) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.08 [0.90, 7.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Mental state: 14a. Specific ‐ various other symptoms (average endpoint score various scales high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 Psychotic symptom ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐0.72, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 Somatization ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.86 [‐1.98, ‐1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.3 Sensitivity of interpersonal relationship ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐1.19, ‐1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.4 Obsessive‐compulsive ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.29 [‐1.36, ‐1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.5 Hostility ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.84 [1.00, ‐0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.6 Phobia ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.61, ‐0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.7 Paranoia ‐ SCL‐90 ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐0.80, ‐0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.8 Paranoia ‐ GPTS ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.32 [‐22.97, ‐3.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.9 Worry ‐ PSWQ ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.70 [‐7.12, ‐0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.10 Rumination ‐ PTQ ‐ short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.40 [‐8.96, ‐1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.11 Hopelessness ‐ BHS ‐ medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.56 [‐1.93, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.12 Hopelessness ‐ BHS ‐ long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [‐0.54, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Mental state: 14b. Specific ‐ various other symptoms (average endpoint score SCL‐90, high = poor) ‐ long term (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.1 anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.2 depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.3 psychotic symptom</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.4 somatization</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.5 sensitivity of interpersonal relationship</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.6 obsessive‐compulsiive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.7 hostility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.8 paranoid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.9 phobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Adverse effect/event(s): 1a. General ‐ any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.27, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Adverse effect/event(s): 1b. General (average total endpoint score TESS, high = poor) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐1.43, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Adverse effect/event(s): 2a. Specific ‐ various effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 Drowsiness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.05, 5.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.2 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 16.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.3 Mild lactation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.01, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.4 Opsomenorrhea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Adverse effect/event(s): 2b. Specific ‐ suicide attempt <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.84, 4.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Adverse effect/event(s): 2c. Specific ‐ death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.38, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.1 Any cause</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.38, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Functioning: 1. General (average endpoint score GAF, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐5.82, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.37 [‐1.66, 8.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [‐1.95, 5.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 Functioning: 2a. Social (average endpoint score ILSS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.02, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 Functioning: 2b. Social (average endpoint score SFS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.80 [1.85, 9.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.88 [1.99, 11.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 Functioning: 2c. Social (average endpoint score SOFAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>49.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [‐4.40, 6.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>49.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐8.02, 6.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>49.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [‐2.64, 3.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 Functioning: 2d. Social (average endpoint score PSP, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>50.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.96 [3.15, 12.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>50.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.23 [2.91, 11.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>50.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.66 [8.65, 16.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 Functioning: 2e. Social (average endpoint score UPSA, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.10, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.07, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 Functioning: 3. Life skills (average endpoint score LSP, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>52.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.32 [‐8.40, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">53 Functioning: 4a. Cognitive ‐ overall (average total endpoint score WCST, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>53.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐8.89, 8.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>53.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.80 [‐17.76, ‐1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">54 Functioning: 4b. Cognitive ‐ memory (average endpoint score WMS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>54.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.33 [1.54, 17.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">55 Functioning: 4c. Cognitive ‐ memory (average endpoint score CMS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐7.42, 8.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐6.24, 8.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">56 Functioning: 4d. Cognitive ‐ various (average endpoint score MCCB, high = poor) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.1 Continuous performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐44.10 [‐52.40, ‐35.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.2 Mood management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐2.15, ‐1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.3 Sematic influencing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.40 [‐4.63, ‐0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.4 Verbal memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.80 [‐5.06, ‐0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.5 Visual memory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.60 [‐5.64, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">57 Functioning: 5. Intelligence (average endpoint score WAIS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>57.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.89 [‐2.43, 12.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>57.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.83 [9.27, 14.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">58 Functioning: 6. Disability (average endpoint score WHODAS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.52 [‐14.65, ‐6.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">59 Quality of life: 1a. General (average total endpoint score various scales, high = good) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.1 QLS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐10.63, 6.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.2 WHOQOL‐BREF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.64 [‐1.36, 14.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">60 Quality of life: 1b. General (average total endpoint score various scales, high = good) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>60.1 WHOQOL‐BREF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.20 [0.66, 15.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">61 Quality of life: 1c. General (average total endpoint score various scales, high = good) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>61.1 QLS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.60 [‐11.32, 4.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>61.2 GQOLI‐74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.82 [1.62, 4.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>61.3 WHOQOL‐BREF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.85 [1.01, 16.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>61.4 EuroQOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.50 [‐10.65, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">62 Quality of life: 1d. General (average total endpoint score SQLS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>62.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐29.5 [‐40.28, ‐18.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">63 Quality of life: 2a. Specific ‐ physical (average endpoint score WHOQOL‐BREF, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [‐1.01, 4.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [0.20, 5.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [0.11, 5.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">64 Quality of life: 2b. Specific ‐ physical (average endpoint score GQOLI‐74, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>64.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.69 [9.62, 17.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">65 Quality of life: 3a. Specific ‐ psychological (average endpoint score WHOQOL‐BREF, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>65.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.22 [0.28, 4.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>65.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.52 [0.71, 4.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>65.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.37 [0.56, 4.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">66 Quality of life: 3b. Specific ‐ psychological (average endpoint score GQOL‐74, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>66.1 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.03 [13.07, 20.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">67 Quality of life: 3c. Specific ‐ psychological (average endpoint score SQLS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>67.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.26 [‐5.19, 2.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">68 Quality of life: 4a. Specific ‐ various other aspects (average endpoint score WHQOL‐BREF, high = good) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>68.1 Environment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [‐1.71, 5.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>68.2 Social relationship</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [‐0.62, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">69 Quality of life: 4b. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>69.1 Environment (WHOQOL‐BREF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [‐0.21, 5.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>69.2 Physical functioning (SF‐36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>22.30 [17.65, 26.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>69.3 Role emotional (SF‐36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>26.9 [19.74, 34.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>69.4 Role physical (SF‐36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>31.20 [25.94, 36.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>69.5 Social relationship (WHOQOL‐BREF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐0.60, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">70 Quality of life: 4c. Specific ‐ various other aspects (average endpoint score various scales, high = good) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>70.1 Environment (WHOQOL‐BREF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [‐0.31, 5.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>70.2 Social function (GQOLI‐74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.19 [11.72, 20.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>70.3 Social relationship (WHOQOL‐BREF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [‐0.55, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">71 Quality of life: 4d. Specific ‐ various aspects (average endpoint score various scales, high = poor) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.1 Insight / treatment attitude (SQLS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.14 [1.96, 4.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.2 Motivation / vitality (SQLS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.43 [‐5.45, ‐1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.3 Social function (SDSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.51 [‐2.34, ‐0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.4 Symptoms / side effects (SQLS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐2.76, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">72 Quality of life: 5a. Specific ‐ psychological (average endpoint score SQLS, high = poor) ‐ medium term (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">73 Quality of life: 5b. Specific ‐ role functioning (average endpoint score QLS, high = good) ‐ long term (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">74 Quality of life: 5c. Specific ‐ symptoms/side effects (average endpoint score SQLS, high = poor) ‐ medium term (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">75 Satisfaction with treatment: 1. Leaving the study early ‐ for any reason <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.77, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.74, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1945</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.77, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">76 Engagement with services: 1a. Compliance to medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.81, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [1.02, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [1.10, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">77 Engagement with services: 1b. Refusing treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>77.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.18, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">78 Engagement with services: 1c. Compliance with medication (average endpoint score MARS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>78.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.41, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>78.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>38.02 [33.48, 42.56]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">COMPARISON 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SENSITIVITY ANALYSIS 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE (NON‐BLIND OUTCOME ASSESSMENT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 With non‐blind outcome assessment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Without non‐blinded outcome assessment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 With non‐blind outcome assessment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.65, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Without non‐blind outcome assessment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SENSITIVITY ANALYSIS 1: CBT+ STANDARD CARE versus STANDARD CARE ALONE (NON‐BLIND OUTCOME ASSESSMENT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 With less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.38, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Without less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.41, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 With less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Without less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>957</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.76, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 2. Clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 With less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.39, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Without less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.25, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 With less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.65, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Without less‐well defined CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.50, 1.33]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SENSITIVITY ANALYSIS 2: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS‐WELL DEFINED CBT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 With less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.38, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Without less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.41, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 With less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Without less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.64, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 2. Clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 With less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.39, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Without less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.25, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 With less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.21, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Without less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.11, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 1. General ‐ clinically important change (no improvement) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 With less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.65, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Without less‐experienced therapist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.80, 1.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SENSITIVITY ANALYSIS 3: CBT+ STANDARD CARE versus STANDARD CARE ALONE (LESS EXPERIENCED THERAPIST)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SENSITIVITY ANALYSIS 4: CBT+ STANDARD CARE versus STANDARD CARE ALONE (ASSUMATPION FOR MISSING DATA)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 With assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Without assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.72, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mental state: 1. General ‐ clinically important change (no improvement) ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 With assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.21, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Without assumption</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.19, 0.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SENSITIVITY ANALYSIS 4: CBT+ STANDARD CARE versus STANDARD CARE ALONE (ASSUMATPION FOR MISSING DATA)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SENSITIVITY ANALYSIS 5: CBT+ STANDARD CARE versus STANDARD CARE ALONE (IMPUTED VALUES)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1a. Relapse ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 With imputed values</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.04, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Without imputed values</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.69]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SENSITIVITY ANALYSIS 5: CBT+ STANDARD CARE versus STANDARD CARE ALONE (IMPUTED VALUES)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007964-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SENSITIVITY ANALYSIS 6: CBT+ STANDARD CARE versus STANDARD CARE ALONE (RANDOM EFFECT MODEL)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 2. Clinically important change (no improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.61, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.40, 0.85]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SENSITIVITY ANALYSIS 6: CBT+ STANDARD CARE versus STANDARD CARE ALONE (RANDOM EFFECT MODEL)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007964.pub2/references#CD007964-tbl-0016">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007964.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007964-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007964-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007964-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD007964-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD007964-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD007964-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007964-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007964\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007964\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007964\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007964\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007964\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007964.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007964.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007964.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007964.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007964.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717407146"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007964.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717407150"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007964.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db7242f519365',t:'MTc0MDcxNzQwNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 